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Abstract 
Shigella flexneri is a pathogen capable of invading the colonic epithelium causing 
shigellosis or bacillary dysentery. World Health Organisation estimates that there are over 
a billion cases of diarrhea and dysentery, annually, making the development of vaccine 
against the different Shigella serotypes a WHO priority [WHO., 1991 #529][WHO, 1997 
#96]. SW is a temperate bacteriophage capable of mediating S. flexneri 0-antigen 
modification that confers serotype -conversion from Y to 5a. Aside from its role in 
serotype -conversion, little is known about its biology. The genetic composition of phage 
SW needs to be examined in the prospect of discovering other phage- encoded factors which 
may have greater role in conferring virulent traits. In this project, we have endeavoured to 
further characterise the SW genome beyond the serotype -conversion gene region. 
To proceed with the molecular characterisation of the SW genome, the 10.1 kb BamHI 
fragment A region adjacent to the pac site was sequenced using a direct DNA sequencing 
approach which employed cloning and primer walking combined with Southern 
hybridisation techniques. Initially, universal forward and reverse primers were used to 
sequence both strands of the pNV728 insert which carries the initial 5.5 kb portion of SW 
BamHI fragment A. Afterwhich, the gaps were filled through primer walking using 
customised primers. The DNA beyond pNV728 SadI site was sequenced from 
overlapping fragments detected by probes containing pNV728 nucleotide sequences 
adjacent to the SacI site. A total of 54 input sequences were assembled to derive the 10109 
bases of SW BamHI fragment A. 
Analysis of the 10.1 kb sequence revealed the presence of 1 incomplete and 13 complete 
open reading frames. Based on database homology search and comparative analysis 
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between fragment A open reading frames and the non -redundant protein database, this 
region was found to encode for gene products which share homology to essential major and 
minor structural proteins of bacteriophages, primarily of the family Siphoviridae. Of the 
14 open reading frames predicted, eight were deduced as encoding for the putative 
termínase subunits, the portal protein, protease, head protein and tail assembly 
components. 
Functional studies of orf200 and orf409 were performed to ascertain their identity. 
Preliminary Western immunoblotting and amino acid sequencing results indicated ORF409 
product as the capsid protein. N- terminal amino acid sequence of the 32 kDa phage SfV 
protein band H, AQGVAQDEKG, was located internal to the ORF409 predicted amino 
acid sequence suggestive of ORF409 processing as part of the head protein maturation. 
This process was demonstrated through experiments involving recombinant constructs, one 
carrying the 2055 bp complete orf200 and complete orf409 insert (B876) and the others 
carrying the 1616 bp incomplete orf200 and complete orf409 insert (B877 and B878). 
Overexpression of B877 and B878 by IPTG induction revealed the accumulation of the 
45.8 kDa ORF409 capsid protein which was not observed in B876. The experiments 
suggest that a complete functional ORF200 protease is required to mediate cleavage of the 
ORF409 capsid protein to its mature 32 kDa form. A similar head morphogenetic pathway 
was observed in other bacteriophages including Pseudomonas phage D3, Streptomyces 
phage C31 and coliphage 197. In addition, the striking similarity in the organisation of 
the DNA packaging and head assembly genes among bacteriophages, supports not only the 
designation of o;1200 and orf409 as the protease and capsid genes, respectively, but also 
that of the putative orf577 terminase and orf367 portal protein genes. The cluster 
arrangement of these genes denotes a well conserved organisation reflective of their 
movement as a single module during gene transfer and its origin from a common ancestral 
source. 
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In order to assess the role of phage SfV genome in host S. flexneri virulence, a SW lysogen 
strain wild -type serotype Y strain carrying bacteriophage SW, a SW cured serotype 5a 
strain, and recombinant SFL1339 strains carrying different segments of the SW genome 
were produced. These strains were compared based on their ability to invade HeLa cells. 
The invasion level of the lysogen strain SFL1338 was significantly higher than the invasion 
level of its serotype Y parental strain SFL1339, and the invasion level of the cured strain 
SFL1337 was significantly lower compared to the level detected for its serotype 5 parental 
strain SFL1336. These results suggest that the SN genome is enhancing the invasive 
potential of S. flexneri. To investigate which portions of the genome are most responsible 
for the observed increase in cell invasion, isogenic SFL1339 strains were produced 
containing various SW genomic segments. SFL1346 containing the serotype- conversion 
genes gtrAM, gtrB,,,,, and gtrV showed the most significant difference to the invasion level 
of the control strain SFL1342 containing only the vector. These experiments implicated 
that the three -gene cluster was the only SN gene locus effective in enhancing bacterial 
invasiveness. Further studies were conducted to determine if the invasion level of SFL1346 
would decrease upon the disruption of the glucosyltransferase gene, gtrV. Plasmíd 
pNV731 was mutated by inducing a frameshift mutation in the gtrV gene, then transformed 
into SFL1339, designated as SFL1394. The invasion level of SFL1394 compared with 
SFL1342 and SFL1346, showed partial reduction in its invasive capabilities, suggestive of 
the influence of gtrAM, and gtrBM, in conferring S. flexneri invasive traits. 
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I INTRODUCTION 
CHAPTER 1 
Introduction 
Shigellosis or bacillary dysentery, is a disease of major public health concern particularly 
in developing countries where the mortality rate is high [Kotloff, 1999 #193]. The World 
Health Organization (WHO) has estimated an annual morbidity of 200 million people 
worldwide with at least 650,000 deaths among young children [WHO, 1997 #96]. 
Shigella species are the etiological agent isolated in approximately 10 -20% of acute 
diarrhoeal episodes worldwide [Kotloff, 1999 #193]. Children under five years of age are 
most susceptible due to undeveloped immune response against Shigella, exacerbated by 
the effects of malnutrition, poor sanitation and lack of clean water [Black, 1993 
#43][Cohen, 1991 #528]. Adding to this problem is the increasing level of antibiotic 
resistant strains isolated in many countries [Brito -Alayon, 1994 #531][Lin, 1992 #532]. 
As early as 1969, severe outbreaks of Shigella dysentertae type 1 carrying plasmids 
conferring resistance to tetracycline, streptomycin, chloramphenicol and sulphonamides 
have been reported [Mata, 1969 #533]. Due to the urgency of the problem, WHO has 
been focusing on the development of an effective vaccine against Shigella [WHO., 1987 
#534]. Mass immunisation against Shigella would be an economical alternative to the 
prevention of Shigellosis, if widely and properly administered. Recently, a live 
attenuated Shigella flexneri Y strain (SFL124) with an aroD gene deletion, was developed 
and has been shown to be effective among simian and human volunteers [Karnell, 1992A 
#17][Karnell, 1992B #81]. This was followed by studies involving the use of SFL124 in 
16 
the development of a recombinant vaccine strain which would express various S. flexneri 
serotypes, after realising that immunity to S flexneri is serotype specific [Lindberg, 1993 
#13][Hale, 1992 #535][Mavris, 1997 #16][Verma, 1993 #116][Huan, 1995 #15][Guan, 
1998 #11][Adhikari, 1999 #112][Adams, 2001 #523]. 
1.1. Genus Shigella 
Shigella is a gram -negative, non -motile, nonsporulating, bacteria which can be either an 
aerobe or facultative anaerobe. Their cultural and biochemical characteristics indicate that 
they are most closely related to E. coli [Koneman, 1988 #363]. The genus Shigella is 
divided into four main species based on antigenic and biochemical characteristics. These 
are S. dysenteriae (subgroup A), S. flexneri (subgroup B), S. boydii (subgroup C), and S. 
sonnei (subgroup D). Some of the more important distinguishing biochemical 
chareacteristics of the four Shigella species are presented below (Table 1.1). 
Table 1.1. Biochemical Characteristics of Species within the genus Shigella 
(Modified from Koneman, 1988) 
S. dysenteriae S. flexneri S. boydii S. sonnei 
Serogroup A B C D 
Glucose + + + + 
Lactose - 
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Raffinose 
Sucrose 
Xylose 
Indole production 
(3- galactosidase 
Ornithine decarboxylase 
1.2. Shigellosis 
S. dysenteriae S flexneri 
+/- 
+/- 
S. boydii S. sonnet 
+/- 
+/- +/- 
Shigellosis or bacillary dysentery is an acute infectious disease of the large bowel. The 
most common early symptoms are fever, watery diarrhea and cramping abdominal pain 
[Carpenter, 1982 #364]. Fluid and electrolyte losses also occur due to the enterotoxin 
acting on the intestinal cells. The dysentery phase of illness then follows, this is 
characterised by the presence of blood, pus, and mucus in the feces and the onset of 
stool straining (tenesmus), suggesting penetration of bacteria into the colonic epithelium. 
Patients excrete the organisms in the feces throughout the acute phase of the disease and 
for about 4 weeks post recovery. This poses a potential source of infection to others 
since the principal cause of Shigella infection is food or drinking water contaminated with 
intestinal discharges of infected patients [Mosley, 1962 #365]. 
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Shigella can initiate infection from a small infective dose of 10 -100 organisms and spread 
easily in situations where sanitation or personal hygiene is poor [Mims, 1998 #366]. S. 
dysenteriae is the most virulent serotype since it produces a toxin called Shiga toxin which 
has enterotoxic, cytotoxic and neurotoxic effects [Olsnes, 1980 #367]. Similar toxins are 
also produced by some strains of S. flexneri, S. sonnei, and E. coli strains expressing 
Shiga -like toxins, that are related antigenically to Shiga toxin [Keusch, 1977 #368][0' 
Brien, 1982 #369]. S. sonnei may also undergo antigenic shifting from form I (S) to form 
II (R), this effects the somatic antigen and is attributed to the presence of a 120 
megadaltonplasmid [Kopecko, 1980 #370]. 
1.3. Epidemiology 
Shigella infection accounts for 200 million diarrheal cases annually, with children under 
the age of 5 being the most susceptible [WHO, 1997 #96]. In fact, a recent study 
reported that 69% of all episodes and 61% of all deaths caused by shigellosis involved 
children under 5 years of age [Kotloff, 1999 #193]. 
Bacillary dysentery occurs in most parts of the world but with greatest frequency in 
Asia, Africa and Central America where it is endemic and occasionally epidemic [Mata, 
1969 #373][Rahaman, 1975 #374][Gross, 1979 #375][Khan, 1985 #383][El -Rafie, 1990 
#384] [Adkins, 1987 #385][Black, 1982 #386][Katouli, 1990 #387]. S. sonnei was the 
predominant organism isolated from Asia, Africa, and Central America and is also 
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common in diarrheal disease in industrialised countries like the United States [Black, 1978 
#376]. In industrialised countries, S. boydii, S. dysenteriae, S. flexneri, and S. sonnet 
were isolated in 2 %, 1 %, 16% and 77 %, respectively, while for developing countries 
the percentage of cases was divided at 6 %, 6 %, 60% and 15 %, respectively [Kotloff, 
1992 #89]. The most predominant serotype of S. flexneri is the 2a type. Other 
serotypes were also isolated such as lb, 3a, 4a and 6. 
Epidemiological surveys in developing countries have shown increasing isolation of 
Shigella strains which are resistant to antimicrobial therapeutic drugs such as sulfonamide, 
tetracycline, ampicillin, and trimethoprim -sulfamethoxazole [Sack, 1997 #388]. For 
example, outbreaks of Shigella dysenteriae serotype 1 in developing countries have been 
observed with the emergence of multi - antibiotic resistant strains, due to indiscriminate 
use of antimicrobial agents [Macaden, 1980 #378][Murray, 1986 #379]. Therefore, 
development of an efficacious Shigella vaccine against the common serotypes would 
assist the existing prevention measures and antibiotic treatment which cannot adequately 
control shigellosis. 
1.4. Pathogenesis 
The initial step in Shigella pathogenesis is bacterial invasion via penetration of the colonic 
mucosa. The point of entry is the gut membranous epithelial cells (M cells) in the 
follicular epithelium that overlie the lymphoid follicles [Sansonetti, 1999 #3891[Neutra, 
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1999a #188]. M cells are the preferred adhesion and transport sites of microorganisms 
rather than the apical pole of the gut epithelial lining since the former have scarce mucus 
covering, no brush border microvilli and have poor production of glycocalyx which 
allows enhanced physical contact between the pathogen and the M cell membrane 
[ Neutra, 199911 #390][Jepson, 1998 #391]. Following adhesion to M cells, actin and 
myosin accumulate at the site of attachment in preparation for the internalisation of 
Shigella by phagocytosis [Clerc, 1987 #3921. An alternative pathway by which the 
bacteria can gain entry is by insertion of Shigella through the basolateral side of epithelial 
cells [Perdomo, 1994a #411. Responsive polymorphonuclear neutrophils (PMN) 
squeeze through adjacent cells creating a gap sufficient for Shigella entry into the 
basolateral side of the epithelium (Figure 1.1). 
The next step in the invasion process involves lysis of the phagocytic vacuole membrane, 
releasing the bacteria into the cytoplasm where it rapidly reproduces [Sansonetti, 1986 
#339][Kadurugamuwa, 1991 #3931. Bacteria located at the top of tightly packed actin 
filaments form protrusion which extend and penetrate into an adjacent cell, thus allowing 
passage of Shigella intercellularly without their release into the extracellular medium 
[Prevost, 1992 #394]. The presence of actin in cell movement was confirmed when 
treatment with cytochalasin D prevented polymerisation of actin monomers into 
filaments that also prevented Shigella spread, and when trails of labelled F -actin was 
shown at one pole of the bacteria [Bernardini, 1989 #135]. This movement of Shigella 
was termed Ics for intra- and intercellular spread, and is aided by the collection of actin 
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Figure 1.1. Shigella invasion of the colonic epithelium. A, Shigella enters through 
the basolateral side with the assistance of polymorphonuclear cells (PMN, dark blue) 
or through the apical M cell (light blue cell). B, Shigella survive and escape PMNs 
and macrophages of the lymphoid follicle by inducing apoptosis. C. Shigella can 
gain entry through the basal side by cell phagocytosis. D. Shige /la move around the 
cell cytoplasm with the aid of actin fibers (intracellular spread) and, E. migrate to 
adjacent cells through membrane protrusions (intercellular dissemination). F, Inva- 
ding bacteria instigate apoptosis leading to ulcerations of the intestinal epithelium. 
(Adapted from Pedromo et al. 1994 and Sansonetti, 1999a). 
filaments at one pole of the bacteria, as has been similarly observed for Listeria 
monocytogenes [Sansonetti, 1991 #82][Tilney, 1990 #3951. 
Phagocytosis of invasive Shigella by macrophages results in programmed cell death of the 
macrophage [Zychlinsky, 1992 #397]. Studies involving infection of Peyer's patches in 
a rabbit ligated loop model, showed numerous apoptotic cells when an invasive Shigella 
is inoculated compared to a non -invasive mutant, in which case apoptosis is only 
detected at background level [Zychlinsky, 1996 #396]. IpaB (invasion plasmid antigen 
B) is required for macrophage killing owing to its capacity to bind interleukin -lß (IL -1 f3) 
converting enzyme (ICE or caspase 1)[Chen, 1996 #398]. Binding of IpaB to the 
cysteine protease caspase 1 elicits cleavage of pro- IL -113, engagement of apoptosis and 
release of mature IL -1 f3 and other proinflammatory cytokines like TNFa, IL -6 and IL -1 
[ Sansonetti, 1995 #399]. 
Inflammation enhances polymorphonuclear leukocyte migration through the epithelium, 
loosening cellular junctions and promoting Shigella entry [Perdomo, 1994b #55]. Apical 
Shigella also stimulate influx of basal PIVINs by disrupting the epithelial lining and 
allowing basolateral invasion of epithelial cells [Beatty, 1997 #400]. Invasion of colonic 
epithelial cells triggers the expression of additional pro -inflammatory molecules 
(chemokines) such as IL -8 which aggravates inflammation by attracting more PMNs. 
This cycle of invasion and inflammation could explain the severity of colonic epithelium 
destruction which is characteristic of Shigellosis [Rout, 1975 #401]. 
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1.5. Virulence Factors. 
1.5.1. Plasmid -encoded Virulence Factors 
Shigella carry a large 220 kb virulence plasmid containing a 30 kb sequence [Maurelli, 
1985 #343] that encodes genes essential in the expression of invasive phenotype 
[Sansonetti, 1982 #349][Sansonetti, 1983 #4021 The mxi (membrane expression of 
antigens) and spa (secretion of protein antigens) operons encode type III secretion 
proteins that assemble into a flagellum -like structure and deliver Shigella effector proteins 
from the bacterial cytoplasm directly onto the surface or into the cytoplasm of epithelial 
cells [Menard, 1994 #346]. About 20 proteins are secreted through this assembly. The 
first set includes IpaB, IpaC and IpaD, proteins necessary for bacterial entry into the 
host cell [Clerc, 1987 #392]. The flow of proteins through the secretion tube is regulated 
by IpaB and IpaD. IpaB is also involved in forming a complex with IpaC which inserts 
into the eukaryotic cell membrane, creating a pore that serves to induce actin 
polymerisation via IpaC and inject proteins into the cell cytoplasm [Menard, 1993 
461] [Menard, 1994 #346]. The second set of proteins secreted by the type III secretan 
system include IpaA. IpaA can bind vinculin once injected into the cell, mediating 
maturation of the entry focus composed of a dense meshwork of actin filaments 
[Sansonetti, 1992 #24][Nhieu, 1997 #191. The compound Congo red was identified to 
fully activate the mxi -spa secretory system [Bahrani, 1997 #403]. 
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Other proteins encoded by the virulence plasmid are SepA, a serine protease which 
enhances inflammation of infected tissues and IcsA also known as VirG [Makino, 1986 
#404]. IcsA is a 120 kDa surface protein localised at one pole of the bacterial cells that 
helps to induce actin -dependent motility by binding vinculin and promoting the 
movement of the F -actin comet tail [Bemardini, 1989 #135]. The complete genetic 
composition and protein products of S. flexneri virulence plasmid pWRI00 were recently 
characterised. The study reported on 25 proteins secreted by the type III secretion 
apparatus and discovered that pWR100 had blocks of genes which were traced to be 
initially carried by four different plasmids [Buchrieser, 2000 #536]. 
1.5.2. Chromosome -encoded Virulence Factors 
There are several Shigella chromosomal virulence genes important for survival in the 
intestinal tissues and those that can regulate the expression of plasmid- encoded virulence 
genes. For example, the iucABCD and the iutA genes encode for the synthesis of 
aerobactin and its outer membrane receptor, respectively [Lawlor, 1984 #405][Griffiths, 
1985 #406]. Aerobactin is a hydroxamate siderophore used by Shigella flexneri for the 
transport of iron and whose role in virulence was studied in transposon- induced mutants 
[Lawlor, 1987 #4071. The sodB gene has a critical role in Shigella pathogenicity, since it 
encodes for a superoxide dismutase that protects Shigella from oxygen toxicity. soda 
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mutants were observed to be negative in the Sereny test and produced little detectable 
damage in ligated loops [Franzon, 1990 #408]. 
Other genes have been identified following transposon mutagenesis. The virR gene was 
found to be involved in temperature regulated invasion. Transduction of the virR:Tn10 
mutation to wild -type Shigella resulted in a strain that was invasive at both 30 °C and 
37 °C. The invasion genes were expressed at 37 °C but not at 30 °C in the wild -type strain 
[Maurelli, 1988 #409][Maurelli, 1984 #410]. The virR gene encodes for the histone -like 
protein Hl, which induces change in DNA supercoiling thereby modulating gene 
expression [Hulton, 1990 44111 Transposon insertion in the virulence associated 
chromosomal gene, vacB resulted in decreased invasion and absence of intercellular 
spread. This was attributed to decreased amounts of IcsA and IpaB in the vacB mutants 
[Tobe, 1992 #4121. 
The S. flexneri loci required for the biosynthesis of lipopolysaccharide (LPS) are alleles of 
the E. coli rfb and rfa loci involved in the expression of the LPS basal core and group 
somatic antigen, respectively [Formal, 1970 #4131[Okada, 1991b #414][Schnaitman, 
1993 #1101. LPS basal core synthesis, as specified by the rfa locus, starts with 2 -keto- 
3- deoxyoctonate -lipid A and to this, L- glycero -D- phosphate, D- glucose, D- galactose, 
and N- acetyl -D- glucosamine are sequentially added [Watanabe, 1984b #415]. 
Transposon insertion in the rfa locus increases the mobility of the core constituent of 
smooth S. flexneri 2a LPS, resulting in a mutant exhibiting delayed plaque formation and 
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Sereny reaction [Okada, 1991a #22]. This suggests that the structure of the LPS core 
affects the virulence of S. flexneri. The rfb locus encodes rhamnose synthetase, 
rhamnose transferase and N- acetylglucosamine transferase, which are all required for the 
synthesis of the 0-antigen repeating unit of the group 3,4 or Y variant antigen of S. 
flexneri serotypes la, 2a and 5a, respectively [Simmons, 1971 #416]. 
The individual repeat units of 0-antigen are transferred to a carrier lipid and polymerised 
by the rfc gene product. The completed 0-specific side chain is finally attached to the 
basal core structure by a translocase encoded by genes from both rfa and rfb loci 
[Simmons, 1987 #21 The chromosomal T locus was discovered as the integration site for 
incorporation of lysogenic phage encoding type -specific conversion genes. Invasion 
experiments on Y variants expressing only the 3,4 antigen showed decreased virulence 
[Timokov, 1970 #419]. 
Other chromosomal loci associated with Shigella virulence include the kcpA locus 
responsible for the regulation of bacterial motility plasmid gene virG (icsA) [Yamada, 
1989 #417], and the Shiga toxin stx gene. Mutants lacking kcpA showed a negative 
Sereny test with limited intracellular and intercellular bacterial spread in tissue culture 
monolayers [Makin, 1986 #404]. Conversely, the stx gene unique to S. dysenteriae 1 
encodes a potent cytotoxin that binds to Galctl -4 Gal[i (galabiose) glycolipid receptors. 
This binding results in the inhibition of mammalian protein synthesis due to cleavage of 
the N- glycosidic bond at adenine 4324 in 28S rRNA [Lindberg, 1987 #418]. Mutations 
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in the stx gene leads to a decrease in vascular damage in the colonic epithelium of orally 
challenged monkeys [Sekizaki, 1987 #420]. Also, culture filtrates of S. dysenteriae I 
have enterotoxigenic activity that causes fluid accumulation in ligated rabbit ileal loops 
[Eiklid, 1983 #421]. 
1.6. Immune Responses to Shigellosis 
LPS 0-antigens and the invasion plasmid antigens of the outer membrane surface have a 
prominent role in stimulating the immune system. This has been demonstrated in 
endemic countries where significantly higher anti -LPS and anti -Ipa serum titers were 
recorded in children between 2 -5 years of age [Oaks, 1986 #63]. These strong LPS and 
Ipa -specific antibody responses ware also observed among currently infected dysenteric 
patients [Lindberg, 1984 #422][Oberhelman, 1991 #4231. Patient convalescent sera 
contained antibodies recognising several plasmid- encoded polypeptides such as the 120 
kDa VirG protein product, the 78 kDa IpA, 62 kDa IpaB, 43 kDa IpaC and the 38 kDa 
IpaD protein [Hale, 1985 #345]. 
1.6.1. Mucosal Humoral Immunity 
The active "coproantibodies" of the intestinal secretory immune system were first 
observed in rabbits protected against dysentery after oral immunisation with killed 
Shigella dysenteriae 1 [Brandtzaeg, 1989 #425]. These coproantibodies were identified 
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in 1965, as the principal determinant of human humoral mucosal immunity and are 
known as secretory immunoglobulin (sIgA) [Brandtzaeg, 1989 #425]. Synthesis of sIgA 
has been shown to be triggered in response to several bacterial and viral antigens [Tomasi, 
1965 #426]. About half of the total antibody producing cells of the lymphoid system 
resides in the submucosa and an estimated 20 -30 IgA cells per IgG cell were found in the 
human gut mucosa [Mims, 1995 #427]. Prior to mucosal secretion, the sIgA dimer is 
complexed with a secretory piece that protects against proteolytic degradation. During 
mucosal infection, the submucosal sIgA enters the blood via the lymphatics to give 
increased serum IgA levels [Roitt, 1997 #526]. 
Local immunity to Shigella infection is characterised by the appearance of circulating 
antibody secreting cells in the peripheral blood and the production of Shigella specific 
sIgA, which can block interactions between the bacteria and the mucosa [Reed, 1971 
#39] [Oberhelman, 1991 #423] [Keren, 1989a #37] [Keren, 1989b #428]. Specific 
antibodies could also mediate antibody- dependent cellular immunity against Shigella 
[Lowell, 1980 #73]. In the mucosal gut- associated lymphoid tissue (GALT), precursor 
B and T lymphocytes are stimulated after exposure to antigen by antigen presenting cells 
(APC) and then migrate via the efferent lymphatics through to the systemic circulation. 
The lymphocytes enter the mucosal effector sites such as the lamina propia of the 
intestine, bronchi and the genitourinary tract, guided by homing receptor molecules. At 
these effector sites, B cells clonally expand and mature into IgA secreting plasma cells. 
This migration from IgA inductive tissues such as the GALT and MALT (mucosa 
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associated lymphoid tissue) to IgA effector sites is called the common mucosal immune 
system, and can be primed by oral or intranasal antigen administration [Roitt, 1997 
#526]. Local anti -Shigella antibody responses have also been detected in intestinal 
secretions of infected monkeys [Dinari, 1987 #441, dysenteric patients [Oberhelman, 
1991 #423] and in colostrum, breast milk, bile, saliva, and tears [Achi, 1992 
#430][Schultz, 1992 #431][Cleary, 1991 #125][Cleary, 1989 #432]. 
1.6.2. Systemic Humoral Immun ty 
Unlike IgA, IgG antibodies generated through natural infection or vaccination have been 
observed to be serotype -specific [Li, 1994 #4291[Cohen, 1991 #38][Cohen, 1992 #433]. 
This stresses the dominant role of LPS as the primary target antigen for protective 
immunity and is supported by studies performed on blood and fecal samples which show 
significantly high Shigella LPS -specific responses [Cohen, 1988 #62][Lindberg, 1991 
#434][Achi, 1994 #435][Cam, 1993 #436]. Also, antibody levels are observed to be 
kept elevated in endemic population due to repeated exposure to the microbe, resulting in 
subclinical infection and boosting the immune response. Studies have reported that 
protective host immune response to S. flexneri is raised against the 0-antigen component 
of the LPS stressing that immune response to 0-antigen is serotype- specific and protects 
against re- infection with an organism possessing the same serotype [Brahmbhatt, 1992 
#51][Hale, 1992 #9][Lindberg, 1993 #131. 
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According to Lindberg and Pal [Lindberg, 1993 #13], the role of Ipa- specific antibodies in 
host defence against dysentery is not clear since various trial results for Ipa -specific 
responses are not consistent. For example, very weak anti -Ipa responses were observed 
in monkeys vaccinated with an invasive E. coli strain expressing S. flexneri antigens 
[Oaks, 1986 #63]. However, in another study, strong responses comparable to 
infections with wild -type strain were noted in monkeys vaccinated with S. flexneri 
vaccine candidate strain that is unable to spread intercellularly [Sansonetti, 1991 
#82][Sansonetti, 1989 #4371. Interesting findings were also noted during immunogenicity 
trials using an attenuated AaroD S. flexneri Y strain, it was observed that significant LPS 
specific responses were evident with or without previous Shigella infections while only 
those volunteers with history of bacillary dysentery infection showed Ipa -specific serum 
responses [Li, 1992 #438].. 
1.6.3. Cell- Mediated Immunity 
There are few reports regarding cell -mediated immunity (CMI) to shigellosis. Two well - 
studied CMI responses include the proliferative T- lymphocyte reaction induced by S. 
flexneri antigens [Zwillich, 1989 #439] and the sensitivity of Shigella infected HeLa cells 
to natural killer (NK) cell activity. In the latter case, NK cells were shown to be active 
against S. flexneri infected cells but not against uninfected cells [Klimpel, 1986 #328]. 
Conversely, among volunteers vaccinated with the polysaccharide part of the 
homologous LPS molecule, significant peripheral lymphocyte proliferation was noted 
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[Li, 1992 #4381. A similar increase in intraepithelial T cell number was also seen in 
guinea pigs infected with Shigella [Sinha, 1992 #4401. 
Shigella induces interferon production in infected fibroblasts [Hess, 1989 #64] and 
inhibits cell invasion by Shigella [Niesel, 1986 #66]. Interferon gamma (IFN -y) has also 
been shown to suppress the intracellular multiplication of Shigella in vivo, while IFN -ß 
mediated HeLa cell resistance to Shigella infection [Gober, 1972 #4411[Hess, 1987 #4421. 
It is still uncertain whether the cell mediated immune response by T cells and NK cells are 
as effective in protecting against dysentery as is the case in viral infections or against 
tumor cells, however, the observation leading to increased frequency and severity of 
shigellosis among AIDS patients indicates that CD4+ T cells are important in protecting 
against Shigella infection [Baskin, 1987 #443][Blaser, 1989 #4441. 
1.7. Somatic Antigen (0- antigen) of the Lipopolysaccharide 
17.1. Structure and Function 
The somatic antigen (0- antigen) is the outermost component of the outer structural cell 
surface layer of Gram- negative bacteria, the lipopolysaccharide (LPS) [Makela, 1984 
#121](Figure 1.2). The 0- antigen is composed of oligosaccharide repeat units linked to 
the LPS lipd A component by the core polysaccharide. Lipid A is the innermost 
hydrophobic component of the LPS. The repeating tetrasaccharide unit of the 0- antigen 
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Figure 12. Bacterial lipopolysaccharide (LPS). LPS is present in most Gram - 
Negative bacteria and comprises the lipid A (blue), core polysaccharide (red) and 
0-antigen (green). The bacterial cell wall components are shown by arrows with 
their names abbreviated: CM, cytoplasmic membrane; PG, peptidoglycan; PP, 
periplasm; OM, outer membrane. Each 0-antigen unit is a linear polymer of four 
sugar groups (Rha, rhamnose; G1eNAc, N- acetylglucosamine) forming the basic 
0-antigen serotype Y (adapted from Reeves, et al., 1996 and Simmons and Roma - 
Nowska, 1987). 
is representative of S. flexneri serotype Y and has the basic configuration [Simmons, 1987 
#2]: 
-3)-ß-D-GIcNAc-(1--32)-a-L-RhaI-(1 2)-a-L-RhaII-(1->3)-a-L-RhaIII-(1 
Variations in type -specific and group -specific antigenic determinants are attributed to 
either glucosyl or 0-acetyl groups being added to specific sugar residues of the repeating 
unit in a linkage- specific manner [Kenne, 1977 #312](Figure 1.3). For instance, S. 
flexneri serotype Y with group 3,4 antigen was converted to group 6 antigen by Shigella 
bacteriophage SF6 which possesses transferase proteins needed for the 0-acetylation of 
the rhamnosellI sugar residue [Lindberg, 1972 #445][Lindberg, 1978 #120]. 
Glucosylation can occur to any of the four sugar residues [Gemski Jr., 1975 #113]. 
The somatic antigen plays a critical role in Shigella virulence. Early experiments on 
bacterial pathogenesis produced rough S. flexneri derivatives (devoid of 0-antigen) which 
were avirulent [Okamura, 1977 #446][Okamura, 1983 #4471. Rough strains were able to 
invade tissue culture cells and multiply intracellularly but had lost the ability to spread to 
adjacent HeLa cells and failed to elicit keratoconjunctivitis in the Sereny test. It has been 
demonstrated that S. flexneri 0-antigen is able to facilitate adhesion to guinea pig 
intestinal mucosa in vitro [Izhar, 1982 #4481. Izhar et al., (1982) proposed the role of 
the 0-antigen polysaccharide in bacterial colonisation of the colonic epithelium although it 
is not required for cell penetration. This is supported by experiments involving mutated 
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Figure 1.3. Chemical composition of 0- antigens of the different Shigella flexneri 
serotypes. Modification results from the glucosylation and 0- acetylation of the sugar 
residues N- acetylglucosamine (G1cNac, green) and rhamnose (Rha, blue) comprising the 
the basic serotype Y 0- antigen tetrasaccharide repeat unit. Type -specific (Roman nume- 
rals) and group -specific (arabic numeral) antigenic determinants are enclosed in paren- 
thesis. 
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S. flexneri LPS. Okada et al., (1991) observed that mutants with altered core structure, 
no 0-antigen, or with decreased length of 0- polysaccharide were capable of invading 
MK2 cells, and multiplying and spreading within infected cells but were unable to spread 
intercellularly [Okada, 1991a #22]. Okada suggested that the Shigella 0-antigen is 
required for intercellular spread and for protecting the bacteria from nonspecific host cell 
defences. 
The 0- antigen is critical for virulence since rough strains with exposed lipid A were 
susceptible to the host defense molecule, the LPS -binding protein [Tobias, 1989 #4551. 
This plasma protein enhances the crosslinking of bacterial lipid A to the receptors on 
mononuclear phagocytes and stimulates synthesis of tumor necrosis factor alpha (TNF- 
a), IL -1 and IL -6 lymphokines. Furthermore, the 0- antigen polysaccharide chains 
function as receptors for the adsorption and invasion of many bacteriophages capable of 
mediating 0-antigenic conversion. This contributes to the diversity of the 0- antigen 
enabling it not to be recognised by antibodies secreted by memory cells [Lindberg, 1973 
#456]. 
The defensive function of LPS was also observed in Salmonella. Studies showed that the 
more virulent Salmonella serotype BO does not influence complement activation via the 
alternative pathway as efficiently as the less virulent DO and CO serotypes. This 
results in decreased bacterial opsonisation, thus Salmonella BO can evade phagocytosis 
[Pluschke, 1983 #450][Penn, 1983 #451][Goldman, 1984 #452][Joiner, 1986 
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#453][Timmis, 1985 #454]. This is a virulence process which may also occur in 
Shige/Ia's counteraction against host defence, 
1.7.2. Biosynthesis 
There are several gene loci in the chromosome that code for the expression of factors 
necessary for the synthesis of the core and 0-antigen polysaccharide. The rfa gene 
cluster encodes factors necessary for LPS core biosynthesis while the rfb cluster is 
involved in 0-antigen synthesis and attachment [Bachmann, 1990 #457][Jiang, #458]. 
The 0-antigen monomers are not linked directly to the core polysaccharide. Instead, 
they are primarily polymerised on a lipid carrier by enzyme products of the rfb gene 
cluster [Whitfield, 1995 #3]. The reactions commence with an N- acetyl -glucosamine -I- 
phosphatetransferase (Glcp NAc- I- phosphatetransferase) initiating enzyme Rfe [Meier - 
Dieter, 1992 #459] that transfers G1cNAc residues found in the 0-polysaccharide units of 
Shigella dysenteriae type 1 and S. flexneri [Klena, 1993 #460] [Yao, 1994 #157]. The rfb 
encoded nucleotide diphosphate sugar synthetases produce activated sugar derivatives 
which are transferred by glycosyl transferase enzymes to the antigen carrier lipid (ACL) 
forming the lipid -linked O unit [Robbins, 1971 #4611. Undecaprenol phosphate (und -P) 
is the lipid carrier derived from C55- polyisoprenoid [Osborn, 1972 #462]. Lipid linked O 
antigens are sequentially assembled in a blockwise fashion by the polymerase encoded by 
the rfc locus [Collins, 1991 #463]. The Rol protein (regulator of 0-chain length) controls 
the addition of 0-antigens to the growing chain by modulating the activity of rfc to shift 
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between its functions of polymerisation and the transfer of 0-antigens to the RfaL for 
ligation [Batchelor, 1991 #464][Bastin, 1993 #465][Morona, 1994 #466]. 
The rfbT and rfaL gene products catalyse the ligation of the lipid -linked, polymerised 0- 
polysaccharide to the lipid -A core [Gemski Jr., 1967 #467]. The construction of the LPS 
molecule occurs on the periplasmic face of the inner membrane [McGrath, 1991 #468] 
followed by its secretion into the outer leaflet of the outer membrane phospholipids 
[Raetz, 1990 #469][Lugtenberg, 1983 #470]. 
1.8. Bacteriophage mediated 0-antigen Modification 
1.8.1. Temperate Bacteriophages 
Bacterial evolution has been riddled with the acquisition and loss of properties which are 
primarily attributed to the exchange of genetic information between various agents. One 
notable carrier of genetic elements is a bacteriophage, whose Iysogenic capabilities provide 
opportunity for horizontal transfer of genes from one host to another [Calendar, 1998 
#302]. Temperate bacteriophages can integrate their DNA into bacterial chromosomes 
[Campbell, 1993 #472]. In the lytic pathway, the phage infects and multiplies in a 
suitable host to produce several hundred progeny particles which are released when the 
bacterial cell lyses. The bacteriophage can assume a latent proviral role in the lysogenic 
pathway after the integration of its DNA into the circular host chromosome by a site - 
specific recombination event [O' Gorman, 1991 #473][Stark, 1992 #474]. The integrase 
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enzyme catalyses a recombination process by binding tightly to a specific DNA sequence 
on the circular bacteriophage genome resulting in a complex that can now bind to a 
homologous DNA sequence on the bacterial chromosome. The integrase then catalyses 
the DNA cutting and resealing reactions around a short region of sequence homology to 
form a tiny heteroduplex joint at the point of union [Alberts, 1994 #475](Figure 1.4). 
Several studies have been focused on investigating the molecular mechanism involved in 
lysis- lysogeny decision [Herkowitz, 1980 #303][Rosner, 1972 #304]. Bacterial host 
tRNA genes are the preferred sites for bacteriophage chromosome integration because of 
their presence in multiple copies, thus providing multiple integration sites. The 
conserved secondary structure of tRNA genes may contain important sequences 
recognised by enzymes involved in recombination [Reiter, 1989 #476][Marschalek, 1994 
#477] 
Lysogenic phage DNA is inserted at a specific host chromosomal site, arB, by the 
phage- encoded integrase (Int) [Weisberg, 1983 #485]. The substrates for this reaction are 
240 bp of phage DNA specific sequence flanking the crossover point, and a 21 bp host 
DNA segment. The process involves the N- terminal of integrase molecules binding to 
so- called "arm sites" which are close to the extremes of the 240 bp attP DNA. Then a 
host protein (integration host factor) binds between the arm sites and the crossover point, 
bending the DNA so that the catalytic sites on the C- terminal ends are positioned close to 
the crossover point [Kim, 1992 #486]. Int recognises weakly binding core sites in the 21 
bp host sequence surrounding the crossover point. Crossover occurs by the formation of 
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Figure 1.4. The insertion of bacteriophage lambda DNA into the bacterial chromosome. This is 
an example of site -specific recombination in which the lambda integrase enzyme binds to a specific 
attachment site sequence on each chromosomal strand, where it makes cuts that bracket a short 
homologous DNA sequence. The integrase thereby switches the partner strands and reseals them so 
as to form a heteroduplex joint 7 base pairs long. Reproduced from Alberts et al., 1994. 
a crossbridge. Phage DNA is excised from the lysogenic bacterial chromosome when 
repression is lifted. This process mediated by a phage- encoded protein, Xis, and occurs 
when Xis binds to X DNA between the Ieft arm and the core [Thompson, 1987 #4871. 
1.8.1.1. S. flexneri Bacteriophage SfV 
Temperate bacteriophage SfV has an isometric head, a long non- contractile tail and 
belongs to the group B morphology class of Bradley [Bradley, 1967 #179]. It inserts its 
DNA through site -specific recombination and requires recombinase enzymes belonging to 
the integrase family [Argos, 1986 #306]. The process of genetic exchange occurs 
between the attachment site (attP) of the circular phage genome and the attachment site 
(attB) of the linear bacterial chromosome. This recombination between phage and 
bacterial genome occurs when short homologous common core sequences overlap, 
producing the prophage attachment sites attL and attR that flank the phage genome 
[Campbell, 1992 #307] [Campbell, 1962 #308]. Other essential factors like the integrase 
(Int) and the integration host factor (IHF) participate in the recombination event, while 
excisionase protein (Xis) is more active when the prophage enters the lytic phase [Miller, 
1980 #309]. In phage SfV, the attP, xis and int genes located on a 2.2 kb sequence 
cluster adjacent to the serotype conversion genes have been sequenced and characterised 
[Huan, 1997A #118]. In addition, the conserved order of this gene cluster is not unique 
to phage RV. Salmonella Phage P22 and S. flexneri phage SfX and Sf6 also exhibited 
homologous cluster arrangement wherein the attP site is immediately adjacent to the 
37 
serotype conversion region [Clark, 1991 #119][Leong, 1985 #198][Poteete, 1988 
#310][Leong, 1986 #311][Guan, 1999 #151][Verma, 1993 #116]. 
Another well -characterised region of the SW genome is the serotype- conversion gene 
cluster located downstream of the attP site. These genes mediate the modification of the 
LPS 0- antigen that creates variation in the 0- antigenic specificity. With the exception of 
S. flexneri serotype 6, the 0- antigen subunit of S. flexneri (serotype Y) consists of a 
basic repeating tetrasaccharide unit structure: [-3)-13-D-L-GlcpNAc-(1-2)-a-L-RhapI-(I- 
2)-a-L- RhapII- (1- 3) -a -L- RhapIII -(1 -] [Simmons, 1987 #2][Kenne, 1978 #1111. In 
accordance to the posítíon of glucosyl or 0 -acetyl residues attachment to the repeating 
hexose unit, the antigenic type (I, II, III, IV, V) and group specificity (3,4; 4; 6; 7,8) of 
the strain may vary [Kenne, 1977 #312] (Figure. 1.3). The addition of glucosyl moieties 
in serotype V 0- antigen is catalysed by the phage encoded glucosyl transferase enzyme, 
part of the early genes eliciting 0- antigen conversion [Huan, 1997A #118]. The gene 
operon has been sequenced and contains three continuous open reading frames capable of 
serotype- converting S. flexneri serotype Y (group antigen 3,4) to serotype 5a expressing 
type V and group antigen 3,4 [Huan, 1997B #1171. 0- acetylation of LPS by S. flexneri 
phage Sf6 was also observed to cause 0- antigen conversion from group 3,4 antigen to 
group 6 [Gemski Jr., 1975 #113][Lindberg, 1978 #120][Verma, 1991 #76]. Recent 
findings have elucidated the role of the three -gene 0- antigen glucosylation system in S. 
flexneri bacteriophage Sfll and SIX [Mavris, 1997 #16][Guan, 1999 #151]. It has also 
been proposed that the first two of the three gene cluster be designated as gtrA(type) and 
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gtrB(type) due to their sequence homology to phages SRI, SfV and SfX. The third 
glucosyl transferase genes are divergent in primary nucleotide sequence despite their 
structural similarity [Guan, 1999 #151] [Allison, 2000 #199]. 
The site -specific integration and the serotype -conversion regions discussed earlier are 
encoded in approximately 5 kb length of the SW genome. At the left side of these genes 
is a 15 kb segment of the DNA which has been characterised recently (Allison et al., 
submitted for publication). It was discovered to encode for the early regulatory genes 
involved in the phage repression, regulatory, superinfection immunity, and transcription 
termination systems. Comparative sequence analyses indicate that this 15 kb region of 
phage SW shared numerous features of the sequences encoded in bacteriophages of the 
lambdoid family. Therefore, knowledge of the the molecular profile of phage ? is 
essential since it could provide a basis or a comparative example in the analysis of 
unsequenced phage SW DNA. 
1.8.1.2. Colíphage Lambda (.l) 
Bacteriophage A. -encoded genes have a variety of functions [Campbell, 1994 #1641. For 
example, upon infection with lambdoid phages, RNA polymerase begins the leftward 
and rightward transcription from the pL and pR promoters, respectively (Figure 1.5). 
The immediate transcription products are the N protein on the left and the cro protein on 
the right. The gene product (gp) N is able to override ordinary termination signals such 
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Figure 1.5 . Map of X. prophage showing major gene clusters with some of the genes they 
contain and major transcripts. Antiterminated transcripts contain arrowheads at terminator 
sites. The late regulator Gene Q appears between clusters. DNA recognition sites are not 
shown. Adapted from Campbell, 1994. 
as tLI and tRl allowing transcription to proceed throughout the X genome [Campbell, 
1994 #164]. Thus, gpN promotes Iysogeny because cil and cIII (repressor genes) are 
immediately downstream of tL1 and tRl. The rightward transcript includes genes O and 
P, the replication origin within O and the late gene activator Q (Figure 1.5). If the phage 
enters the lytic phase, the early protein product made from the pR transcript (gpQ), 
stimulates transcription of genes for lysis and virion formation as accumulation of this 
protein slows early transcription [ Goliger, 1989 #478]. The productive cycle genes are 
not expressed in the lysogenic phase because the repressor binds to two operators, oL 
and oR. Rightward transcription is prevented by the repressor binding to oR2 and oR3. 
The first gene product on the right, cro, binds the same sites as the repressor, 
specifically to oR3, to prevent cl transcription [Ptashne, 1986 #4791. cro accumulation 
also reduces CII production by repressing pR. The ell gene product stimulates leftward 
transcription of cI from promoter pE within cII [Bushman, 1993 #480][Casjens, 1992 
#2651. Cells that have a high CII concentration express the repressor, shutting off their 
pR promoter and enter the lysogenic phase. 
Replication of X phage requires the pR transcript gene products, gp0 and gpP. 
Replication occurs bidirectionally from an origin within gene O. As replication proceeds, 
virion components are synthesized by the late genes and assembled into proheads and 
tails [Campbell, 1994 #164]. Packaging starts at the cos site where DNA is cut by the 
terminase protein complex (gpA and Nul). DNA to the right is packaged into the 
prohead until the next cos site is reached and cleavage occurs. Once the prohead shell 
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(composed of gpE) is filled, it expands to assume an icosahedral shape before a second 
major protein, gpD is added [Hendrix, 1992 #4821. Tails are then attached to the heads. 
The X tail is made up of a long hollow tube with bent tail fibers at the sides (stf and Ifa 
genes), terminating in a single fiber encoded by gene J [Haggard -ljungquist, 1992 #483]. 
All the head genes lie at the left end of the map followed by the tail genes. Three 
adjacent genes of the late operon, S, R, and Rz encode proteins for lysis [Taylor, 1971 
#484]. The S protein is a holin that forms holes in the cytoplasmic membrane disrupting 
the membrane potential and allowing the endolysin (R protein) to reach and cleave 
between the N- acetylglucosamines of the rigid murein layer. 
1.8.2. Serotype- Converting S. flexneri Bacteriophage and 0- antigen Modification 
Several Shigella flexneri bacteriophages have been known to cause modification of the 0- 
antigenic polysaccharide chain upon lysogeny [Allison, 2000 #199]. Integration of the 
bacteriophage genome occurs at a specific site identified as the T locus within the pro (6 
min) and lac (8 min) region of the Shigella chromosome [Petrovskaya, 1982 
#48][Simmons, 1987 #2]. The repeating sugar units of the 0- antigen backbone is 
modified by the addition of an acetyl or glucosyl group. This occurs via the action of 
phage- encoded acetyltransferase or glucosyltransferase genes [Lindberg, 1977 #488] 
[Makela, 1984 #121]. The process leads to serotype conversion from the basic 0- 
antigen serotype Y to serotypes la, lb, 2a, 2b, 3a, 3b, 4a, 4b, 5a, 5b, and X (Figure 
1.3)[Simmons, 1987 #2] and results in the production of various bacterial serotype 
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specificities [Gemski Jr., 1975 #113][Lindberg, 1972 #4451[Sasaki, 1974 #489][Wright, 
1971 #490]. Genetic and phage sensitivity studies showed that S. flexneri 0- 
polysaccharide chain with group 3,4 antigen (serotype Y) functions as the receptor for 
phage adsorption and attachment, thus, 0- antigen modification prevents superinfection 
by other homologous bacteriophages [Lindberg, 1978 #120]. Also, this alteration of 
surface antigenic epitopes enhances bacterial virulence and survival by evading the host's 
anamnestic immune response. Due to the occurrence of serotype conversion, therefore, 
an effective vaccine will need to contain immunogenic epitopes for the different Shigella 
serotypes. 
The glucosyl transferase genes of host- induced bacteriophages SITI, Sty, and SIX have 
been characterised and occur in a conserved three gene cluster. This is located 
downstream of the phage attachment site (attP), preceeded by the integrase (int) and 
excisionase (xis) genes (Figure 1.6)[Verma, 1993 #116][Mavris, 1997 #16][Huan, 1997B 
#117][Huan, 1997A #118][Guan, 1999 #151]. The first two genes in the cluster, 
designated as gtrA(type) and gtrB(type), have high sequence homology and have been 
observed to function interchangeably among serotypes. The specific glucosyltransferase 
genes found in the third position of the cluster, gtrul, gtrV, and gtrX, were less 
conserved [Allison, 2000 #199]. 
There are two steps involved in the 0- antigen glucosylation mediated by S. flexneri 
bacteriophage SIII [Mavris, 1997 #161 Initially, the bgt product catalyses the transfer 
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Figure 1. 6 . Comparison of the 0- antigen modification gene organization. Represented 
are the serotype conversion and adjacent factors in the genome of phage SW (Huan, P.T. 
et al., 1997A and Huan, P.T. et al., 1997B), SIX (Guan, S. et al., 1998; Guan, S. et al., 
1999; and Verma, N.K. et al., 1993), SfII (Mavris, M. et al., 1997), and Sf6 (Clark, C.A. 
et al., 1991; Verma, N.K. et al., 1991), and in the bacterial chromosome of serotype la 
strain Y53 (Adhikari, P. et al., 1999) and Escherichia coli (Blattner, F.R. et al., 1997). 
Genes encoding proteins showing >85% identity are the same colour. orfl, orf6, orf2 
(SfTI) and o120 are gtrA homologs; orf2 (strain Y53), orf5, bgt and o306 are gtrB 
homologs; int and int' are complete or partial integrase genes, respecvtively; xis, 
excisionase gene; oac, 0- acetyltransferase gene; argW, arginine tRNA gene; attP, 
attL and attR are phage attachment sites. ( Reproduced from Allison and Verma, 2000) 
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of the glucose residue from UDP- glucose onto a bactoprenol lipid carrier molecule, this is 
followed by a location- and linkage -specific transfer of glucose to the 0-antigen sugar 
units by GtrII. It was observed that genes bgt [gtrB(H)] and gtrll were sufficient to 
mediate full 0-antigen conversion [Mavris, 1997 #16]. On the other hand, three steps 
involving the sequential transfer of molecules were proposed in the 0-antigen 
glucosylation mediated by S. flexneri bacteriophage SIX [Guan, 1999 #151]. Guan et al. 
(1999) proposed that the glucosyl residue is transferred first from UDP -GIc to a 
membrane bound bactoprenol lipid, a process mediated by GtrB. This is followed by a 
second step involving the lipid -linked glucose being flipped out (by either the GtrA alone 
or by GtrA in association with GtrX), across the cytoplasmic membrane onto the 
periplasmic region. In the third step, the glucosyl residue is attached by GtrX onto the 
rhamnose I of the partially polymerised O side chain which is still bounded to its lipid 
carrier. This process is depicted schematically as a hypothetical model in Figure 1.7. 
To determine the role of each gene in the serotype conversion casette, Guan et aI. (1999), 
have demonstrated that the three genes, gtrA(x0, gtrB(x), and gtrX are required to mediate 
full 0-antigen conversion. In order to evaluate the role of individual genes, separate 
mutations were introduced in each component of the glucosylation cassette. Mutants 
with deletions in the 5' terminal half of gtrA,x) can only partially convert to a serotype X 
strain, furthermore, insertion of 470 bp of exogenous DNA into the EcoRI site of gtrB(x} 
also resulted into incomplete serotype conversion since a frameshift mutation was 
created. This established that gtrA and gtrB are required for full serotype conversion. 
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Figure 1.7. Hypothetical model for O antigen glucosylation. The 0-antigen repeat unit (Y- serotype 
antigen) is synthesized in the cytoplasm on the lipid, ACL, `lipped" into the periplasm by the protein, 
RfbX and polymerised by Rfc. The glucosyl residue from UDP- glucose is transferred to a lipid carrier 
bactoprenol by GtrB. This lipid -linked glucose is also "flipped into the periplasm by GtrA alone, or in 
conjunction with the specific glucosyltransferase, Gtr. The group or type specific Gtr protein then 
transfers the glucose to a particular site on the O antigen chain as it is polymerised by Rfc, and returns 
the bactoprenol molecule to the cytoplasmic face of the membrane (Reproduced from Guan et al., 1999). 
Deletion mutants of gtrX did not show any conversion activity, implying this gene is 
essential for serotype conversion. Thus, the three genes are necessary for full 
conversion while gtrX alone or in combination with either gtrA or gtrB can only mediate 
partial conversion [Verma, 1993 #116]. Similar results have been observed in phage SfV 
[Huan, 1997A #118][Huan, 1997B #117]. 
Conversely in phage Sf6, an 0-acetyl transferase gene, oac, catalyses the addition of 0- 
acetyl group to the rhamnose III sugar unit of the polysaccharide chain. This converts 
serotype Y to 3b, carrying the group antigen 6, 3, 4 (Figure 1.3) [Clark, 1991 
#119][Verma, 1991 #76]. The acetyltransferase has been localised downstream of the 
integrase (int) in a similar organisation to the glucosyl transferase gene cluster in 
bacteriophages SfII, SfV and SIX [Mavris, 1997 #161[Huan, 1997A #118][Guan, 1999 
#151]. The 37185 daltons Oac protein is made up of 333 amino acids and is a 
hydrophobic, membrane -hound enzyme based on hydrophilicity plot prediction [Verma, 
1991 #76]. 
A recent report revealed the presence of a putative three -gene operon from a cryptic 
prophage which mediates serotype la 0-antigen modification [Adhikari, 1999 #1121. 
The predicted proteins ORF1 [(gtrAw] and ORF2 [gtrB(1)] show remarkable homology 
(88 -99% identity) to proteins encoded by the serotype conversion loci of S. flexneri 
bacteriophages SfI, SfV, and SfX. No significant sequence similarity was noted for 
ORF3 (gtrl). This gene organisation having two conserved genes followed by a unique 
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glucosyltransferase gene, is reflective of that observed in bacteriophage Sf1, SfV, and 
SfX (Figure 1.6). 
In the 0- glucosylation of Salmonella species, the addition of glucosyl groups occurs 
before the lipid -linked 0- antigen repeating sugar units have been transferred to the core 
polysaccharide [Takeshita, 1971 #491], and it involves two major chemical reactions 
characterised by the step -wise transfer of a glucosyl residue from undecaprenol 
phosphate (UDP) to a lipid intermediate followed by another transfer step onto the 0- 
antigen subunits [Wright, 1971 #490][Makela, 1973 #492][Nikaido, 1971 #493]. A 
parallel glucosylation process was observed in Salmonella bacteriophage epsilon 34 which 
can convert Salmonella serotype 0,15 to 0,34 by the addition of a glucosyl residue to the 
galactose sugar in the 0- antigen repeat unit [Robbins, 1962 #494][Robbins, 1971 #461]. 
Conversely in Salmonella typhimurium, the chromosome- encoded oafA near the rfa 
region produces the factor that mediates 0- antigen acetylation [Makela, 1966 #495]. 
The trans -acylase enzyme product has provided evidence which suggests that, unlike 
periplasmic glucosylation, the acetylation of the 0- antigen occurs in the cytoplasm 
[Slaugh, 1996 #496]. Yao and Valvano (1994), proposed that acctylation in E. coli K -12 
takes place at a point prior to the polymerisation of the repeat units, since both the 
smooth polysaccharide and repeat units are acetyl- modified in the process. This 
supports the idea of cytoplasmic acetylation as the assembly of repeat units takes place 
in the cytoplasm before its periplasmic transfer. 
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1.9. Bacteriophage and their Role in Virulence 
Upon lysogeny, temperate bacteriophages can impart properties encoded in its genes 
that changes the host bacterium, a process termed as lysogenic conversion [Waldor, 1998 
#537]. Examples include for exotoxin- encoding genes that are located in the genomes of 
bacteriophages such as diphtheria toxin, botulinum toxin, Streptococcal erythrogenic 
toxin, Staphylococcal enterotoxin A, Shiga toxins Stxl and Stx2, and cholera toxin 
[Bishai, 1988 #352]. Reports on the filamentous phage phi -CTX revealed that the phage 
did not only serve as means for the horizontal transfer of virulence genes but its life cycle 
also played a role in the regulation of the synthesis and secretion of these toxins [Lazar, 
1998 #539]. Other bacteriophage- encoded virulence factors include extracellular enzymes 
such as Streptococcal hyaluronidase, the Lom and Bor outer membrane proteins of phage 
Lambda, and enzymes that changes the antigenic properties of LPS in Salmonella and 
Shigella [Hynes, 1995 #540][Barondess, 1990 #542][Whitfield, 1995 #3]. The spread 
and persistence of these genes in the bacteriophage genome suggests that these genes 
provide an evolutionary advantage by enhancing the survival and replication of its host 
bacteria. 
Several studies have assessed the role of LPS in S. flexneri invasion and virulence. Rough 
mutants of S flexneri which lacked 0-antigen were shown to be incapable of intercellular 
spreading despite normal invasion capability [Okamura, 1983 #447]. It was proposed 
that the smooth surface of invading shigellae is required for spread to adjacent cells and 
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for protection of intracellular bacteria from the host defense mechanism [Okada, 1991A 
#22]. In another experiment, the plaque forming ability of S. flexneri was not observed 
in strains that had galU or rfc mutations [Sandlin, 1995 #543][Sandlin, 1996 #544]. 
Sandlin et al., (1996) observed that the polar localisation of IcsA on the bacterial surface 
was altered when galU, rfe, rfaL, and rfc mutations were created. Actin 
polymerisation was affected which caused reduced bacterial intracellular and intercellular 
movement. Studies of Hong et al. [Hong, 1997 #5451, showed that both length and 
distribution of LPS are important for invasion and virulence. The experiments were 
performed by producing mutations in the chromosomal LPS synthesis genes rfa, rfb, and 
rol, and in a plasmid- encoded 0-antigen chain length regulator pHS -2. Any change in 
LPS type may have varied effects on the surface characteristics of the mutant that may in 
turn, show a corresponding effect on the normal organisation of polymerised actin and 
impair bacterial movement as a consequence [Parker, 1992 #546]. 
1.10. Objectives 
The general objective of this project is to proceed with the sequencing and 
characterisation of bacteriophage SfV genome in order to discover other gene- encoded 
properties of phage SfV. The specific objectives are: 
To sequence and analyse phage SfV BamHI fragment A portion of the genome. 
To characterise some fragment A putative genes as to their functionality 
To evaluate the role and effect of phage SW genome on host virulence. 
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CHAPTER 2 
Materials and Methods 
2.1. Culture Conditions and Growth Media 
Bacterial cultures were generally grown at 37 °C overnight in Luria -Bertani (LB) broth and 
grown on LB agar supplemented with ampicillin, kanamycin or a combination of both for 
strain selection. LB Congo red agar was used to screen Shigella flexneri strains for 
invasive phenotype, the plates were incubated overnight at 30 °C. NZCYM was the 
liquid medium used for the propagation of phage SN in its host SFL124. Broth cultures 
were incubated in a shaking incubator at about 200 rpm. Plate cultures were stored at 
4 °C while heavy inoculum of strains intended for long -term preservation were 
resuspended in LB glycerol (1:1) solution before storage in a -80 °C freezer. 
2.2. Bacterial Strains, Plasmids and Vectors 
2.2.1. Bacterial Strains 
The bacterial strains used and transformed in this study are listed in Table 2.1 and 2.2 
with their distinctive characteristics. The host for most ligation products was JM109 
derived from E. coli K -12 [Yanisch -Perron, 1985 #411]. Shigella. flexneri strain 124, a 
live -attenuated vaccine strain in which the aroD gene has been deleted from a virulent 
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Table 2.1. Escherichia coli strains used and prepared in this study 
STRAIN DESCRIPTION SOURCE /REFERENCE 
JM109 
rec Al, end Al, gyr A96, thi -1, 
hsd R17 (rk -mk +), sup E44, rel Al 
Yanisch- Perron et al ., 
1985 
SY327 lambda 
pir 
F aro D (lac pro ), lambda pir (Or 
gene encodes pie protein necessary for 
the function of R6K origin 
Miller and Mekalanos, 
1988 
B866 
P4189- a lysogen with T7 RNA 
polymerase gene under inducible 
lac UV5 promoter control Tabor et al ., 1985 
B869 P4404 containing pT7 -5 Tabor et al ., 1985 
B150 SY327 lambda pir containing pNV731 P. T. Huan 
B367 JM109 containing pNV314 P. T. Huan 
B377 JM109 containing pNV324 P. T. Huan 
B815 JM109 containing pNV724 G. Allison 
B823 JM109 containing pNV728 G. Allison 
B834 P2780 his dam 3 dam cloning strain P. Reeves 
B856 JM109 containing pNV749 This study 
B857 JM109 containing pNV750 This study 
B858 JM109 containing pNV751 This study 
B859 JM109 containing pNV752 This study 
B860 JM109 containing pNV753 This study 
B861 JM109 containing pNV754 This study 
B862 JM109 containing pNV755 This study 
B863 JM109 containing pNV756 This study 
B885 pTrcc 99A containing SfV Xis gene This study 
B876 B866 containing pNV769 This study 
B877 B866 containing pNV770 This study 
B878 B866 containing pNV770 This study 
B879 B866 containing pT7 -5 This study 
B885 JM109 containing pNV775 This study 
B1039 JM109 containing pNV909 This study 
B1040 B834 containing pNV909 This study 
B1076 B834 containing pNV934 This study 
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Table 2.2. Shigella flexneri strains used and prepared in this study 
I 
STRAIN DESCRIPTION SOURCE /REFERENCE 
SFL1 Wild -type serotype Y SIIDC* 
SFL124 Serotype Y aro D Karnell et al. , 1992A 
EW595/52 Wild -type serotype 5a SIIDC* 
SFL1339 SFL1 Congo red positive G. Allison 
SFL1342 SFL1339 containing pUC18 G. Allison 
SFL1346 SFL1339 containing pNV731 G. Allison 
SFL1266 SFL124 containing pUC18 This study 
SFL1333 SFL124 lysogen with phage SfV This study 
SFL1334 SFL1012 containing pTrcc 99A This study 
SFL1336 SFL1012 containing pNV775 This study 
SFL1337 Cured SFL1012 containing pNV775 This study 
SFL1338 SFL1 lysogen with phage SN This study 
SFL1347 SFL1339 containing pNV724 This study 
SFL1348 SFL1339 containing pNV314 This study 
SFL1349 SFL1339 containing pNV324 This study 
SFL1367 SFL1339 containing pNV909 This study 
SFL1394 SFL1339 containing pNV934 This study 
* SIIDC, Swedish Institute for Infectious Disease Control 
serotype Y strain, was used as a host for phage propagation, plaque assay and as a 
serotype Y (group antigen 3,4) positive control strain [Karnell, 1992 #364][Karnell, 1993 
#363]. Capsid and protease protein were over -expressed in E. coli B866, formerly 
P4189, which is a lysogen with a single copy of the T7 RNA polymerase gene under the 
control of the isopropyl -f3-D- thiogalactopyranoside (IPTG)- índucíble lacUV5 promoter. 
T7 RNA polymerase is needed to induce promoter 010 in pT7 -5 for the consequent 
transcription of the genes (see Plasmids and Vectors). Wild -type S. flexneri strains 
EW595/52 and Congo red positive SFL1339 (SFL1, Congo red binding, Pcr +) were used 
as hosts for the expression of xis gene and invasion assay experiments respectively. 
2.2.2. Plasmids and Vectors 
Table 2.3 Iists the plasmid vectors and constructs created in this study. Most works in 
recombinant DNA preparation involved the plasmid vector pUC19 (Figure 2.1). 
pNV728 were ligated into this plasmid in order to prepare template DNA for sequencing 
portions. pUC19 is a small high copy number plasmid (due to the absence of the copy 
number control gene rop) with a pBR322- derived ampicillin resistance gene and origin of 
replication. It also contains the 146 amino acid terminal portion of the E.coli lacZ gene 
flanking its 54 hase pair polycloning site. The former encodes for the amino- terminal 
fragment of 3- galactosidase and this can associate with the host- encoded carboxy -terminal 
portion of 13- galactosidase to form an enzymatically active protein, a process called a- 
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Table 2.3. List of Plasmids used and constructed in this study 
PLASMIDS DESCRIPTION SOURCE /REFERENCE 
pUC18 
pBR322 and MI3mp19 derivative; on pBR322, 
AmpR, lac Z+ Yanisch- Perron et al ., 1985 
pUC19 
pBR322 and Ml3mp19 derivative; on pBR322, 
AmpR, lac Z+ ; polycloning site in opposite 
orientation to pUC19 Yanisch- Perron et al ., 1985 
pT7 -5 
T7 polymerase with Tap I /Xba I frag. phi -10 
promoter plasmid; polylinker region of pUC12; 
Beta lactamase and ColE1 on from pBR322 Tabor et al ., 1985 
pTrcc 99A 
pKK233 -2 derivative with trc promoter upstream 
of MCS, rrn B transcription termination signal, lacl4 
and beta lactamase gene Amann et al ., 1988 
pNV731 
pUC18 with Xba I /Sac I frag. containing phage SN 
2.8 kb 3 -gene casette: gtrA, B, V (Barn HI -C) P. Khinda 
pNV314 pUC19 with 3.4 kb Eco RI fragment D of phage SN P. Huan 
pNV324 
pUC19 with 7.3 kb Barn HI fragment B of phage 
SN P. Huan 
pNV724 SN G. Allison 
pNV728 
pUC18 with 5.5 kb Barn HI /Sac I fragment of 
phage SN BamHI frag. A G. Allison 
pNV775 pTrcc 99A with 1 kb Xis gene from pNV324 This study 
pNV749 pUC19 with 1.4 kb Hin dill frag. of pNV728 This study 
pNV750 pUC19 with 1.2 kb Hin dill frag. of pNV728 This study 
pNV751 pUC19 with 2.0 kb Hin dill frag. of pNV728 This study 
pNV752 pUC19 with 0.6 kb Hin dill frag. of pNV728 This study 
pNV753 pUC19 with 0.3 kb Hin dill /Sac I frag. of pNV728 This study 
pNV754 pUC19 with 4.2 kb Pvu II SN Barn HI frag. A This study 
pNV755 pUC19 with 2.7 kb Pst I SN Barn HI frag. A This study 
pNV756 pUC19 with 2.0 kb Hin dill SN Barn HI frag. A This study 
pNV769 
pT7 -5 with PCR amplified phage SfV complete 
protease and complete capsid gene nt. 6556 -5897 This study 
pNV770 
pT7 -S with PCR amplified phage SN incomplete 
protease and complete capsid gene nt. 6267 -5897 This study 
pNV775 pTrcc 99A with 1 kb Hindlll xis gene from pNV324 This study 
pNV909 pNV731 cut and filled at the Ncol site of gtrV gene This study 
pNV934 pNV731 cut and filled at the Bcll site of gtrV gene This study 
Hindlll-Sphl-PstI-Sall-Xbal-BamHI-SmaI-Kpnl -Sácl-EcoRI 
Figure 2.1. Schematic map of pUC19 showing the polycloning site, the lac genes, 
beta -lactamase gene and the origin of replication. Reference: Yanisch - Perron et 
al., 1985 
complementation [Ulmann, 1967 #234]. In the presence of chromogenic substrate 5- 
bromo- 4- chloro- 3- indolyl -3 -D- galactopyranoside, X -Gal [Horwitz, 1964 #235], Lac+ 
bacteria produced by a- complementation form blue colonies while lac- bacteria which 
carry an insert that disrupts the amino -terminal fragment of [3- galactosidase form white 
colonies. The structure of recombinant plasmids was verified by restriction analysis of 
minipreparations of plasmid DNA. pUC18 is identical to pUC19 with the polycloning 
sites arranged in opposite orientation. 
Vector pT7 -5 (Figure 2.2), a 2404 bp T7 RNA polymerase- promoter system, was used 
to overproduce bacteriophage SfV capsid and protease protein. The plasmid contains the 
phage T7 Tagl/Xbal fragment from nucleotides 22879 -22928 (010), the 70 bp polylinker 
region of pUC12 and nucleotides 2065 -4360 from pBR322 (the 3- Iactamase gene and the 
ColE1 origin) [Tabor, 1985 #245]. Strain B869, formerly P4404, hosts the pT7 -5 
vector and was provided by P.A. Manning of Adelaide University, Australia. Our 
cloning experiments exploited the specificity of T7 RNA polymerase for its promoters in 
order to express inserted genes. 
Plasmid pTrc 99A (Figure 2.3) expression vector from strain B879 was utilised in the 
overexpression of the phage SW xis gene. This was the strategy employed in serotype V 
wild -type EW595/52 to remove the SfV genome which was recombined with its 
chromosomal DNA [Leffers, 1998 #246]. pTrc 99A is a derivative of pKK233 -2 
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ClaI-HindIII-Pstl-SalI-Xbal-BamHl-Smal-SacI-ECORI 
Amp 
Col El Ori 
Figure 2.2. Schematic map of pT7 -5 showing the polycloning site, the phi -I0 
promoter gene, the beta- lactamase gene and the ColE1 origin of replication. 
Reference: Tabor et al., 1985 
Ncol-EcoRI-Sacl-KpnI-Smal-BarnHI-XbaI-SalI-Pstl-SphI-HindIll 
I 
laclq 
pBR322 Ori 
Figure 2.3. Schematic map of pTrc 99A showing the polycloning site, the Ptrc 
promoter, the laclq repressor, the beta -lactamase gene and the pBR322 origin of 
replication. Reference: Amann et al., 1988 
expression vector with a strong trc promoter and a strong rrnB transcription termination 
signal downstream [ Amane, 1988 #247]. It contains a multiple cloning site which include 
a Ncal site adjacent to the trc promoter which is inducible with 1 -5 mM IPTG. pTrc 
99A also has a pBR322 origin of replication, iaclq repressor region (nt 3055- 4135), and 
a (3- Iactamase gene (nt 846 -1704) conferring resistance to 100 µg/ml ampicillin. In 
preparation for the curing experiment, the ligated pTrc 99A and xis gene construct was 
initially cloned into non -pathogenic JM109, then subcloned into wild -type EW595/52. 
2.3. Bacteriophage Induction 
Three protocols were performed throughout the experiments to extract the phage from its 
host. UV irradiation [Seyedirashtí, 1991 #143] was used to confirm identity of 
SFL1338, a phage SfV lysogen of virulent Congo red positive SFLI (SFL1339). Phage 
DNA was purified after induction and digested with enzymes to check for the presence of 
the typical phage SfV fingerprint (Figure.3.1A and B). While Mitomycín -C treatment 
[Stanley, 1999 #2481 [Ehara, 1997 #2491 and xis gene overproduction [Leffers, 1998 #246] 
were done to cure EW595/52 by inducing phage SfV out of its host. 
2.3.1. Phage Induction by UV irradiation 
SFL1338 was cultured overnight in LB broth and the next day a 5 nil aliquot of SFL1338 
lysogen was pelleted at 4000 rpm in Sorvall RT6000B refrigerated centifuge. The pellet 
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was resuspended in 2.5 nil of IOmM MgSO4 and the supernatant discarded. The ceII 
suspension was transferred onto a sterile petri dish and exposed to 254 nm UV light 
source (Phillips UV germicidal lamp) at a distance of 15 cm for 30 seconds. The 
suspension was then immediately transferred into 15 nil of LB placed in the dark in a 
shaking incubator for 24 -48 hours at 37 °C. Culture was examined after 24 hours of 
incubation to check for occurrence of lysis, extending incubation for a further 24 hours if 
lysis was not evident. After incubation the cell culture was centrifuged to remove cell 
debris and the supernatant filtered through a 0.45 µm Millipore filter. The supernatant 
was then serially diluted for phage titration. Phage identity was confirmed by 
fingerprinting and colony PCR. 
2.3.2. Phage Induction by Mitomycin -C treatment 
In order to isolate a cured derivative of EW595/52, 10 ml, 100 ml, and 150 ml aliquots of 
overnight culture were plated onto mitomycin C plates of various concentrations namely 
1.0, 0.5, 0.25, 0.125, 0.0625 tg/ml in duplicate. The plates were inoculated using the 
streak plate technique, and observed for 24 -48 hours to check for colonies that survived 
the toxicity of mitomycin C. The colonies were screened for the absence of the phage 
through phage sensitivity test (streak and drop method), and slide agglutination test. 
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2.3.3. Phage Induction by Xis overexpression 
Recombinant pTrc 99A, xis gene plasmid was transformed initially into .1M109 host 
applying the heat -shock method. The plasmid was also electroporated into EW595/52, 
the wild -type strain intended for phage curing. Transformants were grown at 37 °C 
overnight in 5 ml of 100 Rim' ampicillin supplemented LB broth. A 50 µl aliquot of the 
overnight culture was subcultured into fresh 5 ml LB- ampicillin broth (1% subculture) 
and incubated for a further 2 hours to achieve log phase growth concentration with 
approximately 1x108 cells per ml. xis gene was overexpressed by inducing the vector 
promoter by the addition of 25 µl of 20 mg/ml IPTG stock (0.4 mM final concentration) 
to the log phase bacteria culture. At 60 mins and 180 mins post- induction, 10 1A1 
samples were aliquoted and serially diluted ten -fold with 90 µl LB- ampicillin broth. 
Each dilution from both induction points were plated out on LB- ampicillin plates and 
incubated overnight at 37 °C. Isolates from plates showing 200 -500 colonies were picked 
onto replica plates for colony blotting. 
2.4. Preparation of Bacteriophage 
2.4.1. Phage Propagation 
Propagation of bacteriophage SW was conducted according to the procedures described 
for the preparation and purification of bacteriophage A. [Sambrook, 1989 #145]. Five ml 
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of NZCYM media was inoculated with a representative SFL124 colony and shaken 
overnight at 37 °C. A 50 ¡Al aliquot of the overnight culture (1x109 colony forming unit 
per milliliter [cfu/ml]) was transferred into 5 ml of fresh NZCYM for a further six hour 
incubation. The 1x10$ cfu/ml culture was then inoculated with a 1x107 plaque forming 
unit per milliliter (pfu/ml) stock of the phage. The volume of phage used depended on the 
multiplicity of infection required (MOI, pfu/cfu). The bacteria and phage mixture was 
incubated at 37 °C for 25 minutes and then subcultured into 100 ml of prewarmed 
NZCYM and incubated in a shaker overnight at 37 °C. The next day 2 ml of chloroform 
was added to the culture in which apparent cell lysis was visible as cell debris settle at the 
bottom of the flask and incubation continued for another 30 minutes. The mixture was 
centrifuged twice at 8000g (Sorvall RC plus GSA rotor, 7000rpm), 4 °C for 10 minutes. 
The supernatant was decanted into a flask, 1 µg/ml of pancreatic DNAse (Boehringer) 
and RNAse ( Boehringer) were added and the solution stirred for 30 minutes at room 
temperature. NaCl, 5.84g, was dissolved into solution and then the flask was kept on 
ice for 1 hour. The cold mixture was spun down at 13000g (Sorvall RC plus, GS3 rotor, 
9000 rpm), 4 °C for 20 minutes. Ten grams of polyethylene glycol (PEG) 6000 was 
added to the supernatant, stirred slowly for 15 minutes at room temperature, then 
incubated on ice for another hour. The mixture was centrifuged at 16,000g (Sorvall RC 
plus, GS3 rotor, 10,000 rpm) 4 °C for 20 minutes and the supernatant discarded. 
Sedimented bacteriophage particles were suspended in 1 ml SM buffer. 
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2.4.2. Phage Purification and DNA Extraction 
The propagated phage in SM buffer was extracted 3 times with equal volume of 
chloroform to remove PEG and cellular debris. To each 500 1d aliquot of the purified 
phage preparation, the following were added: 167.5 pl MilliQ water; 37.5 µl 10% SDS 
(0.5% final concentration), 30 41 0.5M EDTA (20mM final concentration), 7.5 µl 1M 
Tris -HCL pH 8 (10 mM final concentration) and 150 lug Proteinase K from 20 mg/ml 
stock solution. The mixture was incubated at 55 °C for 30 minutes before extracting 
twice with phenol and chloroform. Organic phases were saved for chloroform back 
extraction and mixed with the aqueous phase of the main extract. The aqueous phase was 
placed in dialysis tubing and incubated overnight at 4 °C against three changes of 1X TE 
buffer. The purified DNA was collected and stored at 4 °C. 
An alternative cesium chloride ethidium bromide gradient centrifugation protocol was 
used to purify the phage. Using this method, the propagated phage was extracted with 
an equal volume of chloroform before collecting the aqueous phase to which 0.5 g/m1 solid 
CsC1 was added The mixture was centrifuged at 36,000 rpm for 24 hours in an SW40 
rotor Beckman centrifuge. The band containing the phage particles was collected with a 
needle through the centrifuge tube wall. The CsCI was removed by overnight dialysis 
against 2L buffer (10mM NaC1, 50 mM Tris -HCI, pH8, and 10 mM MgCl2). 
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2.4.3. Plaque Assay for Phage Titration 
A ten -fold serial dilution of the purified phage particle stock in SM buffer was prepared, 
10 W. of phage stock and 90 µ1 of SM buffer per dilution point. To each dilution 100 .d 
of 3 hour incubated SFL124 log phase growth was added and the mixture incubated at 37 
°C for another 20 minutes. The 200 41 content of each tube was pipetted on top of LB 
agar plate, mixed with 3 ml of 50 °C melted 0.5% agar, spread plated then allowed to 
settle for 5 minutes. The plates were inverted and incubated overnight at 37 °C. The 
number of plaques were counted and the titer in pfu /ml was derived. 
2.5. Bacteriophage Detection and Identification in Lysogen 
2.5.1. Phage Sensitivity Test 
A bacterial clone expressing group antigen acquired through phage directed serotype- 
conversion can confer immunity to superinfection by the same phage [Clark, 1991 #462]. 
The phage sensitivity test is based on this premise with experiments involving their 
sensitivity or resistance to a particular phage species to assess the lytic spectrum of the 
infecting phage [Haan, 1997B #117]. For our purpose, SFL124 SfV Iysogen strains 
were challenged with phage SN to confirm successful phage lysogeny, as demonstrated 
by the resistance to SfV infection. An LB plate was streaked heavily with an overnight 
culture of S. flexneri Iysogen test strains and allowed to settle for 10 minutes. Twenty 
56 
microliter of purified phage SW was dropped over the lawn of test bacteria and left to 
absorb for 20 minutes. Then the plates were incubated at 37 °C overnight. The strain 
was judged sensitive to the phage if a clear zone in which no bacterial growth occurred 
was seen in the area where the phage had been applied, likewise suggesting unsuccessful 
phage lysogeny. Alternatively, a streak method was employed by placing a phage drop 
in a location near the edge of the agar plate. The drop was allowed to flow along the 
center of the plate by tilting the plate form a diameter line of phage inoculum. The phage 
suspension was left to dry for 30 minutes. Using a loop, the surface of the test colony 
was lightly touched and streaked across perpendicular to the phage inoculum line. The 
plates were inverted and incubated overnight at 37 °C. As in the drop method, 
sensitivity was shown by a clear zone of no growth at the cross point of bacterial streak 
and phage inoculum. For each test batch, SFL124 was used as the sensitive positive 
control and the serotype V strain, EW595/52 as the resistant negative control. 
2.5.2. Slide Agglutination Test 
Lysogen and cured strains of S. flexneri were screened by the slide agglutination test 
using sero -type and sero -group specific antisera (Denka Seiken Co., LTD., Japan). This 
involved a glass slide which was divided into two parts and a 20 ul drop of each 
polyvalent serum and physiologic saline control (0.9% NaCI) was placed onto each 
section of the slide. Spontaneous agglutination of antigen was checked by employing 
physiologic saline, as a negative control. A 20 ul drop of the test bacterium, which had 
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been densely suspended in physiologic saline, was transferred in the vicinity of both 
drops of solutions previously placed on the slide. Using a sterile toothpick, the antigen 
and serum drops and the antigen and physiologic saline were mixed well in their 
respective sections. The glass slide was tilted back and forth and the mixtures were 
observed for agglutination. Only agglutinations occurring within one minute were taken 
as positive and plus signs were used to score the relative strength of clumping. The name 
of the subgroup of the organism corresponded to the name of the serum which 
agglutinated the organism. 
2.6. DNA Processing and Basic Manipulations 
2.6.1. Preparation of Plasmid DNA 
2.6.1.1. Minipreparations of Plasmid DNA. 
Extrachromosomal plasmid DNA was extracted following the alkaline lysis method with 
slight modification [Sambrook, 1989 #145]. Bacterial culture was grown overnight and 
then 1.5 ml was pelleted in a microcentrifuge at 13,000 rpm for a minute. The pellet was 
resuspended in 100 µl of ice -cold solution I (50mM glucose, 25 mM Tris -HCL, pH 8.0, 
10 mM EDTA, pH 8.0) by vigorous vortexing. Next, 200 µl of freshly prepared 
solution Il (100 Id 3N NaOH, 150 1.51 10% SDS, 1250 µl MilliQ water) was added at 
room temperature, the solution mixed by inversion and kept on ice for 5 minutes to lyse 
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the cells. Cold neutralising solution III, 150µ1 (600 µ1 5M KOAc, 115 Sul glacial acetic 
acid, 285 µl MilliQ water) was then added to precipitate cellular debris and 
chromosomal DNA. The tube was vortexed and placed on ice for 5 minutes and then 
spun at 13,000 rpm in a microcentrifuge for 6 minutes to obtain the supernatant 
containing the plasmid DNA. The supernatant was treated with 50 111 of 20 µg/ml 
RNAse A solution for 20 minutes at 37 °C, then extracted with one volume each of 
phenol and chloroform followed by a volume of chloroform extraction two times. The 
plasmid DNA in the aqueous solution was precipitated by adding two volumes of 
absolute ethanol, incubated at room temperature for 5 minutes, then spun for 8 minutes 
at 13,000 rpm to collect the DNA. The pellet was washed with 1 ml of ice -cold 70% 
ethanol. The liquid was drained from pellet before vacuum oven drying at 45 °C for 10 
minutes. The DNA pellet was resuspended in 20 µl of MilliQ water and stored at -20 °C 
freezer. 
2.6.1.2. PEG Precipitation of Plasmid DNA as Template for Automated Sequencing. 
The volume of purified DNA was increased by dilution with MilliQ water to 50 or 100 
µl volume then extracted twice with 1 volume of chloroform. After this, 0.16 volumes 
of 5M NaCI and 1 total volume of 13% PEG was added to the aqueous phase before it 
was incubated on ice for 20 minutes. The mixture was microcentrifuged at maximum 
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speed at 4 °C for 20 minutes. The pellet was rinsed twice with cold 70% ethanol and 
dried in a vacuum oven for 6 -8 minutes. 
2.6.2. Preparation of Chromosomal DNA 
Overnight bacterial culture of 1.8 ml was microcentrifuged at 13,000 rpm for 1 minute. 
The supernatant was discarded and the cell pellet resuspended in 1 ml of TES buffer (50 
mM Tris HCI pH 8.0; 5mM EDTA; 50 mM NaCI) and recentrifuged. The pellet was 
resuspended in 300 µl of solution containing 25% sucrose and 50 mivi Tris HCL, pH 8.0. 
Next 1501.0 of 10 mg/m1 lysozyme in 0.25 M EDTA solution was added and the solution 
placed on ice for 20 minutes. After incubation, 75111 of 1X TE buffer and 25111 of lysis 
solution (10% SDS, 0.25 M EDTA, 1M Tris HO pH 8.0) was added, followed by 
addition of 1 mg pronase (Boehringer Mannheim) or proteinase K (Sigma) and incubation 
at 55 °C for 1 hour. After protein digestion, 600 pi of phenol was added to the clear 
suspension, which was then gently mixed and centrifuged for 4 minutes. The upper, 
less viscid, yellowish phenol layer was collected with a tuberculin needle and discarded 
then another extraction was performed with equal volume of phenol, which was added to 
the lower, more viscid colorless DNA. The DNA layer was extracted twice with equal 
volume of chloroform, using a tuberculin needle to collect and discard the bottom, less 
viscid yellowish chloroform layer. The DNA layer was precipitated by adding 1.5 ml of 
cold 95% ethanol. Once precipitated, the DNA was spooled out using the hooked tip of 
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a pasteur pipette and dipped twice into cold 70% ethanol solution and finally transferred 
into 200 µl of MilliQ water or TE buffer. The DNA was dissolved in a 55 °C water bath 
for 5 minutes then stored at 4 °C. 
2.6.3. Preparation of DNA for Radiolabelling as Probe 
2.6.3.1. Gel -purified Restriction Fragments The Gigaprime DNA labelling kit 
(Bresatec, S.A.) employing the oligonucleotide labelling system described by Feinberg and 
Vogelstein [Feinberg, 1983 #236] was utilised for random primer radio -labelling For use 
as a probe, 8 of the gel purified 0.6 kb EcoRV -Sacl and the 0.6 kb HindIII -Sacl, 
BamHI Fragment A insert was denatured for radiolabelling after quantitation based on its 
fluorescence intensity in comparison with the SPP1 marker cut with EcoRI. The DNA 
was rendered single - stranded by heating in 100 °C water bath for 5 minutes, snap -chilled 
on ice for 5 minutes to prevent re- annealing and spun briefly to bring down condensation. 
To the cold denatured DNA , the following reagents were added: 6 p.1 of decanucleotide 
solution; 6 41 of nucleotide- buffer cocktail specific for a -32P -dCTP; 4 µ1 (50pCi) of a- 
32P 
-dCTP (aqueous solution, 3000 Ci /mmol), and 1 µ1 of Klenow enzyme solution. The 
tube was kept on ice to discourage premature enzyme activity. The reaction solution 
was incubated at 37 °C for 15 -25 minutes and the reaction stopped by heating at 95 °C 
water bath for 10 minutes. The labelled probe was added to the hybridisation cylinder 
with the membrane and prehybridisation solution. 
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2.6.3.2, PCR Extension Product. 
The 1.3 kb serotype conversion gene gtrV was amplified by PCR using plasmid pNV323 
(contains gtrA, gtrB, and gtrV gene of StV fragment C) in strain B376 as template. The 
extension products were purified using the Bresatec DNA purification kit. The 
concentrated amplified product, 4µl, was diluted with 4 µ1 MilliQ water for a total 81A1 
volume to be denatured for labelling. Similar steps were followed as that in section 
2.6.3.1 except that a hybridisation box was used instead of glass cylinder for 
hybridisation. The probe was used in colony blot hybridisation experiment in chapter 6 
to detect successfully cured EW595/52 strain which have lost the gtrV gene it had 
acquired during phage SfV lysogeny. 
2.6.3.3. SfV Genomic DNA. 
To check the identity of our lysogen and cured strains prior to the invasion assay 
experiments, their chromosomal DNA were digested with restriction enzymes EcoRV 
and BamHI, blotted onto Hybond N+ nylon membrane (Amersham Pharmacia Biotech), 
and probed with genomic SfV DNA to detect which strains contain the SfV genome in its 
chromosome. For this activity the -39 kb SfV genomic DNA was degraded to attain 1- 
2 kb fragment sizes suitable to use as probe. This was achieved by taking 30 µl of 
dialysed SfV DNA, diluting with 270 µl MilliQ water and sonicating at 8 microns for I 0 
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seconds. The sheared DNA was then purified and resuspended in 15 µI MíIIíQ water 
(Bresatec, SA) and visualised on a 0.7% agarose gel to ensure generation of appropriate I- 
2 kb fragments for probe preparation. The sonicated 8 1.t1 DNA was denatured and 
processed as the protocol in section 2.6.3.1. 
2.6.4. Agarose Gel Electrophoresis 
DNA size and concentration were visualised using 0.6 -1.0% agarose gel. The agarose 
powder was dissolved in 0.5X TBE buffer, ethidium bromide at a final 0.5 lag/nil 
concentration was mixed with the melted agarose. The gel was then poured onto the gel 
tray and allowed to set usually for an hour. DNA samples were mixed with the loading 
dye containing 0 25% bromophenol blue (w /v) and 30% glycerol (w /v) and the gel was 
run at 80 V for 2 hours or before the dye front reach the end of the gel, or 12 V 
overnight. DNA bands were visualised under 11V transillumination and captured by the 
camera with the Gel -Doc system (Mitsubishi). For each batch, phage SPP I DNA 
marker cut with EcoRI was used to compare band sizes and fluorescence intensity. 
2.6.5. Quantitation of DNA Concentration 
The amount of DNA in suspension was estimated by comparison of band fluorescence 
intensity on a agarose gel between a known volume of test DNA and a known volume of 
phage SPP1 marker cut with EcoRI which has predetermined concentration value in 
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nanogram amount (Bresatec catalogue, 1991). However, a more accurate method was 
performed by measuring the DNA suspensions absorbance value spectrophotometrically 
at OD260 wavelength (Hitachi U- 1100). The suspension was measured in quartz cuvettes 
and the spectrophotometer was set at zero absorbance using MilliQ water as blank 
control. The equation applied was: 
C= 4) x dilution factor x A, 
where C is the DNA concentration in pg/ml, (1) is a constant value of 50 for double 
stranded DNA and 33 for single stranded DNA, and A being the absorbance value 
measured at OD260. 
2.6.6. DNA Purification by Silica Matrix Binding 
DNA was excised with razor blade and eluted from agarose gel or purified from solution 
using the Bresatec ( Bresatec) or BandPure (Progen) purification kit. The procedure 
utilises silica matrix to bind DNA, in this technique DNA is bound to glass powder in 
high salt conditions [ Vogelstein, 1979 #2321. The process requires 2.6 volume of the Nal 
binding buffer to be added to the DNA solution. Next 5 µl of resuspended silica matrix 
suspension was added and the mixture incubated for 5 minutes at room temperature with 
regular mixing to enhance DNA binding to the matrix. The silica matrix was then pelleted 
at 13,000 rpm for 15 seconds and resuspended in ice -cold ethanol wash solution. The 
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suspension was centrifuged again for 30 seconds and the supernatant discarded. The 
silica pellet was dried in a 45 °C vacuum oven before resuspending in 15 -20 gl of MiIliQ 
water, incubating in a 55 °C water bath for 5 minutes then spinning for 1 minute at 
13,000 rpm. The DNA containing supernatant was collected and the pellet discarded. 
2.6.7. Restriction Enzyme Digestion 
DNA was characterised by digestion with restriction endonuclease enzymes used with 
appropriate buffers and incubation conditions specified by the manufacturer. Master 
mixes were prepared in large volume digestions comprising of MilliQ water, buffer and 
the enzyme. Digestions were usually carried out in a 37 °C water bath for 1 -2 hour 
period using 2 Units of enzyme and 0.05 -1.0 µg of DNA sample in a 20 µl volume 
reaction mix. Digestion was arrested by the addition of loading dye, heat inactivation or 
storage at -20 °C. Double digests of DNA samples were carried out using buffer 
compatibility tables prepared by manufacturers (Amersahm Pharmacia Biotech, 
Boehringer Mannheim, Bresatec, MBI Fermentas, Promega). The One -Phor -All buffer 
was also used for this purpose after referring to the chart for buffer compatibility 
(Amersham Pharmacia Biotech). In some instances, DNA samples were digested first 
with the enzyme favouring the Iower -salt buffer followed by the higher sait buffer and a 
corresponding increase in the total reaction volume or the DNA was purified after the 
first digestion using the BandPure or Bresatec purification kit prior to digestion with 
another enzyme. Digests were usually visualised on varied concentration of agarose gel. 
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2.6.8. Dephosphorylation of Linearised Plasmid DNA 
Calf intestinal alkaline phosphatase (CIAP, Boehringer) was used to cleave the 5' 
phosphate groups from linearised DNA fragments with 5' overhang after a preliminary 
single digestion to prevent recircularization of the plasmid vector. For a total 50 s1 
reaction mixture, dephosphorylation was conducted by adding 1 -2 units of CIAP, 
appropriate IX dephosphorylation buffer and MilliQ water directly to the tube 
containing the 20 µl restriction enzyme digest, then incubated for 30 minutes at 37 °C. 
The CIAP was inactivated by heating the solution at 75 °C for 10 minutes followed by gel 
purification of the digested dephosphorylated plasmid vector using the Bresatec 
purification kit. The process effectively removed traces of CIAP which would have 
inhibited subsequent ligation reactions. 
2.6.9. Klemm, Treatment 
The DNA polymerase I large fragment, Klenow (MBI), was used to fill -in overhanging 
ends of linear DNA fragments to create blunt ends. Following a one hour digestion with 
restriction enzymes (NcoI or Bell) , one Id of both the Klenow enzyme and dNTP's were 
added making sure that the restriction enzyme buffer was compatible with the Klenow. 
The solution was incubated for a further 30 minutes at 37 °C prior to gel purification 
using the Bresatec purification kit. Alternatively, the DNA was extracted with phenol 
choloform (1:1) and precipitated with ethanol. 
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2.6.10. Ligation 
T4 DNA ligase was used with its corresponding ligase buffer to splice the vector and 
insert DNA together. The reaction was carried out overnight in a 16 °C water bath in a 
final volume of 10 µl containing 1 of 10X ligase buffer and 4 Weiss units of T4 ligase 
enzyme with a 1:3 vector to insert ratio. Control reactions containing uncut and cut 
vectors only were included. The ligated recombinant plasmids were transfected into its 
host or stored at -20 °C, 
2.7. Competent Cell Transformation 
2.7.1. Preparation of Competent Cells 
2.7.1.1. Electrocompetent Cells. 
Electrocompetent strains of B866 (P4189) and SFL1339 were prepared following the 
method presented by Dower et al., [Dower, 1988 #252]. LB broth, 100 ml was 
inoculated with 1 ml of overnight bacterial culture (1% inoculum) grown from a 
representative colony. The culture was grown at 37 °C for 3 hours (Log phase) before 
pelleting the cells by centrifugation at 4 °C, 7000 rpm (GSA rotor) for 7 minutes. The 
pellet was washed twice by resuspending in sterile cold milliQ water, 100 ml the first 
time and 50 ml the second time, re- pelleting each time at 4 °C, 7000 rpm (GSA rotor) for 
7 minutes. The pellet was resuspended in 2 ml of sterile cold 10% glycerol solution, 
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microcentrifuged for 5 minutes at 4 °C, 7000 rpm, and resuspended in a final in 400 pl 
volume of 10% cold glycerol solution. Aliquots of 40 t l were immediately placed at - 
70 °C for preservation and storage. 
2.7.1.2. Rubidium Chloride Competent Cells. 
The method adapted in preparing E. coli JM109 competent cells was that of Rob 
Hallewell of Chiron Corporation. LB, 100 ml broth was inoculated with 1 ml of 
overnight bacterial culture (1% inoculum) grown from a representative colony and 
incubated in a 37 °C shaker (250 -300 rpm) until OD550= 0.48 (approximately 2.5 -3 hours). 
The cells were chilled on ice and spun for 10 minutes at 4 °C, 7000 rpm (GSA rotor). 
The pellet was resuspended with brief vortexing in 30 ml of ice -cold transformation 
buffer I (30mM KOAc, 50mM MnCl2, 10mM RbCI, 10mM CaC12, 15% (w/v) 
glycerol, pH 5.8) per 100 ml starting culture. The cell suspension was kept on ice for 2 
hours, centrifuged for 5 minutes at 4 °C, 3000 rpm (GSA rotor), then resuspended as 
gently as posssible in 4 ml ice -cold transformation buffer II (10mM NaMOPS at pH 7.0 
with 1 N NaOH, 75mM CaC12, 10mM RbC1, 15% glycerol) per 100 ml starting 
culture. Competent cells were aliquoted in 100 µl quantities into ice -cold Eppendorf 
tubes and stored at -70 °C. 
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2.7.2. Transformation 
2.7.2.1. Transformation by Electroporation. 
Electroporation is the application of high voltage pulses which permeabilizes the cell 
envelope and permits efficient uptake of DNA by bacteria [Davis, 1990 4213]. The 
process involves adding 2 µl of ligation mix to 40 pl of thawed electrocompetent cells. 
The mixed DNA and cells are then transferred to the pre -chilled cuvette(Bio -Rad). 
Electroporation was carried out with the Genepulser (Bio -Rad) set at 2.5 kilovolts, 200 
ohms and 25 µFD. The cell mixture was immediately added to 1 ml of LB broth and 
incubated at 37 °C for 20 -30 minutes to allow gene expression. Afterwhich, 100 µl, 150 
pi, and 250 pl aliquot of the cells were spread plated on to plates with appropriate 
antibiotic supplement for selection, and incubated overnight at 37 °C. 
2.7.2.2. Transformation by Heat -Shocking. 
Aliquots of rubidium chloride competent cells, 100 µl were thawed on ice for 10 to 60 
minutes before adding 3 pl of overnight ligation mixture. After 20 minute incubation, 
heat -shocking followed by incubating the cells for 90 sec. at 42 °C or 120 sec at 37 °C. 
The cells were returned to ice for 2 minutes, then 5 volumes of room temperature LB 
broth was added before shaking gently at 37 °C for one hour. Aliquots, 50 -200 µl were 
spread on selective nutrient agar plates and these were incubated overnight at 37 °C. 
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2.8. Polymerase Chain Reaction (PCR) 
2.8.1. Amplification for DNA Sequencing 
2.8.1.1. Checking Primers for Secondary Structures. 
The most appropriate primers used were picked by a primer selection program found in 
the Massachussetts Institute of Technology website (http: / /www- genome.wi.mit.edu). 
The computer selection output is based on 200 -300 single strand base sequence 
submitted for analysis. The base sequence was located adjacent to the gene to be 
amplified ensuring inclusion of RBS and other regulatory genes necessary for expression. 
Some primers were also manually picked by taking note of reverse complement pairing 
between the candidate primers 5'- 3'sequence and its 3' -5' counterpart. See illustration 
below: 
5`-GTTATCGT ATGCCTCTC-? 
3'-CTCTCCGTACTGCTATTG-E 
2.8.1.2. Preparing Sequencing Reactions. 
Using 0.5 ml GeneAmp thin -walled PCR tubes, A total 10 ¡Al sequencing reaction mixture 
was prepared containing 200 -500 ng of double stranded DNA template, 2.5 pmol/µl 
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primer, 411l (half -reaction) Big dye terminator cycle ready reaction pre -mix consisting of 
dye- labelled deoxynucleoside triphosphates, MgC12 and Amplitaq DNA polymerase FS 
and MíIIíQ water made up to 10 µl. The mixture was centrifuged for 15 secs, then 25 
cycles of PCR amplification in Perkin Elmer GeneAmp PCR system 2400 was 
conducted. The primers used in sequencing reactions were typically 18 bp in length 
containing approximately 50% G +C content and the cycle sequencing parameter setting 
used were as follows: 
Rapid Thermal Ramp to 96 °C 
96 °C for 10 sec. 
Rapid Thermal Ramp to 50 °C 
50 °C for 5 sec. 
Rapid Thermal Ramp to 60 °C 
60 °C for 4 min. 
Rapid Thermal Ramp to 4 °C 
Hold until ready to purify 
2.8.1.3. Purification of PCR Extension Products. 
After DNA amplification, the PCR tube was centrifuged for 15 -20 seconds to bring 
down condensation. MilliQ water, 10 µl was added to the PCR extension mixture and 
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the total 20 ill volume added to a tube containing 2 µl 3M NaOAc, pH 5.2 and 50 ttl of 
95% ethanol and briefly vortexed. The tube was iced for 10 minutes to allow 
precipitation of DNA , then centrifuged at 4 °C maximum speed for 20 -30 minutes in a 
microcentrifuge. The supernatant was aspirated and discarded before rinsing the pellet 
with 250 µl of 70% ethanol and vortexing briefly. The tube was re- centrifuged for 10 
minutes, supernatant carefully aspirated and discarded then the pellet was dried in a 45 
°C vacuum oven for 10 minutes. 
2.8.2. Amplification of Gene using a Plasmid Template. 
pNV323 in strain B376 contains the phage SW serotype conversion three -gene cassette 
insert which includes gtrA, gtrB, and gtrV ligated to pUC19 [Huan, 1997B #117]. The 
1.3 kb gtrV gene unique to the SfV genome was PCR amplified, radiolabelled and used as 
a probe in colony hybridisation to detect successfully cured strain of wild -type serotype 
V S. flexneri EW595/52. The 20 µl PCR reaction mixture contained 4 µl of 200 -500 ng 
double stranded DNA template (pNV323 was tested in three dilutions: 1 in 50, 1 in 100 
and 1 in 200), 10.6 µl of MilliQ water, 1 unit of Taq DNA polymerase and 4.4 µl of the 
master mix consisting of 2.5 pmol of forward and reverse primers, 2 µl each of 10X Taq 
polymerase buffer, and 2 mM dNTPs. The 30 -mer forward and reverse primers 
designed by Dr. David Bastin of our laboratory and the cycle parameter setting used to 
amplify SW gtrV are shown below: 
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-> DB2 (Forward ) 5'- AGAGAATTCCTACCATTCAACATTAAGGCT-3' 
DB3 (Reverse) 5'-AGAGGATCCACATCGCCCAAAATACATCAT-3' 
Initial Denaturation Step 
94 °C for 5 min. (IX); Pause here, add enzyme 
Denaturation Step 
94 °C for 30 sec. (30X) 
Primer Annealing Step 
50 °C for 30 sec. (30X) 
Extension/Elongation Step 
72 °C for 1 min. (30X) 
Final Extension Step 
72 °C for 7 min. (1X) 
The elongation step is estimated to accomplish extension at 1 -2 kilobases per minute. 
Therefore, the one minute elongation time used was sufficient to produce the 1.3 kb SIN/ 
gtrV coding DNA. The extension products were used as probe for colony hybridisation 
(see section 2.6.3.2.). 
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2.8.3. Amplification of Gene using Whole SfV Genome as Template 
To characterise the functionality of phage SfV protease protein in processing its capsid 
units, two constructs were developed wherein one contained the complete capsid and 
protease gene and the other having complete capsid but interrupted gene for the protease. 
In order to compare expressed resultant protein products, one construct was engineered 
containing the complete capsid -protease gene inserted into the IPTG inducible expression 
vector pT7 -5 and the other having the complete capsid and only the carboxy -terminal half 
of the protease gene. The first task was to amplify the inserts for cloning. Primers were 
designed to contain an EcoRI restriction site at the 5' terminus and a BamHI site at the 3' 
terminus. The cleavage sites corresponded to the appropriate order in the multiple 
cloning site of pT7 -5 that would promote ligation in the correct orientation similar to the 
promoter's transcriptional direction. The 20 1.11 PCR reaction mixture contained 2 tl of 
200 -500 ng double stranded whole SfV genome template, 12.6 sl of MilliQ water, 1 unit 
of Taq DNA polymerase and 4.4 µl of the master mix consisting of 2.5 pmol of forward 
and reverse primers, 2 ltl each of l0X Taq polymerase buffer, and 2 mM dNTPs. The 
26 -27 mer forward and reverse primers and the cycle parameter setting used to amplify 
the 2055 bp (nt 6706 to 4651) SfVcomplete protease -capsid gene and the 1616 bp (nt 
6267 to 4651) incomplete protease -capsid gene are shown below: 
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-> Proteastart 5'-AAT GAATTC ATCTGACGGGGCTTTTAC-3' 
EcoRI 
-3 Proteasemiddle 5'-AAT GAATTC GCACGCTGAATCTCTCAG-3' 
EcoRI 
Capsidend 5'-AAT GGATCC GACTAATCAACCACCAAC-3' 
BamHI 
Initial Denaturation Step 
94 °C for 5 min. (1X); Pause here, add enzyme 
Denaturation Step 
94 °C for 30 sec. (30X) 
Primer Annealing Step 
49 °C for 30 sec. (30X); Complete Protease -capsid 
48 °C for 30 sec. (30X); Incomplete Protease -capsid 
Extension/Elongation Step 
72 °C for 1 min. and 15 sec. (30X) 
Final Extension Step 
72 °C for 7 min (IX) 
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The elongation step is estimated to accomplish extension at 1 -2 kilohases per minute. 
Therefore, the one minute and 15 seconds elongation time used was sufficient to produce 
the 2 kb complete protease -capsid gene and the 1.6 kb incomplete protease and capsid 
gene. The extension products were spliced with the overexpression vector pT7 -5 and 
cloned in its host strain B866 (P4189)(see Chapter 5). Another application which used 
the UV induced and purified phage genomic DNA as template was the amplification of its 
inherent gtrV gene by colony PCR in order to ascertain its identity. 
2.8.4. Colony PCR 
The protocol used was adapted from the method of Schuch and colleagues [Schuch, 1997 
#191] with some modifications. The phage SW serotype conversion gene gtrV which is 
unique to the phage was amplified from a lysogen colony to ensure its acquisition of 
phage SW DNA into its chromosome. A single isolated colony of subcultured candidate 
SfV lysogen was resuspended in 25 pl of 0.5mM NaOH then incubated for 30 minutes at 
room temperature. After incubation, 25 IA of 1M Tris -HC1, pH 8 was added to the 
NaOH- treated cells and this was immediately diluted by the addition of 450 pi MilliQ 
water. A 4 ill aliquot of this DNA preparation was used as template in a PCR reaction 
mixture identical to section 2.8.2. The 30 -mer forward and reverse primers designed by 
Dr. David Bastin and the cycle parameter setting used to amplify SW gtrV gene were also 
the same. 
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2.9. DNA Sequencing and Computer Analysis 
Purified extension products (see Section 2.8.1.2) were sequenced in the ABI Automated 
DNA sequencer, Model 373A which employs the dideoxy method developed by Sanger 
et al. [Sanger, 1977 #2331. The method takes advantage of DNA polymerase's ability to 
incorporate analogues of nucleotide bases by using 2',3'- dideoxynucleotides as substrate. 
When a 3' -dye labelled dideoxynucleotide triphosphate (dye terminator) is incorporated 
at the 3' -end of the growing chain, elongation is terminated selectively at A,C,G or T 
because the added triphosphate residue lacks a 3'- hydroxyl group (Figure. 2.4). The PE 
Applied Biosystem sequencer detects fluorescence from four different dyes that are 
used to identify the A,C,G and T extension reactions. Each dye emits light at a different 
wavelength when excited by an argon ion laser. All four colors and therefore all four 
bases can be detected and distinguished in a single gel lane or capillary injection 
(Automated DNA Sequencing, Chemistry guide: Applied Biosystems, 1998). 
Simple text base sequence and its electropherogram output were compared and edited on 
submission to Telnet 2.6 using the Australian National Genomic Information Service 
(ANGIS) sequence analysis software package. Phage SfV BamHI Fragment A contigs 
were assembled into a single contiguous sequence using the Fragment Assembly menu of 
the GCG program package (2D ANGIS), and submitted to various WEBANGIS 
programs like WAG's FastA and FastX for nucleic acid and protein database similarity 
searches, respectively, Map program to extract the amino acid sequence in six reading 
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Figure 2.4. Schematic diagram of DNA strand synthesis by formation of phosphodiester 
bonds. Dideoxycytidine triphosphate (ddC) was used in place of deoxycytidine triphosphate 
(dCTP) to terminate chain elongation. Inset shows the representation of the process. Source: 
The Perkin -Elmer Corporation automated sequencing manual, 1998. 
frames, Mapsort to locate important restriction sites, Frames to detect likely open 
reading frames, Eclustalw to perform multiple sequence alignment. 
2.10. Southern Hybridisation 
2.10.1. Alkali Blotting of DNA onto Nylon Membrane. 
Initially, restriction digests of DNA were prepared and photographed with a standard 
marker on the side that served as reference for fragment analysis after hybridisation. 
This is followed by a procedure of alkaline blotting the DNA digests onto a solid nylon 
membrane support as prescribed in the Hybond+ (Amersham) protocol for nucleic acid 
transfers. The 0.6% agarose gel was treated with 0.25M HC1 solution until the 
bromophenol blue dye component of the loading dye changed from blue to yellow color. 
The gel was soaked briefly in a tray of MilliQ water while the capillary transfer 
apparatus was being set up on a rectangular glass dish half -filled with 0.4M NaOH as the 
blotting buffer. An improvised platform was placed in the buffer topped with a glass 
plate where a wick of three Whatman 3MM filter paper sheets saturated with the blotting 
buffer were laid across the platform making sure their ends touched the buffer pool. The 
agarose gel with a small diagonal cut at the upper right -hand corner was placed face down 
on the 3MM filter paper wick and a similar sized, corner cut and MílIiQ water saturated 
Hybond N+ nylon membrane was layered carefully on top of the gel. The membrane 
was topped with three sheets of same -sized Whatman 3MM filter saturated with the 
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0.4M NaOH blotting buffer, and a 5 cm high stack of absorbent paper towels, glass 
plate, and finally a one kg. weight. A schematic representation of the set -up is presented 
in Figure. 2.5. 
2.10.2. Membrane Blocking with Non- Homologous DNA 
This pre- hybridisation step involved blocking the DNA blotted membrane with 25 ml of 
pre- hybridisation solution (Final concentration: 5X SSPE, 5X Denhardt's solution, 
0.5% SDS and 100 p.g /rnl of denatured snap -chilled Herring sperm DNA) for 2 hours in a 
hybridisation oven (Scientronic HB900) at 65 °C. The membrane was placed with blot 
side facing inside the glass rolling cylinder bottle or facing up when the hybridisation box 
was used. 
2.10.3. Hybridisation and Autoradiography 
After incubation with the pre -hybridisation solution, the denatured radiolabelled DNA 
probe (Section 2.6.3) was added into the hybridisation container with the membrane then 
re- incubated at 65 °C in the hybridisation oven for at least 12 hours. Then the membrane 
was washed twice 10 minutes each with 2X SSPE containing 0 1% SDS at 45 °C, with a 
final wash with 1X SSPE with 0.1% SDS for 15 minutes. The amount of radioactivity 
was measured on the surface of the membrane with a Geiger counter to determine if 
further washes are required. Membranes registering up to 15 counts per second reading 
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Figure 2.5. Schematic diagram of the capillary transfer set -up for alkaline blotting of 
DNA onto Hybond N+ nitrocellulose membrane. 
were not washed further while membranes emitting 20 counts per second or higher were 
subjected twice to stringent washes with 0.1X SSPE, and 0.1% SDS at 65 °C for 10 
minutes each wash. After the final wash, the membrane was covered with Cling wrap, 
and placed on a film casette. Inside the dark room, a piece of Biomax Maximum 
Sensitivity film (Kodak Scientific Imaging) on top of the membrane and incubated at -70 
°C for the appropriate length of time. Membranes with 5 -15 counts per second were 
incubated overnight while those with higher counts were incubated for few hours. The 
exposed film was fed into the Kodak X -OMAT 1000 Film Processor for 5 minutes before 
the radiograph was developed. 
2.10.4. Membrane Stripping 
The method prescribed by Hybond N+ manufacturer (Amersham) to remove bound 
probe on the membrane was followed. It required rinsing with cupious amount of 0.4N 
NaOH for 2 hours at 65 °C in a shaking water bath, followed by a rinsing in a solution of 
O.1X SSC, 0.1% SDS and 0.2M Tris HC1, pH 7.5 for 1 -2 hours in a 45 °C shaking water 
bath. The desired radioactivity reading was a background reading of <2 counts per 
second for successful stripping. 
2.11. SDS -PAGE and Western Immunoblottíng 
2.11.1. Protein Assay- Trichloroacetic Acid (TCA) Precipitation 
80 
Protein precipitation was performed to quantitate the amount of phage particle protein in 
the sample in order to determine the optimum volume for gel loading. The assay was 
based on TCA precipitation of protein samples whose spectrophotometric absorbance 
reading was plotted against bovine serum albumin (BSA) standard curve to identify the 
concentration of protein [Peterson, #254]. The first step was to prepare the BSA 
solution series for the standard curve. Amounts of 0µl, 10 Al, 20 µI, 30 µI , up to 100 
µI were aliquoted from a 1 mg/ml BSA stock solution at -20 °C into separate test tubes 
then filling up each tube content up to 0.5 ml with MilliQ water. The phage stock test 
samples of 2 pi, 4µl, 61.11, 8 IA and 10 µl amounts were also transferred into different 
test tubes. To each BSA and test samples, equal volume, 0.5 ml of Reagent A of 
copper tartrate carbonate [CTC][Sigma], 10% SDS, 0.8N NaOH, and MilliQ water was 
added, after vortexing the solution was incubated for 10 minutes at room temperature. 
Next, 0.25 mI each of reagent B (2 ml Folin [Sigma] and 10 ml MilliQ water) was added 
and after vortexing the solution was incubated for 20 minutes at room temperature. The 
samples were then placed in cuvettes or microtiter plate wells for spectrophotometric 
reading of absorbance values at OD750. The concentration of the phage stock test sample 
was derived from the corresponding BSA standard curve. 
2.11.2. SDS -PAGE 
The phage SfV and protease -capsid experiment bacterial clone samples were usually run 
on 12% (unless otherwise specified) sodium dodecyl sulphate- polyacrylamide gel 
electrophoresis (SDS- PAGE). The samples were first denatured by boiling for 5 minutes 
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in SDS -PAGE sample loading buffer (2% SDS, 50mM Tris -HC1, pH 6.8, 10% glycerol, 
0.1% bromophenol blue)[Laemmli, 1970 #255]. Typically, sample mixtures of up to 30 
µl were prepared for each well of the mini -gel set -up (Bio -Rad) and up to 70 µl for the 
large gel. The low molecular weight (LMW) protein marker sample mixture from the 
calibration kit (Amersham Pharmacia Biotech) was boiled with 20 µl of the sample 
loading buffer. Using a pasteur pipette attached to the auto -pipettor, the prepared 
resolving gel mixture was poured carefully in between two ethanol cleaned glass plate 
sandwich bounded at its side and bottom edges with spacer combs and sealed with melted 
1% agarose gel. The glass chamber was filled up to approximately one cm below the well 
comb then overlayed with MilliQ water. The gel was allowed to polymerise for 45 
minutes to 1 hour before the top water was decanted and the set resolving gel surface 
blotted dry with a piece of 3MM Whatman filter paper. The stacking gel was poured 
next on top of the resolving gel , then the comb was immediately inserted through the 
stacking gel ensuring no bubbles were trapped in the stacking gel and around the teeth of 
the comb. Once the stacking gel was set after 30 minutes, the comb was removed and 
the gel assembly was placed in the running tank, attached to the vertical apparatus, and 
filled to the appropriate level with 1X SDS -PAGE running buffer. Samples were loaded 
onto each well with a Hamilton syringe and electrophoresed at a constant voltage (180 V) 
until bromophenol blue reaches the bottom of the gel (approximately 45 minutes for the 
mini -gel and 4 hours for the Iarge gel). After the run, the gel was either stained or the 
proteins blotted onto membrane for Western immunoblotting. 
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2.11.3. Protein Band Staining 
2.11.3.1. Coommassie Blue Staining. 
The stacking gel was cut out after electrophoresis and the resolving gel stained in 
coommassie blue stain (Sigma)(0.05% coommassie blue R250, 40% Methanol, 10% 
acetic acid) sufficient to cover the submerged gel. The pan was covered with cling wrap 
then placed overnight at low setting on a Bio -Line orbital shaker (Edwards Instruments 
Company, N.S.W.). The coommassie stain in the pan was replaced with distilled water 
after overnight incubation then destained in the microwave (Panasonic) at high setting 
three times for 10 minutes. The gels were photographed under light illumination, sealed 
with water in a heat -sealing bag, dried on 2 pieces of 3MM Whatman paper on a gel drier 
(Bio -Rad), or placed in a Western blotting transfer apparatus. 
2.11.3.2. Silver Staining. 
The procedures followed were adapted from the protocols developed by Merril and his 
colleagues [.Merril, 1981 #256][Merril, 1982 #257][Merril, 1984 #258]. After the 
electrophoretic run the proteins were fixed by soaking the resolving gel in 400 ml of 40% 
methanol in 10% acetic acid solution on orbital shaker for 30 minutes, foIIowed by 
soaking in 400 ml of 10% ethanol in 5% acetic acid for 15 minutes. The gel was then 
transferred into 200 ml of oxidizer (Potassium Dichromate and nitric acid) at room 
temperature for 5 minutes, and washed twice with distiIIed water for 5 minutes before 
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soaking in 200 ml of silver reagent (Silver Nitrate solution) for 20 minutes. The gel was 
washed in distilled water for 1 minute and then soaked in 200 ml of developer solution 
(Sodium Carbonate and Paraformaldehyde) for approximately 5 minutes or until the 
bands reach the desired intensity in relation to the background. The reaction was 
stopped with a 5 minute soak in 5% acetic acid. 
2.11.3.3. Ponceau S Staining. 
Some protein gels were visualised for the presence of protein bands after Western blotting 
and before hybridisation. The membrane was soaked in a working solution of Ponceau S 
stain, 3 -hydroxy- 4 -( -2- sulfo- 4- [- 4- sulfophenylazo]- phenyl- azo)- 2,7naphthalenedisulfonic 
acid (Sigma) for 10 minutes with gentle agitation or until the protein bands were visible. 
The membrane filter was washed with several changes of MilliQ water at room 
temperature, then the lane and protein positions were marked with pencil before 
proceeding with the Western blot assay. The working Ponceau S stain solution was a 
1:10 dilution of the stock solution (2 g Ponceau S, 30 g trichloroacetic acid, 30 g 
sulfosalicylic acid, made up to 100 ml with MilliQ water) in 9 parts of MilliQ water. 
2.11.4. Western Immunoblotting 
2.11.4.1. Electrophoretic Protein Transfer. There were two electrophoretic transfer 
system utilised in our experiments. The first one was carried out according to the 
method of Towbin et al. [Towbin, 1979 #2591. Assembly components (the gel, 
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sandwich plates, four support pads, nitrocellulose membrane cut to the size of the gel, 
four sheets 3MM Whatman filter paper also cut to the size of the gel) were immersed for 
20 minutes in the Western blot transfer buffer (50mM Tris -HCI, 250mM glycine, 0.1% 
SDS, and 20% methanol). The transfer assembly were arranged in the following order 
from the bottom: black plate of the sandwich plate, two support pads, two sheets of 
Whatman paper, the gel, the membrane, two sheets of Whatman paper, two support 
pads then closed on top with the white plate of the sandwich holder. The sandwich 
assembly was submerged in the Bio -Rad transblot electrophoretic tank half -filled with the 
transfer buffer in such an orientation that the black side of the sandwich plate was 
positioned nearest to the the negatively charged cathode (black) and the white side nearest 
the positively charged anode (red). For a mínígeI transblot, the ice casette was placed 
next to the sandwich assembly and run at room temperature for 1.5 hours at 40 V or 15 V 
overnight. The large transblot was electrophoresed in the cold room at 15 V overnight. 
Another instrument used was the MiIIipore dry blot apparatus. The gel, ten sheets of 
3MM Whatman filter paper and a sheet nitrocellulose membrane (Hybond -C extra for 
chemiluminescence system) were soaked in the Millipore blot buffer (11.72 g glycine, 
28.24 g Tris -HC1, 1.5 g SDS and 800 ml methanol were made up to 4000 ml with MilliQ 
water). The soaking time was 30 minutes for the minigel and 1 hour for the large gel. 
From the base plate (anode) the components were stacked as follows: five 3MM 
Whatman paper, membrane, gel, five 3MM Whatman paper, capped with cathode lid. 
Electroblotting progressed for 1.5 hours at a constant current of 0.8 mA cm -2 gel supplied. 
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For A Single Minigel: 8.5 x 5.5 cm = 46.7 cm2 
For Two Minigels: 
For Large Gels: 
46.7 cm2 x 0.8 mA per cm2 = 37 mA constant current 
supplied 
74 mA constant current supplied 
9.Ox10cm= 90cm2 
90 cm2 x 0.8 mA per cm2 = 72 mA constant current 
supplied 
2.11.4.2. Acetone Powder Preparation. 
Overnight LB cultures of SFL 124, 1.5 ml, were pelleted at 6000 rpm for 5 minutes and 
resuspended by vortexing for 30 seconds in 500 .tl of iced 0.9% NaC1 solution then 
incubated on ice for 5 minutes. One ml of cold ( -20 °C) acetone was mixed vigorously 
into each tube of bacterial saline suspension, this was then incubated at 0 °C for 30 
minutes with occasional vortexing. Next the solution was centrifuged at 10,000 rpm for 
10 minutes and the pellet was resuspended in fresh cold ( -20 °C) acetone, vortexed and 
incubated at 0 °C for 10 minutes. The pellet was sedimented again at 10,000 rpm for 10 
minutes the supernatant discarded, then air dried for 1 -2 hours. 
2.11.4.3. Adsorption to Remove Nonspecific Binding. 
Polyclonal antisera usually contain a small proportion of antibodies that will bind either 
specifically to contaminating antigens on the membrane blot preparation (anti -bacterial 
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antibodies in the sera) or nonspecifically to charged antigenic residues. To minimise the 
presence of competitor antibodies, their binding sites need to be blocked by exposing 
them to saturating amount of competitor protein (bacterial whole cell acetone powder 
containing disrupted bacterial antigens) that is not the antigen of interest (phage SW 
capsid protein) [Harlow, 1988 #2601. To reduce the amount of anti -SFL 124 (strain used 
to propagate phage SW particles) antibodies in our polyclonal rabbit antiserum raised 
against whole phage SW particles, acetone powders were prepared and added into the 
antiserum to a final concentration of 1 %. This serum- acetone powder mixture was 
incubated for 30 minutes at 4 °C then spun for 10 minutes at 10,000 rpm. The 
supernatant was collected and used as the primary antibody reagent for our 
immunoassay. 
2.11.4.4. Western Immunoassay. The protein blotted nitrocellulose membrane was 
incubated at room temperature for one hour with the blocking buffer (5% skim milk 
[Carnation] -5 g skim milk powder in 100 ml TBS -T) on a rotating platform shaker. The 
membrane was then incubated with the primary antibody, rabbit anti -SW polyclonal 
antisera diluted 1:100 (50 µl of adsorbed antisera in 5 ml of TBST -1% skim milk), for 2 
hours at room temperature on a rotating platform. The membrane was then washed 3X 
for 10 minutes each in TBS -T or PBS -T (0.1% Tween 20 in TBS or PBS) then incubated 
for one hour with the secondary antibody (Sigma Immunochemicals) (Goat anti -rabbit 
IgG conjugated with horseradish peroxidase) diluted 1:12000. The membrane was again 
washed 3 -4 x 10 minutes in TBS -T or PBS -T. The membrane was developed using the 
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BM chemiluminescence blotting substrate -POD kit (Boehringer Mannheim) by soaking 
for 1 minute in the detection solution containing solution A and B at 100:1 ratio. Inside 
the dark room, a sheet of Biomax X -ray film (Kodak) was placed on top of the membrane 
and exposed for 1 -2 minutes then developed in the Kodak X -OMAT 1000 processor. 
2.12. Electron Microscopy 
Negative staining was performed on phage SW particles to visualise at high magnification 
(20K, 50K, 100K). Purified phage particles, 20 µl, was dropped on the surface of 
parafilm M (American National Can). A carbon coated copper grid was laid on the 
surface of the phage solution for 1 minute to allow absorption of phage particles on the 
300 mesh copper grid. The grid was drained of excess phage solution and laid on top of a 
MilliQ water drop for a 5 seconds wash. The grid was drained again then transferred 
onto the surface of a 2% sodium phototungstate, pH 7.0 to stain for 15 -30 seconds then 
drained again and air -dried for 10 minutes. The phage particles were visualised with a 
Hitachi JEOL X electron microscope at 80 -100 kV. 
2.13. HeLa Cell Culture 
2.13.1. Cell Passage and Seeding 
Sterile PBS and Growth media (500 ml RPMI 1640 without glutamine, 50 ml Fetal Calf 
Serum [10 %], 5 ml Glutamine [2mM], and 100 Id Gentamycin [2 tg/ml]) were warmed 
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in a 37 °C water bath. The confluent monolayer was washed and drained twice with 5 ml 
PBS before 2 ml of Trypsin -EDTA was added to detach cells from the flask wall. 
Trypsin -EDTA treatment was done in a 37 °C 5% CO2 incubator for 5 minutes. The 
flask was tapped to ensure cell detachment and 5 ml of growth medium was added to 
inhibit trypsin. The cells were transferred into a tube and centrifuged at 1000 rpm for 5 
minutes (Sorvall). The supernatant was discarded and the cells resuspended in 10 ml of 
growth medium with 2 .tg /ml gentamycin for tissue culture flask seeding, however, 25 ml 
of growth medium with antibiotic was usually used to resuspend the cells for 6 -well plate 
seeding. The resuspended cells, 20 1.61 were also mixed with 20 1.61 tryphan blue for cell 
counting in haemocytometer (see below). Two milliliters of 1x106 cells per ml was 
seeded in a new tissue culture flask in which 20 ml of growth medium with 2 tg/ml 
gentamycin was also added. For the 6 well plate seeding, 2 ml of the 25 ml cell 
suspension was transferred into each well if invasion assay was to be performed after 24 
hours, or 1 ml of cell suspension and 1 ml of growth medium was placed into each well if 
invasion assay was performed after 48 hours. The plates and flasks were incubated in a 
37 °C 5% CO2 incubator and checked everyday for cell growth. 
2.13.2. Cell Freezing and Thawing 
The cells were harvested for cell passage /subculturing and resuspended in 5 ml cold 10% 
DMSO. The cell suspension was aliquoted at 1 ml amounts per vial then placed on ice. 
The vials were incubated for 24 hours at -70 °C freezer before transferring into liquid 
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nitrogen. Cells were thawed immediately at 37 °C water bath then transferred to 10 ml of 
warm growth medium, mixed and centrifuged at 1000 rpm for 5 minutes. The pellet was 
resuspended in 10 ml growth medium and aliquoted accordingly into tissue culture flasks 
prior to incubation. 
2.13.3. Cell Counting in Haemocytometer 
The coverslip was positioned carefully on top of the Neubauer haemocytometer and the 
counting chamber was charged with the 1:1 cell -tryphan blue suspension. Live cells in the 
WBC squares, not absorbing the tryphan blue dye were counted once using the L -rule. 
100 -300 cells were counted to obtain a statistically significant cell count. 
For example, 
131 cells counted in 3 large WBC squares or 48 small WBC squares (16x4) 
Therefore, 131 cells x 48/16 x 104 per ml (one small square= 1/16x104 cm3) 
and cm3 = ml, for aqueous suspension 
= 131 cells x 3 x 104 per ml 
= 3.9 x 106 cells per ml x 2 (I : I dilution with tryphan blue) 
= 7.8 x 106 cells per ml 
2.14. Invasion/ Gentamycin Killing Assay 
LB broth inoculated with bacterial test strains were incubated overnight at 30 °C. The 
following day, 0.1 ml was subcultured for 2 hours in 37 °C incubator shaker. Meanwhile, 
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confluent HeLa cells grown in 6 -well plates were washed twice with 2 ml PBS prior to 
inoculation. Three ml of log phase culture was spun at 13,000 rpm for one minute and 
the cell pellet resuspended in 4.5 ml of RPMI -FCS without antibiotic. Each inoculum 
preparation represented one test strain and 2 ml of this was added to 2 wells, one to be 
gentamicin treated and the other an untreated well. The plate was then incubated in the 
37 °C 5% CO2 incubator for 1.5 hours to allow adsorption and invasion of Shigella strain. 
Following the incubation, 1 nil of inoculum from each well was discarded and replaced 
with 1 ml of RPMI -FCS- 500 µg/ml gentamicin for the treated wells and 1 ml of RPMI- 
FCS without antibiotic for the untreated wells. The plate was then incubated for another 
1.5 hours. The cells were then washed twice with 2 ml PBS and then 500 111 of 0.05% 
Triton -X -100 in PBS was added. The plate was incubated at room temperature for 10 
minutes before adding 500 µ1 of LB broth and resuspending the cells (Figure 2.6). The 
bacterial suspension from each well were diluted with PBS, spread plated onto LB agar 
and incubated overnight at 37 °C. The percentage of invading bacteria was calculated as 
follows: 
Percent 
Invading = No. of Bacteria recovered from gentamicin -treated cells x 100 
Bacteria No. of Bacteria recovered from untreated cells 
Percent 
Invading = Intracellular cells x 100 
Bacteria Total cells 
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Figure 2.6. Flow diagram showing the invasion assay method 
III RESULTS 
CHAPTER 3 
DNA Sequencing Strategy for the Serotype - Converting 
Shigella flexneri Bacteriophage SfV 
BamHI Fragment A 
3.1. Introduction 
SW is a temperate bacteriophage which carries genes important in mediating serotype- 
conversion of S. flexneri through 0-antigenic modification [Huan, 1997A #1181. Phage 
SW 0- antigen modification gene cluster, is composed of three genes designated as gtrA(v), 
gtrB(V), and gtr(V). The function of these genes is to transfer glucosyl residues from the 
carrier molecule to a membrane -anchored lipid, move the lipid -linked glucose from the 
cytoplasmic to the periplasmic region and attach the glucosyl residue to the 0-antigen 
sugar units, respectively [Allison, 2000 #199][Guan, 1999 #151]. The addition of the 
glucosyl group to the rhamnose II of the basic tetrasaccharide repeating units of the O- 
antigen changes S. flexneri serotype Y to serotype 5a [Simmons, 1987 #2] [Huan, 1997A 
#1181. These genes are located immediately downstream of the integration and excision 
locus composed of the attP site preceded by the xis and int genes, and the 
glucosyltransferase gene gtrV is followed downstream by orf2 and orf3 [Huan, 1997A 
#118][Huan, 1997B #117]. This genetic organisation was also observed in the genome of 
Salmonella typhimurium phage P22 and other S. flexneri bacteriophages [Vander Byl, 
2000 #351][Allison, 2000 #199]. 
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Knowledge of the entire phage SW genome is important in order to determine the 
influence of the phage genes on the traits and characteristics of its S. flexneri host. The 
usage of sequence information were described in other double- stranded bacteriophages 
whose functional organisation was derived after completion of its genomic sequence 
[Nakayama, 1999 #203][Kaneko, 1998 #204] [Alonso, 1997 #205][Altermann, 1999 
#206] [Tremblay, 1999 #207]. The recent completion of bacteriophage P22 and prophage 
VT1 -Sakai sequences have been reported [Vander Byl, 2000 #351][Katsushi, 2000 #505]. 
Incidentally in 1999, there were only about 30 completed phage genome sequences 
submitted in the databases [Whitman, 1998 #506] [Hendrix, 1999 #166]. This represents 
a minute proportion of the many known bacteriophages, therefore, more completed 
phage genome should be discovered in order to perform an accurate evolutionary and 
comparative studies on vital phage gene modules. Sequences of prophages have also been 
reported during the sequencing of bacterial genomes such as those of E. coli, H. 
influenzae, and Mycobacterium species [Cole, 1998 #328] [Kunst, 1997 #507][Blattner, 
1997 #4]. 
Many strategies have been utilised in various sequencing projects. Most projects 
involving large -scale DNA sequencing of higher eukaryotic organisms employ the random 
shotgun approach as an efficient strategy to generate fast and reproducible sequence 
information [Messing, 1981 #231] [Dos Santos, 1987 #250] [Hunkapiller, 1991 
#214] [Fraser, 1997 #215]. In sequencing moderate -sized DNA regions containing 
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sequences greater than 500 bases in length, directed strategies are frequently used 
[Henikoff, 1987 #217]. The approach uses insertional plasmid cloning, primer walking 
and creating nested deletions. Several in vivo transposon -based sequencing strategies 
adapting the combined features of random and directed approaches have also been used 
[Adachi, 1987 #219][Kasai, 1992 #221][Berg, 1993 #220]. However, the in vivo 
approach presented requirements which limit its applicability such as the need for special 
host strains and traditional manipulation steps. Thus, the in vitro DNA transposition - 
based sequencing strategy was developed. This was shown to be efficient in sequencing 
repetitive DNA [Devine, 1997 #222]. 
In bacteriophage SN, a large region of the genome has been sequenced, including the O- 
antigen modification and the site -specific integration region. Other portions of SN 
genome sequence has been recently determined providing information on the essential 
early genes, the repressor locus, immunity and regulatory genes (Allison, et al., 
submitted for publication). Sequencing of genomic portions has been based on a physical 
map composed of different BamHI and EcoRI restriction fragments of the entire genome. 
In this study, we intend to proceed with the sequencing and characterisation of phage 
SN genome focusing on the 13 kb SÍV BamHI restriction fragment A portion adjacent to 
the pac site. 
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3.2. Results 
In our experiments, we used a directed approach to clone and sequence the initial 5.5 kb 
portion of S. flexneri bacteriophage SW BamHI fragment A. Southern hybridisation was 
then performed to map overlapping adjacent fragments. A 0.7 kb EcoRV -SacI and a 0.6 
kb Hindlll DNA segment located near or at the end of the initial 5.5 kb Fragment A were 
used as probes for the hybridisation experiments. Detected segments were cloned and 
DNA regions beyond the hybridised segment were sequenced through primer walking 
using the whole SfV genome as template. A 10.1 kb sequence of the approximately 13 
kb fragment A was derived. And as in the serotype conversion genes flanked by the SN 
BamHI fragment C which has been characterised, the sequencing of SW BamHI fragment 
A will contribute to the completion of the entire genomic sequence, an important 
preliminary step in extracting further information on the nature and properties of its 
protein products through sequence analysis and further works in proteomics. 
3.2.1. Bacteriophage SIT/ for confirmation of its identity 
To generate and capture SW BamHI fragment A for cloning and sequencing, our SW 
stock was propagated in attenuated S. flexneri serotype Y strain SFL124, recovered by 
polyethylene glycol (PEG) precipitation, and its genomic DNA purified by chloroform 
extraction and dialysis against Tris -EDTA buffer [Sambrook, 1989 #145]. Once isolated, 
the DNA was digested with BamHI and EcoRI which produced DNA fragments identical 
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to the restriction band pattern visualised in an earlier SfV DNA digest (Figure 3.1A and 
B)[Huan, 1997C #230][Allison, 2000 #199]. 
3.2.2. Characterisation of pNV728 
The 8.2 kb recombinant plasmid pNV728, is composed of pUC18 [Yanisch- Perron, 1985 
#158], conferring ampicillin resistance, and the 5.5 kb phage SIV BamHI -SacI segment of 
BamHI fragment A. pNV728 which was created by G. Allison, was transformed into 
JM109 and the resulting transformant designated as strain B823 (Figure 3.2). The insert 
corresponds to the initial segment of the 13 kb BamHI fragment A adjacent to the D 
fragment. pNV728 was characterised by digesting it with different enzymes and 
observing which would generate fragments of appropriate sizes for subcloning and 
sequencing. The enzyme should have several sites in the insert and none in the vector 
except for the one in the polycloning site. BglII and ClaI sites were not present in 
pNV728 while SmaI cut once at the vector's polycloning site. These were shown by the 
presence of a large single high molecular weight band along the lane while KpnI and PvuII 
produced 6.1 and 2.1 kb fragments and 2.6, 2.3, 2.3, 1.0 kb fragments, respectively 
(Figure 3.3A). The double 2.3 kb band in PvuII digest was detected based on band 
intensity comparison seen in subsequent digests (data not shown) and in consideration of 
the total size of the 8.2 kb pNV728 plasmid. EcoRV generated two bands and HindIIl 
four bands of appropriate sizes which were ligated to pUC19 for cloning and for use as 
sequencing templates (Figure 3.3A and Figure 3.4). 
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Figure 3.1. A, 0.7% Agarose gel electrophoresis of phage SfV whole genome digests. 
Lane 1, Marker phage SPP1 cut with EcoRI; Lane 2, BamHI cleavage products: 
A -13 kb, B -6.7 kb, C -5.0 kb, D -4.6 kb, E -2.8 kb, F -2.1 kb, G -1.7 kb, H -1.5 kb; 
Lane 3, EcoR1 cleavage products: A -15 kb, B -7.4 kb, C -4.8 kb, D -3.3 kb, E -3.0 kb, 
F -1.2 kb. Asterisks represent submoIar bands. 
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Figure 3.1. B, Physical Map of Bacteriophage SfV showing restriction fragments represented by the letters of 
the alphabet. Also indicated are the locations of BamHI Fragment A, pNV728, thexis- int- attPregion 
and the putative pac site (Adapted from Huan et al., 1997 and Allison et al., submitted for publication). 
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Figure 3.2. Construction of pNV728 and transformation into JM109 
A 
8.6\ M 
6.1- 
4.9 - 
3.6' 
2.8' 
1.9- 
1.e i" 
1.5/ 
1.41/ 
1.2 
> 
W 
6.1- 
2.8 
M 
1.8- 
1.5 
1.4-- 
1.2 
1.0- 
0.7- 
Figure 3.3. A, 0.7% agarose gel electrophoresis of pNV728 single digests. B, 0.7% agarose 
gel electrophoresis of pNV728 single and double digests. C, 0.8% agarose gel electro- 
phoresis of pNV728 cut with EcoRV /Sacl and HindIII/Sacl in duplicate lanes. Note 
the resolution of run -off fragments in C which were not shown in B. M designates the 
SPP1 marker cut with EcoRI 
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Figure 3.4. Hind1II digests of recombinant plasmids containing pUC19 vector 
plus the five Hindlll fragments of pNV728: Lanes 1 -2, pNV753 is self -ligated 
pUC19 with 0.3 kb portion from pNV728 insert ; Lanes 3 -4, pNV751 with the 2.0 kb insert; 
Lanes 5 -6, pNV749 with the 1.4 kb insert; Lanes 7 -8, pNV750 with the 1.2 kb 
insert; and Lanes 9 -10, pNV752 with the 0.6 kb insert. M, phage Sppl marker 
cut with EcoRI. 
In order to sequence the SW genome beyond the only SadI site in BamHI fragment A, 
pNV728 was mapped to locate fragments near the SacI site which can be used as probes 
that would detect fragments flanking the SacI site. This was performed by doing a single 
enzyme digestion of pNV728 and a double digestion using the enzyme which was used 
initially plus SacI. The fragments produced upon double digestion were considered 
candidate probes since these were generated only in the presence of both Sacl and the 
initial enzyme and that these fragments must be bounded by the SacI site. Figure 3.3B 
showed a -0.7 kb run off band which was deduced when pNV728 was digested with 
EcoRV and SadI. The size was estimated from the difference between the larger EcoRV 
fragment and its resultant size after digestion with EcoRV and Sac. When the double 
digests were resolved in a higher agarose gel concentration of 0.8 %, the run -off fragment 
was visualised (Figure 3.3C). This 0.7 kb EcoRV -SacI fragment was used to probe 
fragments flanking the SacI site. Similarly at this gel concentration, the 0.6 kb run -off 
fragment of the Hindlll -SacI double digest which was not seen in the single HindllI 
digest, was visualised (Figure 3.3B and Figure 3.3C). This 0.6 kb HindIII fragment was 
also utilised as probe. 
3.2.3. Sequencing of the 5.5 kb portion of BamHI Fragment A 
Hindlll digestion of pNV728 yielded fragments of appropriate sizes for cloning and 
sequencing. These fragments ranging in size from 0.5 -2 kb were chosen because the 
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integrity of sequencing signals in the sequencing reaction covers around the first 500 bases 
of the template past the primer. Therefore, if we could use a template with a 1 kb 
insert, the entire insert would be sequenced in a single sequencing run without the need 
for primer walking. One 3 kb pNV728 digest fragment containing the vector and a 0.3 kb 
DNA from the 5.5 kb fragment A was also purified from the gel, self -ligated and 
transformed into JM109 (Figure 3.4 lanes 1 and 2). The other HindIIl digest products 
from pNV728 with molecular weight sizes of 2.0, 1.4, 1.2, 0.6 kb (Figure 3.4) were 
eluted from the gel, ligated with HindIII cut, gel- purified and dephosphorylated pUC 19 
vector, before transformation into rubidium chloride competent [Davis, 1990 #213] 
JM109 host. Five white colonies were picked from each ligation. These likely 
transformants represent strains which were not capable of a- complementation indicating 
carriage of the recombinant plasmid. After alkaline lysis minipreparations of the 
plasmids, uncut forms were visualised on agarose gel and those which appeared to have 
acquired the insert were selected. These were cut with HindIII and the insert sizes 
verified by agarose gel electrophoresis (Figure 3.4). The successful transformants were 
strains B860 containing pNV753 with self -ligated 2.7 kb pUC19 vector and 0.3 kb insert, 
B858 containing pNV75I with the 2 kb insert, B856 had pNV749 with the 1.4 kb insert, 
B857 had pNV750 with the 1.2 kb insert, and B859 had pNV752 with the 0.6 kb insert 
(Figure 3.4). These plasmids served as templates in the sequencing reactions of pNV728 
inserts initially using the universal forward and reverse MI3 primers. Amplified 
extension products were purified using the sodium acetate protocol in preparation for 
sequencing in the ABI Prism 377 DNA Sequencer. Primer walking using custom primers 
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(Life Technologies, Inc., USA) were used to fill in gaps and to sequence both strands of 
the fragment. At this stage, the initial 5.5 kb BamHI -SacI portion of phage StY BamHI 
fragment A in pNV728 was sequenced and a physical map is presented in Figure 3.5. 
3.2.4 Restriction probes detected fragments flanking DNA immediately downstream of 
the initial 5.5 kb portion of BamH1 Fragment A 
To proceed with fragment A sequencing beyond the lone SadI site of the 5.5 kb pNV728 
insert, we identified and cloned fragments adjacent to and overlapping the SacI site. 
Two probes were chosen based on the proximity of their location to the SadI site of the 
5.5 kb BamHI -SacI portion of pNV728 insert deduced from restriction mapping (Figure 
3.6). The first probe was the 0.7 kb EcoRV-SacI that was not produced when pNV728 
was cut with EcoRV alone (Figure 3,3A and 3.3B). When comparing EcoRV digests of 
pNV728 to EcoRV -SacI double digests, a -0.7kb reduction in the size of the largest 
fragment was noted suggesting that an EcoRV site was 0.7 kb apart from the SacI site 
(Figure 3.3B and 3.3C). Hence this 0.7 kb fragment was used as a probe. Another 
probe was used that provided additional supportive information in the analysis of the 
Southern hybridisation results. This was the -0.6 kb HindIll digest fragment of pNV728 
(Figure 3.6). Assembly of the sequence of the 5.5 kb BamHI -SacI fragment indicated 
that the 0.6 kb HindIII fragment is adjacent to the 0.3 kb sequence of pNV753 (bounded 
by the SacI site), making the 0.6 kb Hindlll fragment another suitable probe to use 
(Figure 3.6). Southern hybridisation was performed using these 32P- labelled probes 
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Figure 3.5. Genetic map of pNV728 insert containing the DNA of the initial 5.5 kb portion of 
phage SfV Bamill fragment A. Relevant restriction sites are indicated. MCS is the multiple 
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Figure 3.6. A, Location of the 0.7 kb EcoRV -Sacl probe and the 0.6 kb HindIII probe . 
relative to the genetic map of pNV728 insert. B, 0.8% agarose gel electrophoresis of pNV728 double 
digests showing the 0.7 kb EcoRV -SacI and the 0.6 kb HindIll fragments which were radio -labelled and 
used as probes for Southern hybridisation. 
which hybridised with alkali- membrane blotted fragments of the SW genome digested 
with different enzymes. Two identical membrane blots were prepared each containing 
various enzyme digests of SW DNA. Membrane blot 1 (Figure 3.7) was probed with 
32P- labelled EcoRV -SacI probe while blot 2 (Figure.3.8) with the 32P- labelled HindIII 
probe. Fragments detected by both probes were the 13.0 kb BamHI band and its 
submolar band; 18.0 kb EcoRI band and its submolar band; 20 kb, 6.5 and 5.1 kb Kpnl 
band; 6.1 kb and 5.3 kb EcoRV band; 7.0 kb Pstl band; 2.0 kb Pvult band and 0.6 kb 
HindIII band (Figure. 3.7 and Figure 3.8). The 2.0 kb HindlIl, 2.7 kb Pstl, and the 4.2 
kb PvuII bands were only detected by the 0.7 kb EcoRV -SacI probe (Figure. 3.7 and 
Figure 3.8). 
3.2.5. Sequencing downstream of pNV728 SacI site 
Three fragments detected by the EcoRV -SacI probe which were not detected by the 
HindIII probe were selected for cloning and further sequencing of the BamHI Fragment A. 
It can be deduced that the fragments detected by the EcoRV -SacI probe and not detected 
by the HindIll probe are DNA segments extending to the right of the SacI site since the 
HindIIl probe is situated 0.3 kb to the left of the SacI site (Figure 3.6). Had the selected 
fragments extended leftward, they would have been detected by the Hindlll probe. The 
three fragments were the 2.0 kb HindlII, the 2.7 kb Pstl and the 4.2 PvuII fragments 
(Figure. 3.7, 3.8). The location of these probe- detected fragments relative to the BamHI 
fragment A of phage SN genome is shown in a schematic representation of the 
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Figure 3.7. Southern hybridisation of the SfVgenome. A, 1.0% agarose gel electro- 
phoresis of SfV DNA digest fragments. B, Autoradiograph of membrane blot 1 showing 
fragments from gel A that hybridised with a 0.7 kb EcoRVISacl radioactive 
probe. (see also Figure 3.8). 
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Figure 3.8. Southern hybridisation of the SfVgenome. A, 1.0% agarose gel electro- 
phoresis of SW DNA digest fragments. B, Autoradiograph of membrane blot 2 showing 
fragments from gel A that hybridised with a 0.6 kb Hindlll radioactive 
probe. 
combination of sequence and hybridisation results in Figure 3.9. Sequence information 
from the overlapping fragments provided a basis that ensured our sequencing through the 
right side past the SadI site of the SW BamHI fragment A. Sequences beyond the 4.2 kb 
Pvull fragment were read through primer walking. 
All the sequence results were initially proofread and edited individually, based on the 
sequence information from the complementary strand of the genome, prior to a fmal 
assembly using 2D WebAngis fragment assembly program. A single contiguous sequence 
of 10109 bases was derived from a total 58 input sequences including 4 major edited 
contigs (editcons1 to 4), and utilised a total of 34 customised primers shown in Figure 
3.10. The complete I0.1 kb sequence is presented in Figure 3.1 1 showing the relevant 
restriction sites. 
To confirm the identity and the correct continuity of sequencing from pNV728 through to 
the Sad site and the three probe- detected fragments, relevant restriction sites which 
were separately predicted by the WebAngis WAG mapsort program for pNV728, the 
three probe detected fragments containing the SadI site [2.0 kb Hindi-II (pNV756), 2.7 kb 
PstI (pNV755) and 4.2 kb PvuII (pNV754) fragments], and the 10.1 kb contiguous 
sequence were compared. Four restriction sites in the order of Hind[ri, PstI, PvuII, and 
SacI sites inherent in the pNV728 insert were also found in the same ordered location in 
pNV756, pNV755, pNV754 and the 10.1 kb fragment A sequence (Figure 3.9 and 3.11). 
The pNV756 HindIIl fragment had the PstI site at nucleotide position 18, Pvull site at 
101 
BamHI Sc c I 
55kb > 13 kb 
BamHI 
Fragment A 
opiammaionameampNV72 
Bant 
MCS 
-II Hindill 
1386 
Hindlll 
2602 
Hind111 
4517 
Hind111 
51S1 
Sad 
5591 
kb 1.4 1.2 2.0 0.6 D.3 
Individual Hindi!! < ><>< ><> 
pNV 750 752 753 
--->"fragments ligated 
to pUC19 Probet 
EcoRV Sad 
4831 5591 
Probe i 
0.6 kb 
Hindi! 
7 0 kb 
Pst1 
2.0kb 
Pvul l 
pNV756 
Sad nt. 5591 
Pvttll nt. 5355 
Pst1 nt. 5220 
% pNV755 r 
y Sad nt. 5591 
Pvull nt. 5355 
2.0 kb 
Hindill 
2.7 kb 
Pst 1 
pNV754 
Sad nt. 5591 
4.2 kb 
Pvull 
Figure 3.9. Schematic representation of the membrane blotted fragments detected by the 
0.7 kb EcoRV -Sacl [..>",:;,:/; and 0.6 kb Hindi"' probes. Relevant Hindlll, Pstl, 
PvuII, and Sucl restriction sites on the 0.3 kb Hindlll -Scrcl pNV728 fragment with their 
corresponding nucleotide position in pNV756, pNV755, and pNV754 are indicated by red 
arrows. The nucleotide position of restriction sites were predicted by the Mapsort program of the 
WebAngis WAG package. The green solid block serves as boundary line distinguishing between 
0.7 kb HíndIII and 2.0 kb HindlII fragments; 7.0 kb Pstl and 2.7 kb PstI; and the 2.0 kb PvuII and 
4.2 kb Pvutt fragments. 
SEQUENCE NO. PRIMER LOCATION/ TEMPLATE HOST/ PRIMER 
DÁ144 +-> /SfV genome/ 5'- CATCTCGGACTCCTGTTC -3' 
DA 146 + -> /SfV genome /5'- GTTGGGGTAAGATTTCCG -3' 
DA145 +- -> /MI genome /5'- CCAAACGCACAGCAGATC -3' 
DÁ133 + --> /SfV genome/ 5'- CGGGAGCCTTTATTGACC -3' 
DA143 + -> (SW genome /5'- CATCTCGGACTCCTGTTC -3' 
DÁ142 < --+ /StV genome / 5'CGCCATCTTGATGACCTG -3' 
DA105 < --+ /ESNO92 Pvu!I/ M13 Universal Forward Primer 
DA141 + - --> /SfV genome / GACACCCAGATATTGAGG -3' 
DA 119 < --+ /ESNO92 Frull/ 5' -GTTTGA ACCGCTGATCGG -3' 
DA126 + -> tESNO92 PvuII/ 5'- GTTCTGGACGATAGTGAC -3' 
DA 127 < - --+ /ESNO92 Pvull/ 5'- CCTCAATATCTGGGTGTC -3' 
DA 121 + --> /ESNO92 PvuII/ 5' -CAGAGCATCAAGCAGCAC-3' 
DA 138 < - - -+ /ESNO92 PvuII/ 5' -GATGAAAGAGCTGGAAGC -3' 
DA103 < -+ /ESNO78 Pull/ M13 Universal Forward Primer 
DA122 < --+ /ESNO78 Pstl/ 5'- GCTACAAATGGCGCGAAC -3' 
editcon4 + > 
DA123 < - --+ /ESNO92 PvuII/ 5'- GCTACAAATGGCGCGAAC -3' 
DA134 + --> /ESNO92 Pvull/ 5'- CGTCAGATTGAACCTGAC -3' 
DA101 < --+ /ESNO75 HIII/ Ml3 Universal Forward Primer 
DA 132 < - -+ /ESNO78 Psi!! 5' -GATCAATGGCAGAAGGCA -3' 
DAI24 + - - -> /ESNO75 Hill/ 5'- CGAATGGTCTGTGTCTCC -3' 
DA 117 <--+ /ESNO75 HIIU 5'- GAGCITAACCGTCGCTTG -3' 
DAI20 +--> /ESNO75 Hn!! 5'- GCTTTGTTCCACTCCGTG -3' 
DA125 < - --+ /ESNO75 Hill! 5'- CTTGGTGATGATGTACGC -3' 
DA 106 + -> ESNO92 PvuIl/ M13 Universal Reverse Primer 
DAOI +-> /ESNO14 (IC)/ M13 Universal Forward Primer 
DA104 + --> !ESNO78 Pst1/ M13 Universal Reverse Primer 
DA 137 < --+ /ESNO75 H111/ 5'- GTGATAACGCATGGACGG -3' 
DA102 +-- >!ESNO75 HIIU M13 Universal Reverse Primer 
DA112 + - - - >l pNV728 (GA95) /5'- CAACACrGAAGCAGGTGC -3' 
editcon3 + > 
DA012 s--> /ESNO36 (6C)/ M13 Universal Forward Primer 
DAOI3 < - - - -+ /ESNO36 (6C)/ M13 Universal Reverse Primer 
DA128 + --> /pNV728 (GA95)/ 5'- CTGGATAACCTTCGCCCA -3' 
DA069 < - --+ /pNV728 (GA95)/ 5'- GTTGGTOGTTGATTAGTC -3' 
DA094 < --+ /ESNO73/ M13 Universal Reverse Primer 
DA03 < --+ /ESNO21 (3Brev)/ M13 Universal Reverse Primer 
DA109 + - - -> / pNV728 (GA95)/ 5'- GATGATGACTACGACGAC -3' 
DA064 <---+ /pNV728 (GA95)/ 5'- CGCCATCACCCATTACAT -3' 
DA063 + - --> /pNV728 (GA95)/ 5'- ATTCAGATCCAGCAGCGT -3' 
DAM <---+ /pNV728 (GA95)/ 5' -CTGGCTCCACGTAATAAC -3' 
DA02 +--> /ESNO21 (3Bfor)/ M13 Universal Forward Primer 
DA093 +--> /ESNO73/ MI3 Universal Forward Primer 
DA 110 < - --+ /pNV728 (GA95)/ 5' -CGCTGCTGGATCTGAATC -3' 
editcon2 +- > 
DA07 <--+ /ESNO32 (SCrev)! M13 Universal Reverse Primer 
DAI 15 + - --> /ESNO32/ 5'- CCGTAGTAATTGAGGCTG -3' 
DA067 + -> /ESNO32/ 5' -TAAACTGGTCACCTTGCG -3' 
DA135 <-- + / pNV728 (GA95) / 5'GAATGTCTATGTGGGACG -3' 
DA06 + --> /ESN032 (SCfnr)! M13 Universal Forward Primer 
DA116 < - --+ /ESNO37/ 5'- TGGTGAACGCAAGGTGAC -3' 
DAI13 +---> iESN026/ 5'- GTTTCCTTGCGGTCCACT -3' 
DA04 < --+ !ESNO26 (4Afor)/ M13 Universal Forward Primer 
DA066 + - --> /pNV728 (GA95)/ 5'- GAGGTATTAAGCCGTCAG -3' 
DA065 < --+ /pNV728 (GA95)/ 5'- ATTGAGGTGCCCATGAAC -3' 
editconl + > 
DA05 + - -> /ESNO26 (4Arev)/ M13 Universal Reverse Primer 
DAl l4 < --+ /ESNO26/ 5'- CGAAATACATTGTGCGGC -3' 
CONSENSUS+ > 
-----i f 
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Figure 3.10. Gelassemble bigpicture of the single contig 10,109 kb bacteriophage SfV 
BamHI fragment A showing the primers used with its location and template host. Arrows 
indicate sequence location, length and direction of strand replication. Total contig input 
was 58 and editcons 1 -4 represent four major edited contigs. 
Figure 3.11. The linear sequence of the 10109 bases of phage SfV BamHI fragment A 
showing the relevant restriction sites used in mapping as predicted by the Mapsort 
program. the restriction sites =indicated in red text and the enzyme recognition 
sequences in italicised bold print. 
BamHI 
1 GGATCCCCTG ACGCACCAGC ATCTGCATCA TGTTCTGGAA ATCAGCCGTT 
51 GTACCGGGTA GCTGGTTACC CAGGCCAATA GCCAGTTTAT TGATGTCCTG 
101 AAAGCTCTTT CCAACCTCGC CGTTCGCATC CATCATGGCG ACTTTCAGCC 
151 CGGTGGCGGC GTTTTCCTGA TCGGCATAAG ATTTCAGGGA AAGCGTCAGC 
201 CCCGCTGCCA GTCCGCCACC AAGCGCCAGC CCACCCTGTG ACGCTTCTTC 
251 CGCCTGGCGT TTAAATCCCC GGATTTTCTT TTGCATTTTC GACAGCGCGG 
301 GAGAAAGCCT GTCGACACCG GTGATCAACG CCTTAAGCTC AAATTCAGCC 
351 ATGTGTGCGT TTCTCCTGCT CTATCCTGTT TGCCTGACTG ACCAGTAAGG 
401 GAATTTCACT GATCGGCATA TTCAGCAATT CGAAAGGATT AATGCGCCAG 
45I TAGCTGGCGC AGTCAAAGAA GCGATCAGTG AGGTATTCAG CCGTCAGGCC 
501 TGGAGGAAAA AACCAGCCAC AAGCCACGCC GCTGCATTCA GGTCTGCCGG 
551 AGACATCTGG TCGACAGAGC TTTGCGGCAC TTTCGCCAGC CGCACAATGT 
601 ATTTCGACAC CACATGCGCC AGAAGTCTGA CTGACTCATC CTGATTCATC 
651 TGGTAGGGAT ACCCCAGCTC GCGGACATCC TTCCCGCTGG GTTCATCAAA 
701 CTCCAGTACG GAGAGTGTCT CGCCATGAGC AGTAATCGGT TTCTTTAACT 
751 CAAGCTCTTT CATTACTGGT AATCCCCTTC TTCACCGTGG AACTCAAGAT 
801 CAACCGTACC TTCTTCGGCA TTATGGTTCG CTTCGCCGTG CAGCCAGGCT 
851 GACGACAATA CATAGACCTG ACCGTTCGCC AGCTCGGCAG TGATGGTCAT 
901 CTCATCAGAC GAGGTGATTT TGCTCACCGG AAAATTCTTC GGCACCTTGA 
951 AGGTCCCTTT GACATAAGGC GCACGGTGAG TTTCCTTGCG GTCCACTGAA 
1001 CCGTCCAGGC CGATGATGTC ATCATTGACC GTCCTGTTCA TGGGCACCTC 
1051 AATGCCGCCG GTCAGCGATA GCTGCTGACC GTCAATTTTG AAATAACAGG 
1101 TTCCCCCGAT ACGGGCCATT ATGCAGACTC CTCTGAATAC TGAAGACGGA 
1151 ACTGGTTAAC CACGGCAAAA ACACGCAACT GGTTAACATA GTCAGGCGGG 
1201 AACAGCGTGT TCAGGCGGTT CGGAACGCTG GCATCACGCT CCACAACCAG 
1251 GTACTGCTTA AACAGTTCGT AGTTTTCCAC GATCCCCGCA CGCTCAAGCT 
1301 GACGGTAGGT TGCCAGCAGT TCCCCTTTGA TTACCGCCGG GGTGACAATC 
1351 GCCTGACCGG GACCAAAGCG GGTACCGTCG CTGGCAAGCT '1GTGACGCCC ffindIII1386 
1401 GTACTTACTG GTAATGACGG ATTTCAGTTT GCGCAGTACA TACGCACTGG 
1451 TATGCAGCGT CTCGCTGTCG AGGTAGCTGT TATCCGCAAC CCCGTAAGCA 
1501 TTTTTCCTGT ACGTGGTGAC ATCACGCTGA ATGCGCAGCA CCCCGCTTTC 
1551 GACATACGCC GTTGCCACGC CATGAGACAG CAGGGTCTGC TGCTCGGTCA 
1601 TCGTGAACCG TTTCCCCTTC GGCGCAGGCA GCATACCCAC CAGCTCACCG 
1651 GTCTGCGTGG GACGTGCCGG ATCGTTGCGG ATAAACACCG CTGCACGGGC 
1701 GGTACGGCTT GCCGCCAGCT CGTCGGCAGG CGTCTGGGTC TCTTTTTCGT 
1751 ACCCCGCCAG GGTGATGTGC TGCTGGTTAA ACTGGTCACC TGCGTTCACC 
1801 AGTTCTGACA GTGTGCCGGT CTTTGCCGTA TACACATGAC CATACAGCTG 
1851 ACGCGCATAG CTCCAGCGAC CGCTGGTATC GTTCATCTCG GTCACCAGCG 
1901 TGTTAACGGA GGCCGTGTCG TTGAACGGCA GACCGATATA ATCAAACGGC 
1951 TCATCCGCCA TTGCAGCCAC CGCGCCGGTG AGAACCGGAG CGCCCGTTCC 
2001 GGCGGTCCCC GTCGCCACGG CAATCTGTAC GCCCGCTGGC AGCACTTCGC 
2051 CCCCACCGAA GCCGTAGTAA TTGAGGCTGA CAGGAATTTC ATTCCCGCAA 
2101 AGCCCCTTAT GACGCGCGGT CAGCGTGACA ACACCAGCCG AAGATGAAGC 
2151 TGTAAACGGC AGAGTCGGAA CGGCATTGAT GGCATCCTGG ATACTGCTGG 
220I CAATCGTCGT GACGTTATCG CCGTTGGTCA CCGGAGCCTG CACGCGGGTA 
2251 CGTCCCACAT AGACATTCAC CGTGCCGCTT TCGGTTGCTT CCCCGGTCAC 
2301 CGTCAGCGTA ACCGTTGCCG CCGCGCCTGT GGCTTCCGGA ACGGCAATCA 
2351 CATACAGCTC ACCAAACGGG TCGGTCTGGC GATAAGCCTC GACCATACGC 
2401 GCCAGCTGAC TTCCCGCACC ACAAATCTGG CGTGCATAGT CTGCCGACGG 
2451 CATCAACACC AGACTGTTGG CAACAATCTC TGCACCGTTA TTGGCGTGAC 
2501 CAATCAGCAA CGATGCCCCG CTGTCCTGTG CAGTATTCGC CGCCTGGTTA 
2551 TCCATTTCCG CATAAAACAG CGGAACCAGC GTATTCGACG GAATGGTGTT 
2601 AAAGCTTATC GTCATCGGTG TTCACCTTTT TATTAACGCG CCGGATATCA HindIII2602 
2651 CCCGCTGCTT CACGGCGCAG CCAGTAGTTG TTCTCGTCAA CATTTCGCCC 
2701 TTCGGCGGGC AAAAGGTCAC CGCGGGCAGG GTCAGGCACT GACCGCCCTT 
2751 TAACAGGTTT CACAAACATG AAGATTCTCA GGAAGGAAGG GTTATTTCGG 
2801 TGTGATGTTC GATATCGCCG TCAGGCCCGT TACCGGGATC GAGATAATCA 
2851 ACATCAATCG CCAGCGTTCG CAGTTCATCC AGACTGTTCA GCTCATCCTG 
2901 CTGGCGGGTA TCGTCTTCGG TCAGCTCGCT GATGACCGAA AAATCGAACT 
2951 GATAAATCAG CTCATGACGA TTCAGATCCA GCAGCGTGCC GCCGTCATAG 
3001 GTAATCGGGT TACCGCACGC TTCCGGGTTC CAGCCCAGCA GGGCCTTAAA 
3051 GAGCATCTGC CGGACATCGT CCACCACATC ATACGAAGCA AACTGACCGC 
3101 GCTCATCACG CCCGTTACTC AGTATGACAA CCACGGAGAA GCCCTCTTTC 
3151 AGCTCCTGCC AGTAGTCGGT CTGGCTTTTG TTTTCTCCCG GAGAGTCATC 
3201 ACCCGGTACC ACATACGCCG CCGGGAGTCT CAGCTTTCCG ACCTCCGGCA 
3251 GATTTTTGAA CTGTGCCGCG CCTGCCACCC GGTTTTCAAA ATACGGGCAG 
3301 CGGGCACGCA GCGCAGCAAT AACAGGCGTC AGTTTCATCT GCGTCGTCGC 
3351 TCCGGCTTCA GTGATTTACG TAATTCCCGC GCCAGAAAAT AGCGTGTCCA 
3401 GCTGCGGTTC TTTTCAAGCG TTTCCACCAT AAAGTTATTA CGTGGAGCCA 
3451 GCCGCCAGCC GCTGCCACCG GATGCACCAC GATGATGACT ACGACGACGT 
3501 TTTGCTCCTC CCCGGACGCC ATAGAACAAA AAAGCCGGAT AAAAATCACC 
3551 GGTGATGCGG CGGTTTCCCT CACCATTACG CTGGTTAGGG GCTATACGTG 
3601 CCATAAAACC GGGGCGATGT TTACTGGCTC TGGGTACCAT GTAACCAATC 
3651 GAACGAGCCA GGCGTCCGGT CTGATAACCG GGGTTTTCAC CCGGTGCCGA 
3701 CCGCGCATGG CGCATCACCA GCCGACGGGC ATCACGCATA TGACGCTGAC 
3751 CAATCGTGAC AAACGCCCGC CGGACACGGG CGCGGTTAAA GCGCATCTCC 
3801 GCGGGCTGCT GAAAATCAAC GTGCAAAAAG GAAGTCGTCA TTGTTGCCTC 
3851 CGTGACTCTG CCTACATTCG CCCAGCTCCG TACACTCCAG CAGCAGAAAA 
3901 CGCCGCGCCC CGTTCAGATC GCGCTGACGT TTCACCCGGT ACACACTGTC 
3951 ACCGCAGACC ACCTCATAAT CAGTGGTGAT CCCCCGGCGG TAACGAATGG 
4001 TGATGTAATG GGTGATGGCG TCCCCGGTCT GCGCGGTTTC CTGCCAGGTG 
4051 GTGGCACTGG TCTGGATAAC CTTCGCCCAT GTCCGGAACG TAACCGGGTA 
4101 TTGAGGCTCC ACGCCAAAGT TATCCGCGGG CATATCCACC CGCAGGCGGA 
4151 TCAGGACGCG TTTATTCAGT TCGCCGGGGT CCGGCAGAAT GTAGGTTGCG 
4201 CTGGTCTGTG CCTGACGAAT TTTCATAGTG GTATAAGGCG ATAAGGAGCA 
4251 ACCAACCAGT TAAAACTCAT TGGCAACTCC ATTTTCTCAA CGTCTGTAAC 
4301 CGTTGAGCGG TTTTCGTAGA AATGGCTGAC AAGTAGCAGA AGTGCCAGCT 
4351 TCACATCATC AGATATCACA AGCCCATCAG GATCATCCGC AGGCCTGTCA 
4401 TCTGCGGTTG CATACAACTT ACGGTTAAGG AAGTTTTCCG TTCGACTCTG 
4451 AGCGGCCTTA CCAAGCAGTT CAAGCAACTC ATCTTCATCA GAGAAATCAT 
4501 CATCCAGACG GAGCTGAAGC TTAATCTCTT CCATTTTTAA CAGCATAAAA HindIII4517 
4551 CCTCCTGTGC CCGCCAGAAC GCGGGCACAA AAAAACCGCA TTACGCGGCG 
4601 TGCTGTATTA CGTAAAAAGA CTAATCAACC ACCAACGCTA CCTTTCCCCA 
4651 CCAGCGCTTT AATGGCAGAG GTGTCTTCCA GGATACAGTC AAAACGATGG 
4701 AAGGCCAGAA AACCGGTCTG ATCATATTCC GCGTAACGCT CAACCAGACG 
4751 TTTAAGAATC ATGTATCGCA CACGACGGAT AATGAAGCGA TCAAAGTCAC 
4801 CACAGAACAT GAATTTTTTA CCCGCCCCGA TATCATCAAT TTCCTGATCA EcoRV4831 
4851 ATGACATACG GTACATTCAA CACTGAAGCA GGTGCCACAC CAACAATATC 
4901 CGGCAACCAT AAAGGGCGTC CCTGACCGTC TTCCATCTCA CTGATCAGTT 
4951 TCAGCGTATT ATCGTTAAAC GCCAGGCGGA ATTTCGGTCC GCGACGATAT 
5001 GCAGGATCAA TGCTGTGTTT CAGAGCCAGA ATTTCCTGCC ACTTCACCGC 
5051 ATTTGCCGCG GCAGTCTGTG TTGTGCCGGT CACTGATGCT GCCAGCCCTT 
5101 TGGGTTGTTT AGGCGTACCA GCACCCGTCC CCTGAATCAG ATAACGGGCT 
5151 TCACCACGAC CAATACGTTC AGCAATGCGA CGGGCAAGAT AAGCTICCAT HindII15191 
5201 ATCGATCGCG CTGTCCTGCA GCAACTCATT AGACACACGA ATGATTTTCG PstI5220 
5251 ATGTCATTTT GAGCGCCCCA AGACTTCCCA TACCGAAATC GGTGTCTTCT 
5301 TCACCGGCTT CTTCATTTTC GCCCAGCAGA ACACCAACTT CGGAAGTACC 
5351 ATCAGCTGTT GCCCACTCCA TGGTGCGACC GTCAGAAGTG GTCAGAATCT PvuII5355 
5401 GCGCCACACT GGCGATGCCA CCGTAGGATT TCATCTTCTC AACAACTTTC 
5451 GCCAGGAATG TTTCTGGTAC GGTATATCCG CCCTTTTCAT CCTGAGCTAC 
5501 ACCCTGGGCA CGAAGTTCAC GCAACGCCTT TCGCTCTTCT GATGTCAGCT 
5551 CACTGGCACC GTGACGCATC CACTTATCAA AAACCTGAGC TCGTTTCTCA SacI5591 
5601 TCCTGTTGCG AATTGTTTTC CGGATCAAGA TTCTGACGCT GCTCTTCCTC 
5651 ATTGCTTTCA ATGTACGCCT GATCCTGACG ACGCAGTTCT TCTTCGCGTG 
5701 CAATTCGTTC ATCAAGCGCT TCCAGTTCGG ATTTTGCTTT GTTCCACTCC 
5751 GTGCGCTGCT CTTCCGTCCA TGCGTTATCA CCAATTTTTT CATTCAGGGC 
5801 GCGCATGTCA GTTGCGATAG TATTACGTTT CTGTTTCAGT TCATGCAGTT 
5851 TCATGATGTT TCCTTTACGC GTTAAGAAGG GTCAGGACGC GTTCACGCGC 
5901 CATACGTTGA TTAATGGCTT TCTGTAGCGC GCCGCTGTTG CGCGCCTCCT 
5951 GCCATGCTTT CATGGAGCGA ACAGCCGAGT CAGCCTCCTG ATAGGCAGGA 
6001 TATGTCACAG GACTGACATC CAGCAGACGG GAAAAGCGGG TTATCTCGCG 
6051 AATAACAACC CCGTCCTCAT CCTGATACCA CTCCTCACCG TCACGGGCGA 
6101 CACGGAAAGC GAAAGATGAC TGGTTAATAT CTCCACGTTG CATCGGGGCC 
6151 AGCACCAGAT CACGAATGGT CTGTGTCTCC GGAGCCTGGA TGTCATAGCG 
6201 TAATCCGCGC TCATCAACTG AGAGATTCAG CGTGCCTGCT GCACTACGCC 
6251 CAAGAATAAA ATTAGGATCG TGGTTAAACA GTGCGCGTAC ATCATCACCA 
6301 AGCACATCGT CAAAAGCGCC GGGCCGGATG ATTTCGCGGA ATGAACCGAA 
6351 TATCAGCTCA GAACGACAGT CAAACACCGA TCCATAACCG ATAATGTGCG 
6401 CCGGGTTATC GTCATGCCTC TCAGCACGCA CCTCACCGCT GTAACAACGG 
6451 ATTTCACGGT CATTCATTGG TTTTTCCCTC ATCGTTTTTT GGGGGCTTAA 
6501 AATCTCCTGC CGGGTTAGCA GCATTCACGC TTACCAGCAT CTCGTCCAGC 
6551 CCTTCAACCG GATTCATATC CTCGAATGCG CGGGCCTCAT TACGGCTCAT 
6601 CCATCCATCG GTAATAGCGA AGTGATAGAA TTGCGCGCGC TCCTGCGGAG 
6651 TTCCGCGTAA AAGCCCCGTC AGATTGAACC TGACGTAATA CCCGGCGGCT 
6701 AACTCAGCGC GGGTAAACAA GCGACGGTTA AGCTCCTGCT CCCAGTTCGT 
6751 CACCCACGGC ATCATCGTGT AGCGGACAAA CTGAATCGCC TGCGCAGAAA 
6801 TATTGGAGAA GGTGGCTTTT TCGAGGTCAT TAATCATGTG CGCAGGAATA 
6851 TTGAAAATAC CGGCGATCAT TGAACGGTTC AGCTTCATCA TGTCAATGAT 
6901 CTGAGCGTCA ACTGGCGACA CAGTCAGTGC CTTGTAATCC AGATCGGCTG 
6951 GCAGCAGCAT GGTTTTGTTT TCCTGGCGGC GTAACGCCTG CGATGCCTTC 
7001 TGCCACTGAT CTTTAAGCCA GCCCCAGCTT TCCTTATTGA GTCCGCTTTT 
7051 AACGGATACT ATCCCCGCCG GACGGGCATT ACCGCTGAAG AAGCTTTCTG HíndIII7091 
7101 TGTACTTCTG ACCGCTCATC CCCATGCCTA TTGTTTCGGC ATGTTGCATA 
7151 ATCGGACTCA GCCCCATCTT CTGATTATTA CCCAGCGCAC GGATGTGGAT 
7201 CATATCGTCC GGACTGATCG CAAACGCCCC ATATTCGTTG TACAAACCGT 
7251 AGGTATATCG GCCACCAGTA TTCATCAGCG TCGTTTCCCA CGGCATACAG 
7301 CAATCCAGGG ATATGACTTC ACCGCGACGA TTACGTTTCA CCCAGGTATA 
7351 CCCATTCCCC CAGCCAAGGA TGTGACGTTG TTTCAGTTCG CGCCATTTGT 
7401 AGCTGGTTTG CCAGGTATTG GGCTCATCAT GAACCAGATA AAACGCCGGA 
7451 TGATCGCGTG CGGGTTCAAC CTTCCCCTTG TGCCTGCGCA TAACATGCAA 
7501 CGGCATCTGG GCAAGGCTGG AAGACAGGAC ATAGATACAG GAATACACCG 
7551 CAGCCAGTTT CATCGCAGTC TCAGGACTGA CATAAACGTC TGCCCGGAAC 
7601 AGCCCATCAG TATCAACGGC ATCACCGGTT ATCGGGGTGG AAGGATTCTC 
7651 CAGTGATTTA CTTCTGAACA GAGCATCAAG CAGCACGCGT CCCCCTTCTG 
7701 GCCATAGCCA GTGCGCCCAC CAGCAGTAAA GCACCGGACA AAATCAGAGC 
7751 CGGAGCCATA CCAAACTGCA GY',TAAACCCC GCACGTAAGC AGGCCAAAAC PStI7770 
7801 CAGCCAGCCC GATAACATCA GCAATTAGTG ATTTCATAGA ATTAAGAGAT 
7851 CATCGTCCGG ATCAAGAGAT GAGAGGAAAT CGTCAGGTTC TTTGAGCATT 
7901 GCCCGACCGA TCGTCATAAT CAGTGCAACC GCACCATCGA TTTTGTTTTC 
7951 CGCCTGCTCC TTGACGGGCT TCACTAAATC ATCGTTACCT GGCATGTTTT 
8001 TGCCGACCAC ATTGCCGATA CACCAGGTCA TGATGGGATT GCCGTCATGA 
8051 TGAAAGCGTC CCGATTCAAT CGCTGCTTCC AGCTCTTTCA TCGGATCGGA 
8101 CATATTGGCG AAGTTCTGGA CGATAGTGAC GGGATTCAGA TCTTCATCAG 
8151 CAAGGTCATG TGACAGCCCG GTCGCCCCGA AGGGGTCGAT GGGTGACTCA 
8201 CTGACCGGGC TGATTTTGTT CGCCGCTTTG GCCTCCTCGA GGATGTAGCG 
8251 ATAATCCACC TCAGCACCAT CGGTAACGGT CAGGACGCCC ATTTCCACCC 
8301 ATTTCTGAAA GCGTTCGGCT GTCCGTCTAT CTTCATTTTT CTCGACGCTG 
835I TACACCGTGT CATACGGTAC CCAGAAGCGC GGGGCCACAC TGTAGTAATG 
8401 CGTTTTACCG TCAATCTCGC GGGTATAAAG TCGCGCCATG CTGTTCATAT 
8451 CCAGCTTACG CGCCAGGTCA AAGGCCAGAA TGCACGGCTG CCCCTCGAAC 
8501 TGCTCAAGGG TCAGTGATTT ATCCTCGCAG CTCTGCCAGC TCACCAGGTT 
8551 GAAATACGCC GAACGCGCCG ACACCCAGAT ATTGAGGTGT TTTGTTTTAA 
8601 AGACGTTTGC CAGACGGGCG TTATTTTTCG CACGCTGCTG CTGACTTAAC 
8651 AAAAATTCGC GATAAACCGA CACGCCAATA TTTGGATTGG CTTTTTCCAG 
8701 CACCTGCGGG TCGGTCCAGT CGTCACCTTC ATCAACGGTA TAGATGATCC 
8751 CGAACAGTTC ATCGTTAGGC ACCGAGCCGT TGAGCATCTC GATGACTTCC 
8801 CGCCGCTTGT CGTAGCACGG CCCCTCAATG TTGTACCCGG CGGTGGTGAT 
8851 GGCCCACATC AGTGGCTGAC GTCGCGCCCC CATCCCGGTA AGCATTGTGG 
8901 TATAAAGCGC ATCGGTGGCA TGCTCGTGAT ATTCATCAAC CACGGCACAG 
8951 TGGGGTGATG AACCATCACC GGGGTTGCCG ATCAGCGGTT CAAACCGCGC 
9001 GCCATCCTCC GGACGGTTCA TGTTTGAGGC GTTAACCTCA ATCCCGAACG 
9051 CTTCCGTCAG CATGGGTGTG CGTTTACACA TCAGTCGCGC CGGGCGAAAG 
9101 ACTTCCCACG CCTGTTTCTC TGTCGTGGCA CCGGAATACA CTTCCGCGCC 
9151 GAACTCGTTA TCACAGGCAA AACAATACAG GGCAACACCG GCAGAGATTG 
9201 CCGATTTGCC GTTCTTACGG GGGATTTCGG TATACACCTC CCTGAAGCGG 
9251 CGCAGCCGGG AGCCTTTATT GACCCAGCCA AACGCACAGC AGATCACAAA 
9301 GAGCTGCCAC GGTTCCAGCG TGATGGGCAT CCTCTTGAAT GCCCACTCCC 
9351 CCTTGGTGTG TGGCAACAGC TGAATAAATT TCGCGACCCG TTCAGCCAGG PvuII9369 
9401 TCCTTGTCGA AGCGGTAACG AAACGACTTA CTTTTTTCCG CCATCAGGTC 
9451 ATCAAGATGG CGCTGGCAGG CCTGAATCAC AAACTGGCAG GCCACAATCT 
9501 TTCCGCGCAC GACATCACGG GCATACTGAT TGGCAGCATT TACGTTGGGG 
955I TAAGATTTCC GGCTCATGAT TCGATGATTT TCAGAAACGG GTTAGTGGCT 
9601 TTCTTCTTCC CCGCCAGGCC AATCAGACGC TGGCGGCTGC TGGGGTCGAG 
9651 TCCGAGCATT GCCCCCGTAC TGCTCATCTC GGACTCCTGT TCTTTTTTGG 
9701 CGGTCAGCTC CGGATTTTTG ACCATACCGC CCATTGCACC GGTGATGGTG 
9751 TTGCCCTGTC TGGCAATATT TTTCACGGCA CGCCGCCAGA ACTCGTAGGC 
9801 CACGCACCAC CGCTCAAGCA CCGCGAGGTC AGTCACGCAC AGCAGGCCCT 
9851 GACCGCAGAG TTCTTTAGTT GTCAGTTGCC ACATGATCGT AGCGAGAGGG 
9901 AGATCTTCTT CAGCGAACCA CTCCGGTGGC TCAACACCTT TGATGGGCGT 
9951 AAAAACAGGT TCATCTTTAT TCAGGGCTCG CTTGCCGGGG TTTCCGGCCA 
10001 GCGCCTTGCG CGCCGTTGGC TTGGGGCGAC GCCCGGAACG CCCCGCCGTT 
10051 CCAGCCATAT GCGGCACTCC TGGTTAAATT TCATTTTTCG CGGGTATAAA 
1010I AAACGATAA 
nt. 153, and SacI site at nt. 389. The pNV755 PstI fragment had the PvuII site at nt. 
142 and SacI site at nt. 378. And the pNV754 containing the PvuII fragment had the 
SacI site at position nt. 264. In the 10.1 fragment A contiguous sequence, these sites 
had corresponding positions at HindlIl 5191, PstI 5220, PvuII 5355, and Sacl 5591. 
These similar enzyme site location and orientation ensured the identity of the DNA 
segments which were cloned and sequenced to attain the contiguous 10.1 BamHI fragment 
A portion. 
3.3. Discussion 
Fragment A of the SW genomic DNA is approximately 13 kb long and is situated 
between fragments D and F according to the BamHI map of the complete genome (Figure 
3.1B). EcoRI and BamHI were used to generate distinct DNA digest fingerprints which 
were used to construct a physical map of the SW genome (Figure. 3.1A) [Huan, 19970 
#230][Allison et al., submitted for publication]. This map served as a guide in 
establishing the identity of our phage stock and locating fragment A during the cloning 
process. Identical digest patterns were visualised on a 0.6% agarose gel electrophoresis 
run of our purified Proteinase K- treated SW DNA (Figure. 3.1A). 
A restriction map of the fragment A section of the phage genome was produced (Figure 
3.9). Due to the moderate size of the portion to be sequenced, a more direct sequencing 
approach was utilised. This involved fragment cloning and subcloning to produce 
102 
templates with inserts of 1 -2 kb length, the optimum insert size range for sequencing 
template. Universal forward and reverse primers were initially used to minimise the need 
for customised primers. Created templates were characterised for insert inclusion prior 
to PCR amplification and automated sequencing (ABI Prism) which employs the dideoxy 
method developed by Sanger et al., [Sanger, 1977 #233]. The vector sequence was 
subsequently removed during the contig assembly process. 
In mapping the 10.1 kb fragment A portion, the cloning experiments provided a valuable 
exercise in the analysis of enzyme restriction products. For example, we have deduced 
that PvuII generated two 2.3 kb pNV728 fragments which had similar electrophoretic 
mobility, an observation confirmed by the appearance of a more intense fluorescence at 
the 2.3 kb band position and by summation of the various sizes of the Pvult digest 
fragments relative to the total size (Figure. 3.3A). More useful were the side by side 
electrophoretic patterns produced by single and double enzyme digests on pNV728 
(Figure. 3.3B and C). The highest molecular weight fragment which were likely vector 
carriers, showed clear reduction in size when restricted with an additional enzyme. The 
EcoRV cut pNV728, for example, had an additional 0.7 kb run off fragment deduced 
through size calculation after an observed size reduction of the higher molecular weight 
vector band when simultaneously digested with SacI (Figure. 3.3B and C). Another 0.6 
kb fragment appeared with the HindIII -SacI digest of pNV728 which was not evident 
when digested with Hindlll alone (Figure. 3.3B and C). In both instances, it was 
obvious that the fragments removed in combination with Sad were cleaved from the larger 
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fragment containing the vector and it was bounded at one end by the lone SacI site of the 
BamHI fragment A. This made the fragments ideal hybridisation probes for detecting 
DNA segments containing the SacI site and DNAs past the SacI site. 
In conclusion, this study has demonstrated a strategy for sequencing the complementary 
strands of a moderate -sized nucleotide fragment through direct sequencing approach using 
DNA cloning and primer walking. The use of DNA hybridisation in sequence targetting 
and determining the order of overlapping sequences from clones have also been employed 
in our experiments. Having determined the 10.1 kb of phage SfV BamHI fragment A, 
subsequent investigations would involve DNA and protein sequence analysis, and 
homology searches in order to gain a more in -depth understanding of the protein products 
encoded in the phage genome. This will be instrumental in designing experimental 
protocols for the molecular characterisation of the putative protein products. 
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CHAPTER 4 
Sequence Analysis of Shigella flexneri Bacteriophage 
SfV Bam HI Fragment A which Encodes for the 
Structural Proteins of the Late Region 
4.1. Introduction 
Temperate bacteriophage SIV is one of several Shigella flexneri bacteriophages involved in 
mediating host serotype- conversion through 0- antigenic variation of the LPS 
[Petrovskaya, 1982 #48]. S. flexneri serotype Y has the basic 0- antigen structure 
consisting of repeating units of tetrasaccharides which comprise the LPS together with the 
lipid A and the core polysaccharide [Brahmbhatt, 1992 #51]. Upon lysogeny, 
bacteriophage SfV confers type V 0- antigen modification by attaching a glucosyl group to 
the rhamnose II sugar of the tetrasaccharide repeat unit through an cd ,3 linkage 
[Simmons, 1987 #2]. The 0- antigen modification genes gtrA(v), gtrBa.), gtrV, are 
located in the BamHI fragment C of the SfV physical map immediately downstream of 
the site -specific integration locus composed of the attP site, int and xis genes [Huan, 
1997A #118] [Huan, 1997B #117](Figure 4.1). 
Recently, 15 kb of sequence upstream of the xis gene was determined (Allison et al., 
submitted for publication). This region to the left of the xis gene in the physical map 
was described to contain early region genes necessary for lysis, regulation, DNA 
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modification, recombination and replication, immunity and regulation (Allison et al., 
submitted for publication). Analysis of the 15 kb sequence and functional studies 
revealed many features that are similar to phage A. Phage SfV was described as utilising a 
lambda -like repression sytem, multiple superinfection immunity systems, and a P4 -like 
transcription termination mechanism (Allison et al., submitted for publication) (Figure 
4.1). Like the coliphage jEnquist, 1984 #305], bacteriophage SIV also inserts its DNA 
through site- specific recombination and requires recombinase enzymes belonging to the 
integrase family [Argos, 1986 #306]. The genetic recombination between phage (attP) 
and bacterial genome (attB) occurs when short homologous common core sequences 
overlap, producing the prophage attachment sites attL and attR that flank the phage 
genome [Campbell, 1992 #307][Campbell, 1962 #3081. The phage SfV attP, xis and int 
genes located in a 2.2 kb sequence cluster adjacent to the serotype conversion genes have 
been sequenced and characterised [Huan, I997A #118]. These three genes have a 
conserved order which is not unique to phage SfV. Salmonella phage P22, S. flexneri 
phage SfX and SOI also exhibited homologous cluster arrangement wherein the attP site is 
immediately adjacent to the serotype conversion region [Clark, 1991 #119][Leong, 1985 
#198][Poteete, 1988 #310][Leong, 1986 #311][Guan, 1999 #151][Verma, 1993 #116]. 
This chapter was focused on the analysis of the 10.1 kb BamHI fragment A sequence 
adjacent to the left side of the pac site. Based on the extensive homologies observed 
between phage X, and phage SfV genome, database homology search and comparative 
analysis between fragment A open reading frames and similar regions from other dsDNA 
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Figure 4.1. Functional Map of Bacteriophage SfV showing restriction fragments represented by the letters of 
the alphabet. Line bars indicate the location of identified functional regions of the SfV genome. Functional 
designations are written below the line bars and the pac site is indicated by an arrow. (Modified and adapted 
from Huan et al., 1997and Allison et al., submitted for publication). 
bacteriophages were also conducted to establish likely gene product functions and to gain 
an understanding of the evolutionary link between various groups of bacteriophages. 
This region contained genes and products which shares homology to essential major and 
minor structural proteins of bacteriophages, primarily of the family Siphoviridae. 
4.2. Results 
4.2.1. Analysis for the presence of ORFs in the 10.1 kb Sequence 
The contiguous sequence of 10.1 kb portion of the BamHI fragment A had an overall 
G +C content of 53.9 %. Analysis of the 10.1 kb fragment using the National Center for 
Biotechnology Information ORF finder (http: / /www.ncbi .nlm.nih.gov /gorf /gorf.html) and 
the Frames program available through the Australian National Genomic Information 
Service (ANGIS) (http: / /www.angis.org.au), identified 1 incomplete ORF and 13 
complete putative ORFs based on the following criteria: 1) A minimum of 50 codons 
per ORF; 2) Presence of start codons AUG (ATG), UUG (TTG), or GUG (GTG); 
and 3) Start codons preceded by a potential Shine- Dalgarno sequence complementary to 
the 3' end of the 16 S rRNA of S. flexneri (Table 4.1). The core consensus sequence of 
the ribosome binding sites, AGGAG, was conserved in most cases for the 14 putative 
ORFs identified. The stop codons UAA (TAA), UAG (TAG), and UGA (TGA) were 
found in 4, 1, and 9 of the ORFs, respectively. All putative ORFs were coded on the 
same coding strand and transcribed in the same leftward direction (Figure. 4.2 and 4.3). 
107 
Table 4.1. Genetic features of bacteriophage SfV Barn Hl fragment A ORFs. 
ORF* START STOP 
INTERGENIC 
DISTANCE 
ISOELECTRIC 
POINT 
LENGTH 
(nt) 
MOLECULAR 
WEIGHT 
(kDa) PUTATIVE RBS AND START CODON 
164 10058 (ATG) 9564 (TGA) 0 10.36 495 17.9 gaaatttaaccAGGAGTGccgcatATG 
577 9567 (ATG) 7834 (TGA) -3 5.33 1734 65.3 
GGGGAAGAAGAAAGAAAGccactaacccgtttctG 
AAAAtcatcGAAtcATG 
367 7563 (ATG) 6460 (TGA) 271 9.45 1104 41.9 GtcAGtcctGAGActGCGATG 
200 6467 (ATG) 5865 (TAA) -8 4.92 603 22.7 GAGGGAAAAAccAATG 
409 5854 (ATG) 4625 (TGA) 11 5.08 1230 45.8 ttAAcGcGtAAAGGAAAcatcATG 
107 4546 (ATG) 4223 (TGA) 34 4.23 324 12.4 ttctGGcGGGcAcAGGAGGttttATG 
104 4130 (ATG) 3816 (TGA) 93 7.26 315 11.5 tgatccgcctGcGGGtGGAtATG 
168 3841 (ATG) 3335 (TGA) -25 12.56 507 20.0 GtAGGcAGAGtcacGGAGGcaacaATG 
186 3338 (ATG) 2778 (TGA) -3 4.20 561 21.0 cactGAAGccGGAGcGAcGcAGATG 
56 2769 (ATG) 2599 (TAA) 9 10.11 171 06.4 ttccttcctGAGAAtcttcATG 
498 2615 (ATG) 1119 (TAA) -16 5.54 1497 54.8 cgcgttaatAAAAAGGtGAAcAccGATG 
118 1119 (ATG) 763 (TAA) 0 4.66 357 12.9 ttcagtattcAGAGGAGtctgcataATG 
89 763 (ATG) 494 (TGA) 0 5.15 270 10.0 tccAcGGtGAAGAAGGGGAttaccagtaATG 
116 352 (ATG) incomplete 142 9.87 351 12.5 AAAcAGGAtAGAGcAGGAGAAAcgcacacATG 
* ORE designation is based on the number of amino acids 
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Figure 4.2. The 10.1 kb phage SfV BamHI fragment A is represented by the solid 
line with a terminal arrowhead specifying the 5-3' transcriptional direction of the 
orfs. Relevant restriction sites with the nucleotide position are indicated by 
dashed arrowlines above the mapline. The incomplete orf116 and thirteen putative 
orf are shown below the mapline as coloured blocks plotted according to their 
approximate length and relative location: Pink blocks represent orfs in reading 
frame D, yellow blocks represent orfs in reading frame F and blue represent orfs in 
reading frame E. The orfs are designated in Arabic numbers based on the number 
of their amino acids and predicted functions based on database homologies are 
shown below the block. 
Figure 4.3. The linear sequence of the 10109 bases of phage SW BurnHl fragment A 
showing the coding strand, its three reading frames and the complementary strand. Start 
codons are shown in bold print and the stop codons are double underlined for each open 
reading frame and the putative ribosomal binding sites are italicised. The predicted 
amino acids for each open reading frame are shown in bold red text. All orfs are 
transcribed in the same leftward direction and these orfs were detected using the ORF 
finder program through the National Center for Biotechnology Information (NCB') 
homepage. 
Coding strand 
- GGATCCCCTGACGCACCAGCATCTGCATCATGTTCTGGAAATCAGCCGTTGTACCGGGTA 
1 + + + + + + 60 
CCTAGGGGACTGCGTGGTCGTAGACGTAGTACAAGACCTTTAGTCGGCAACATGGCCCAT 
d I G Q R V L M Q M M N Q F D A T T G P - 
e D G S A G A D A D H E P F * G N Y R T - 
f S G R VC W C R C * T R S I L R Q V P Y- 
GCTGGTTACCCAGGCCAATAGCCAGTTTATTGATGTCCTGAAAGCTCTTTCCAACCTCGC 
61 + + + + + + 120 
CGACCAATGGGTCCGGTTATCGGTCAAATAACTACAGGACTTTCGAGAAAGGTTGGAGCG 
d L Q N G L G I A L R N I D Q F S R G V E - 
e A P* G P W Y G T* Q H G S L E K W G R- 
f S T V S I A L L W N I S R F AR E L R A - 
CGTTCGCATCCATCATGGCGACTTTCAGCCCGGTGGCGGCGTTTTCCTGATCGGCATAAG 
121 + + + + + + 180 
GCAAGCGTAGGTAGTACCGCTGAAAGTCGGGCCACCGCCGCAAAAGGACTAGCCGTATTC 
d G N A D M M A V K L G T A A N E Q D A T - 
e R E C G D H R S E AR H A R K G S R C L - 
f TR MW .P SR. * G P P P T R R I P M L - 
ATTTCAGGGAAAGCGTCAGCCCCGCTGCCAGTCCGCCACCAAGCGCCAGCCCACCCTGTG 
181 + + + + + + 240 
TAAAGTCCCTTTCGCAGTCGGGGCGACGGTCAGGCGGTGGTTCGCGGTCGGGTGGGACAC 
d S K L S L TL G A AL G G G L A L G G Q - 
e I E P F A D A GS G T R W W A G A F I G T - 
f N * P F R * G R Q W D A V L R W G V R H - 
ACGCTTCTTCCGCCTGGCGTTTAAATCCCCGGATTTTCTTTTGCATTTTCGACAGCGCGG 
241 + + + + + + 300 
TGCGAAGAAGGCGGACCGCAAATTTAGGGGCCTAAAAGAAAACGTAAAAGCTGTCGCGCC 
d S A K E A Q R E F GR 1K R Q M R SL A - 
e V S R G G P T * I G P N E K A N E VA R - 
£ R I C K RR A N L D G S K R K C K R C R P- 
GAGAAAGCCTGTCGACACCGGTGATCAACGCCTTAAGCTCAAATTCAGCCATGTGTGCGT 
301 + 360 
CTCTTTCGGACAGCTGTGGCCACTAGTTGCGGAATTCGAGTTTAAGTCGGTACACACGCA 
41- Start orf116 
d P S L R D V G T I L A R L E F E A M H A - 
e S F A Q R C R H D V G * A * I * G H T R - 
f L F G T S V P S * R R L S L N L W T R T - 
TTCTCCTGCTCTATCCTGTTTGCCTGACTGACCAGTAAGGGAATTTCACTGATCGGCATA 
361 + + + + + + 420 
AAGAGGACGAGATAGGACAAACGGACTGACTGGTCATTCCCTTAAAGTGACTAGCCGTAT 
d N R R S * G T Q R V S W Y P F R V S R C - 
e R E Q E I R N A Q S V L L P I E S I P M - 
f E G A R D Q R G S Q G T L S N* Q D A Y- 
TTCAGCAATTCGAAAGGATTAATGCGCCAGTAGCTGGCGCAGTCAAAGAAGCGATCAGTG 
421 + + + + + + 480 
AAGTCGTTAAGCTTTCCTAATTACGCGGTCATCGACCGCGTCAGTTTCTTCGCTAGTCAC 
d I * C N S L I L A G T A P A T L S A I L - 
e N L L E F P N I R W Y S A C D F F R D T- 
f E A I R F S * R A L L Q R L * L L S * H - 
AGGTATTCAGCCGTCAGGCCTGGAGGAAAAAACCAGCCACAAGCCACGCCGCTGCATTCA 
481 + + + +- + + 540 
TCCATAAGTCGGCAGTCCGGACCTCCTTTTTTGGTCGGTGTTCGGTGCGGCGACGTAAGT 
4F-- Stop orf89 
d S T N L R * A Q L F F G A V L W A A A N - 
e L Y E A T L G P P F F W G C A V G S C E - 
f P I * G D P R S S F V L W L G R R Q M * - 
GGTCTGCCGGAGACATCTGGTCGACAGAGCTTTGCGGCACTTTCGCCAGCCGCACAATGT 
541 + + + + + + 600 
CCAGACGGCCTCTGTAGACCAGCTGTCTCGAAACGCCGTGAAAGCGGTCGGCGTGTTACA 
d L D A P S M Q D V S S Q P V R A L R V I - 
e P R G S V D P R C L R A A S E G A A C H - 
f T Q R L C R T S L A R R C R R W G C L T- 
ATTTCGACACCACATGCGCCAGAAGTCTGACTGACTCATCCTGATTCATCTGGTAGGGAT 
601 + + + + + + 660 
TAAAGCTGTGGTGTACGCGGTCTTCAGACTGACTGAGTAGGACTAAGTAGACCATCCCTA 
d Y R S V V R A L L R V S E D Q N M Q Y P - 
e i E V G C A G S T Q S V ' 
u 
S E D P L S - 
f N R C W M R W F D S Q S M R I * R T P I - 
ACCCCAGCTCGCGGACATCCTTCCCGCTGGGTTCATCAAACTCCAGTACGGAGAGTGTCT 
661 + + + + + + 720 
TGGGGTCGAGCGCCTGTAGGAAGGGCGACCCAAGTAGTTTGAGGTCATGCCTCTCACAGA 
d Y G L E R V D R G S P E D F E L V S L T - 
e V G A R P C G E R Q T * * V G T R L T D - 
f G W S A S M R G A P N M L S W Y P S H R - 
CGCCATGAGCAGTAATCGGTTTCTTTAACTCAAGCTCTTTCATTACTGGTAATCCCCTTC 
721 + + + + + + 780 
GCGGTACTCGTCATTAGCCAAAGAAATTGAGTTCGAGAAAGTAATGACCATTAGGGGAAG 
Start orf89/Stop orf118 
d E G R A T I P R R L E L ER M V P L G R - 
e R W S C Y D T E R V * A R E N S T I G R - 
f A M L L L R N R * S L S R * *WOE- 
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- 3. V S N 'I d s V : Y 3 S a N S x 'I N L A 3 
- Z Z Y S I H a z N )1 Y U T A N N I ma d a 
- 3 M 0 d 1 A S ' I S A N D S M N L I N 3 z P 
V3LS3LSS3VV33IV33SL3VS31ISVS301S3SSSSVL39,LSSVVVV3IV3SYV3LSLI 
OZE1 + + + + + + I9ZT 
AGAAAAAGCATGGGGCGGTCCCACTACACGACGACCAATTTGACCAGTGGACGCAAGTGG 
d A R K T G R V I P S T S S T L S T V Q T * - 
e E K E !G A L T I H Q Q N F Q D G A N V - 
f R R R V G GP RH A A P* V P* R R E G- 
AGTTCTGACAGTGTGCCGGTCI"1TGCCGTATACACATGACCATACAGCTGACGCGCATAG 
1801 + + + + + + 1860 
TCAAGACTGTCACACGGCCAGAAACGGCATATGTGTACTGGTATGTCGACTGCGCGTATC 
d W N Q C H A P R Q R I C M V MC S V R M - 
e L E S L TM T R A T Y V I I G I L Q R A Y - 
f TR V T H A D KG Y V CS WV A S A C L - 
CTCCAGCGACCGCTGGTATCGTTCATCTCGGTCACCAGCGTGTTAACGGAGGCCGTGTCG 
1861 + + + + + + 1920 
GAGGTCGCTGGCGACCATAGCAAGTAGAGCCAGTGGTCGCACAATTGCCTCCGGCACAGC 
d A G A VA P I T * R P * W R T L P P R T - 
e S W A G S T D N M E T V L T N V S A T O - 
f EL SR Q Y R E D R D G A H * R L G H R - 
TTGAACGGCAGACCGATATAATCAAACGGCTCATCCGCCATTGCAGCCACCGCGCCGGTG 
1921 + + + + + + 1980 
AACTTGCCGTCTGGCTATATTAGTTTGCCGAGTAGGCGGTAACGTCGGTGGCGCGGCCAC 
d T S K C V S I I L R S MR W Q L W R A P - 
e N F P L G I I D P P E D A M A A V AG T - 
f Q V AS R Y L *V A * G G N C G G R R H - 
AGAACCGGAGCGCCCGTTCCGGCGGTCCCCGTCGCCACGGCAATCTGTACGCCCGCTGGC 
1981 + + + + + -+ 2040 
TCTTGGCCTCGCGGGCAAGGCCGCCAGGGGCAGCGGTGCCGTTAGACATGCGGGCGACCG 
d S F R L A R K P P G R R W P LR Y AR Q - 
e L V P A G T GA T G T A V A I Q V G A P - 
f S G S R G N R R D G D G R CD T R GS A- 
AGCACTTCGCCCCCACCGAAGCCGTAGTAATTGAGGCTGACAGGAATTTCATTCCCGCAA 
2041 + + + + + + 2100 
TCGTGAAGCGGGGGTGGCTTCGGCATCATTAACTCCGACTGTCCTTAAAGTAAGGGCGTT 
d C C R A G V S A T T ISA SL F K MG A 
L V E G G G P G I C Y N L S VP I E N G C 
f A S R G W R L R L L Q P QC SN * E R L 
AGCCCCTTATGACGCGCGGTCAGCGTGACAACACCAGCCGAAGATGAAGCTGTAAACGGC 
2101 + + + + + + 2160 
TCGGGGAATACTGCGCGCCAGTCGCACTGTTGTGGTCGGCTTCTACTTCGACATTTGCCG 
d F G R I VR P * R S L V L R L H L Q L R - 
e L G I C H R A T L T V V G A S S S A T F P - 
f A G * S A R D A H C C W G F IF S Y V A- 
AGAGTCGGAACGGCATTGATGGCATCCTGGATACTGCTGGCAATCGTCGTGACGTTATCG 
2161 + + + + + + 2220 
TCTCAGCCTTGCCGTAACTACCGTAGGACCTATGACGACCGTTAGCAGCACTGCAATAGC 
d C L R F P MS P M R S V AP L R R S T I - 
e L T P V A N I A D Q I S S AI T T V N D - 
f S D S R C Q H C G P Y Q Q C D D H R * R - 
CCGTTGGTCACCGGAGCCTGCACGCGGGTACGTCCCACATAGACATTCACCGTGCCGCTT 
2221 + + + + + + 2280 
GGCAACCAGTGGCCTCGGACGTGCGCCCATGCAGGGTGTATCTGTAAGTGGCACGGCGAA 
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e K P P C F T V A P L T L C Q G G A L L N - 
f E A P L L D G R A P D P V S R G K V P K - 
CACAAACATGAAGATTCTCAGGAAGGAAGGGTTATTTCGGTGTGATGTTCGATATCGCCG 
2761 + + + + + + 2820 
GTGTTTGlACTTCTAAGAGTCCTTCCTTCCCAATAAAGCCACACTACAAGCTATAGCGGC 
Startorf54_Stoporf186 
d E C V H L N E P L F P * K P T I N S I A - 
e * L C S S E * S P L T I E T H H E I D G - 
f V F M F I R L F S P N N R H S T R Y R R - 
TCAGGCCCGTTACCGGGATCGAGATAATCAACATCAATCGCCAGCGTTCGCAGTTCATCC 
2821 + + + + + + 2880 
AGTCCGGGCAATGGCCCTAGCTCTATTAGTTGTAGTTAGCGGTCGCAAGCGTCAAGTAGG 
d T L G T V P I S I I L M L R W R E C N M - 
e D P G N G P D L Y D V D I A L T R L E D - 
f * A R * R S R S L * C * D G A N A T * G - 
AGACTGTTCAGCTCATCCTGCTGGCGGGTATCGTCTTCGGTCAGCTCGCTGATGACCGAA 
2881 + + + + + + 2940 
TCTGACAAGTCGAGTAGGACGACCGCCCATAGCAGAAGCCAGTCGAGCGACTACTGGCTT 
d W V T * S M R S A P I T K P * S A S S R - 
e L S N L E D Q Q R T D D E T L E S I V S - 
f S Q E A * G A P P Y R R R D A R Q H G F - 
AAATCGAACTGATAAATCAGCTCATGACGATTCAGATCCAGCAGCGTGCCGCCGTCATAG 
2941 + + + + + + 3000 
TTTAGCTTGACTATTTAGTCGAGTACTGCTAAGTCTAGGTCGTCGCACGGCGGCAGTATC 
d F I S 5 I F * S M V I * I W C R A A T M - 
e F D F Q Y I L E H R N L D L L T G G D Y - 
f F R V S L D A * S S E S G A A H R R * L - 
d 
e 
f 
GTAATCGGGTTACCGCACGCTTCCGGGTTCCAGCCCAGCAGGGCC1"1AAAGAGCATCTGC 
3001 + + + + + + 3060 
CATTAGCCCAATGGCGTGCGAAGGCCCAAGGTCGGGTCGTCCCGGAATTTCTCGTAGACG 
P L R T V A R K R T G A W C P R L S C R - 
T I P N G C A E P N W G L L A R F L M Q - 
Y D P * R V S G P E L G A P G * L A D A - 
CGGACATCGTCCACCACATCATACGAAGCAAACTGACCGCGCTCATCACGCCCGTTACTC 
3061 + + + + + + 3120 
GCCTGTAGCAGGTGGTGTAGTATGCTTCGTTTGACTGGCGCGAGTAGTGCGGGCAATGAG 
d G S M T W W M M R L L S V A S M V G T V - 
e R V D D V V D Y S A F Q G R E D R G N S - 
f P C R G G C * V F C V S R A * * A R * E - 
AGTATGACAACCACGGAGAAGCCCTCTTTCAGCTCCTGCCAGTAGTCGGTCTGGCTTTTG 
3121 + + + + . + + 3180 
TCATACTGTTGGTGCCTCTTCGGGAGAAAGTCGAGGACGGTCATCAGCCAGACCGAAAAC 
d * Y S L W P S A R K * S R G T T P R A K - 
e L I V V V S F G E R L E Q W Y D T Q S R - 
f T H C G R L L G R E A G A L L R D P K Q- 
TTTTCTCCCGGAGAGTCATCACCCGGTACCACATACGCCGCCGGGAGTCTCAGCTTTCCG 
3181 + + + + + + 3240 
AAAAGAGGGCCTCTCAGTAGTGGGCCATGGTGTATGCGGCGGCCCTCAGAGTCGAAAGGC 
d T R E R L T M V R-Y W M R R R S D * S E 
e 
f 
N E G P S D D G P V V Y A A P L R L R G - 
R R G S L * * G T G C V G G P T E A R R - 
ACCTCCGGCAGATTTTTGAACTGTGCCGCGCCTGCCACCCGG7^i°1PCAAAATACGGGCAG 
3241 + + + + + + 3300 
TGGAGGCCGTCTAAAAACTTGACACGGCGCGGACGGTGGGCCAAAAGI`iï."PATGCCCGTC 
d S R R C I R S S H R A Q W G T R L I R A - 
e V E P L N R F Q A A G A V R N E F Y P C- 
f G G A S R Q V T G R R G G P R * F V P L - 
CGGGCACGCAGCGCAGCAATAACAGGCGTCAGTTTCATCTGCGTCGTCGCTCCGGCTTCA 
3301 + + + + + + 3360 
GCCCGTGCGTCGCGTCGTTATTGTCCGCAGTCAAAGTAGACGCAGCAGCGAGGCCGAAGT 
41- Stop orf168/Start orf186 
d A P V C R L L L L R * N * R R R R E P R - 
e R A R L A A I V P T L R M Q T T A G A E - 
f P C A A C C Y C A D T E D A D D S R S * - 
GTGATTTACGTAATTCCCGCGCCAGAAAATAGCGTGTCCAGCTGCGGTTCI"i^i°lCAAGCG 
3361 + + + + + + 3420 
CACTAAATGCATTAAGGGCGCGGTCTTTTATCGCACAGGTCGACGCCAAGAAAAGTTCGC 
d L S R R L E R A L F Y R T W S R N R E L - 
e T I * T I G A G S F L T D L Q P E R * A - 
f H N V Y N G R W F I A H G A A T R R L R - 
TTTCCACCATAAAGTTATTACGTGGAGCCAGCCGCCAGCCGCTGCCACCGGATGCACCAC 
3421 + + + + + + 3480 
AAAGGTGGTATTTCAATAATGCACCTCGGTCGGCGGTCGGCGACGGTGGCCTACGTGGTG 
d T E V M F N N R P A L R W G S G G S A G - 
e N G G Y L * * T S G A A L R Q W R I C W - 
f R W W L T I V H L W G G A A A V P H V V- 
GATGATGACTACGACGACGTTTTGCTCCTCCCCGGACGCCATAGAACAAAAAAGCCGGAT 
3481 + + + + + + 3540 
CTACTACTGATGCTGCTGCAAAACGAGGAGGGGCCTGCGGTATCTTGTTTTTTCGGCCTA 
d R H R S R R R R A G G R V G Y F LF A P - 
e S S S* S S T R S R G P R W L V F F G S- 
f I I V V V V N Q E E G S A M S C F L R I - 
AAAAATCACCGGTGATGCGGCGGTTTCCCTCACCATTACGCTGGTTAGGGGCTATACGTG 
3541 + + + + + + 3600 
TTTTTAGTGGCCACTACGCCGCCAAAGGGAGTGGTAATGCGACCAATCCCCGATATGCAC 
d Y F D G T I R R N G E G N R Q N P A I R - 
e L F * R H H P P R G * W * A P * P S Y T - 
f F I V P S A A T E R V M V S T L P * V H - 
CCATAAAACCGGGGCGATGTTTACTGGCTCTGGGTACCATGTAACCAATCGAACGAGCCA 
3601 + + + + + + 3660 
GGTATTTTGGCCCCGCTACAAATGACCGAGACCCATGGTACATTGGTTAGCTTGCTCGGT 
d A M F G P R H R S A R P V M Y G I S R A - 
e G Y F R P S T * Q S Q T G H L W D F S G - 
f W L V P A I N V P E P Y W T V L R V L W - 
GGCGTCCGGTCTGATAACCGGGGTTTTCACCCGGTGCCGACCGCGCATGGCGCATCACCA 
3661 + + + + + + 3720 
CCGCAGGCCAGACTATTGGCCCCAAAAGTGGGCCACGGCTGGCGCGTACCGCGTAGTGGT 
d L R G T Q Y G P N E G P A S R A H R M V - 
e P T R D S L R P K * G T G V A C P A D G - 
f A D P R IV P T K V R H R G R M A C * W - 
GCCGACGGGCATCACGCATATGACGCTGACCAATCGTGACAAACGCCCGCCGGACACGGG 
3721 + + + + + + 3780 
CGGCTGCCCGTAGTGCGTATACTGCGACTGGTTAGCACTGTTTGCGGGCGGCCTGTGCCC 
d L R R A D R M H R Q G I T V F A R R V R - 
e A S P C * A Y S AS W D E C V G AP C P - 
f G V P N V C I V S V L R S L R G G S V P - 
CGCGGTTAAAGCGCATCTCCGCGGGCTGCmnAAAATCAACGTGCAAAAAGGAAGTCGTCA 
3781 + + + + + + 3840 
GCGCCAATTTCGCGTAGAGGCGCCCGACGACTTTTAGTTGCACGTTTTTCCTTCAGCAGT 4- Stop orf104 
d A R N F R M E A P Q Q F D V H L F S T T - 
e R P * L A D G R A A S F * R A F L F D D - 
f A T L A C R R P S S F IL T C F P L R * - 
TTGTTGCCTCCGTGACTCTGCCTACATTCGCCCAGCTCCGTACACTCCAGCAGCAGAAAA 
3841 + + + + + + 3900 
AACAACGGAGGCACTGAGACGGATGTAAGCGGGTCGAGGCATGTGAGGTCGTCGTCT1tP 
_ Start orf168 
d M T AE T V R G V N A W S R V S W C C F 
e N N G G H S O R C E G L E T C E L L L F 
f Q Q R R S E P * M R G AG Y V G A A S F 
CGCCGCGCCCCGTTCAGATCGCGCTGACGTTTCACCCGGTACACACTGTCACCGCAGACC 
3901 + + + + + + 3960 
GCGGCGCGGGGCAAGTCTAGCGCGACTGCAAAGTGGGCCATGTGTGACAGTGGCGTCTGG 
ci V G R GP * I A S V N * G T C V T V A S 
e R R A G S L D R Q R I C V M S D G C V 
f A A G R E S R A STEG PVC Q* R L G 
ACCTCATAATCAGTGGTGATCCCCCGGCGGTAACGAATGGTGATGTAATGGGTGATGGCG 
3961 + + + + + + 4020 
TGGAGTATTAGTCACCACTAGGGGGCCGCCATTGCTTACCACTACATTACCCACTACCGC 
d W R M I L P S G G AT V F P S T I P S P - 
e V E T D T T I G R R T R I T I P H T I A- 
f G * L * H H D G P PL S H H H L P EH R - 
TCCCCGGTCTGCGCGGTTTCCTGCCAGGTGGTGGCACTGGTCTGGATAACCTTCGCCCAT 
4021 + + + + + + 4080 
AGGGGCCAGACGCGCCAAAGGACGGTCCACCACCGTGACCAGACCTATTGGAAGCGGGTA 
d T G P R R P KR G P P P V P R S L R R G - 
e D G T Q A T E Q W T T A S T Q I V R A W - 
f G R D A R N G AL H H C Q D P Y GE G M - 
GTCCGGAACGTAACCGGGTATTGAGGCTCCACGCCAAAGTTATCCGCGGGCATATCCACC 
4081 + + + + + + 4140 
CAGGCCTTGCATTGGCCCATAACTCCGAGGTGCGGTTTCAATAGGCGCCCGTATAGGTGG 4- Start orf104 
ci E I G S R L R T M L S W A L T I R P C I W - 
e T R F T V P T Q P E V O F N D A P M D V - 
f D P V Y O P I S A G R W L * G R AY G G - 
CGCAGGCGGATCAGGACGC ATTCAGTTCGCCGGGGTCCGGCAGAATGTAGGTTGCG 
4141 + + + + + + 4200 
GCGTCCGCCTAGTCCTGCGCAAATAAGTCAAGCGGCCCCAGGCCGTCTTACATCCAACGC 
d GC CAS * S A N I * N A P T R C F TP Q - 
e R L R I L V R K N L E GPO P L I Y T A - 
f A P P D P R T* E T R R P G A S H L N R- 
CTGGTCTGTGCCTGACGAATTTTCATAGTGGTATAAGGCGATAAGGAGCAACCAACCAGT 
4201 + + + + + + 4260 
GACCAGACACGGACTGCTTAAAAGTATCACCATATTCCGCTATTCCTCGTTGGTTGGTCA 4- Stop orf107 
d A P R H R V F K * L P I L R Y P A V L W 
e S T Q A Q R I R M T T Y P S L S C G V L 
f Q D T G S S N E Y H Y L A I L L L W G T 
TAAAACTCATTGGCAACTCCATTTTCTCAACGTCTGTAACCGTTGAGCGGTTTTCGTAGA 
4261 + + + + + + 4320 
ATTTTGAGTAACCGTTGAGGTAAAAGAGTTGCAGACATTGGCAACTCGCCAAAAGCATCT 
d NIT S H P L E M K E VD T V T S R N S Y 
e * F E N A V G N E * R R Y G N L P E E L 
f L V * Q C S W R R L T Q L R Q A T R T S 
AATGGCTGACAAGTAGCAGAAGTGCCAGCTTCACATCATCAGATATCACAAGCCCATCAG 
4321 + + + + + + 4380 
TTACCGACTGTTCATCGTCTTCACGGTCGAAGTGTAGTAGTCTATAGTGTTCGGGTAGTC 
d F HS V L L L L A L I C V D D S I V L G D 
e F P Q C T A S T G A E C * * I D C A W * 
f I A S L Y C F H W S* M M L Y * L G M L 
GATCATCCGCAGGCCTGTCATCTGCGGTTGCATACAACTTACGGTTAAGGAAGTTTTCCG 
4381 + + + + + + 4440 
CTAGTAGGCGTCCGGACAGTAGACGCCAACGTATGTTGAATGCCAATTCCTTCAAAAGGC 
d P O D A P R D D A T A Y L K I C H L F N E 
e 5 * G C A Q * R R N C V V * P * P L E G 
f I M R L G T M Q P Q M C S V T L S T E R 
TTCGACTCTGAGCGGCCTTACCAAGCAGTTCAAGCAACTCATCTTCATCAGAGAAATCAT 
4441 + + + + + + 4500 
AAGCTGAGACTCGCCGGAATGGTTCGTCAAGTTCGTTGAGTAGAAGTAGTCTCTTTAGTA 
d T R S Q A A I C G L L E L L E D E D S F D 
e N S E S R G * W A T * A V * R * * L F 
f E V R L P R V L C N L C S H R M L S I M 
CATCCAGACGGAGCTGAAGCTTAATCTCTTCCATTTTTAACAGCATAAAACCTCCTGTGC 
4501 +- + + + + + 4560 
GTAGGTCTGCCTCGACTTCGAATTAGAGAAGGTAAAAATTGTCGTATTTTGGAGGACACG 
f- Start orf107 
d D D L R L Q L I C I E E M E L L I K F G G T - 
e * G S P AS A * D R G N K V A Y F E R H - 
f M W V S SF S L R R W K * C C L V E Q A - 
CCGCCAGAACGCGGGCACAAAAAAACCGCATTACGCGGCGTGCTGTATTACGTAAAAAGA 
4561 + + + + + + 4620 
GGCGGTCTTGCGCCCGTGTTTTTTTGGCGTAATGCGCCGCACGACATAATGCATTTTTCT 
d G A L VR A C F E R M V E R A T N E L F - 
e G G S R P C L F V A N R P T S Y * T F L - 
f R W F A P V F F G C * A A H Q I V Y E S - 
CTAATCAACCACCAACGCTACCTTTCCCCACCAGCGCTTTAATGGCAGAGGTGTCTTCCA 
4621 + + + + + + 4680 
GATTAGTTGGTGGTTGCGATGGAAAGGGGTGGTCGCGAAATTACCGTCTCCACAGAAGGT 
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VDJDILLVaDJDDVYIYIDYIJYDVaJD`JIIIIJIDDJJJIaaYIyDIIII9VJIDaYI00 
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IaDaVVSDJDJJJJ.VSVJSVDSaSDDJJVVVV9VaJDDVYJDIVDaäVYVaIDVJVIVDD 
1894 
5161 + + + + + + 5220 
GTTATGCAAGTCGTTACGCTGCCCGTTCTATTCGAAGGTATAGCTAGCGCGACAGGACGT 
d G I R E A I R R AL Y A E M D I A S D Q - 
e WY T * C H S P C S L S G Y R DR Q G A - 
f L V N L L A V P L I L K W I S R A TR C - 
GCAACTCATTAGACACACGAATGATTTTCGATGTCATTTTGAGCGCCCCAAGACTTCCCA 
5221 + + + + + + 5280 
CGTTGAGTAATCTGTGTGCTTACTAAAAGCTACAGTAAAACTCGCGGGGTTCTGAAGGGT 
d LL E N S V R I I R S T M R L A G L S G - 
e A V * * V C S R N E I D N Q A G W S R G - 
f C S M L C V F SR R H .K S R G L V E W - 
TACCGAAATCGGTGTCTTCTTCACCGGCTTCTTCATTTTCGCCCAGCAGAACACCAACTT 
5281 + + + + + + 5340 
ATGGCTTTAGCCACAGAAGAAGTGGCCGAAGAAGTAAAAGCGGGTCGTCTTGTGGTTGAA 
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e C I P S T R S S L S P I * _ 
T 
A M L L TM 
f MN A F N Q V I T V P H L D E D A L D H 
TGACAGCCCGGTCGCCCCGAAGGGGTCGATGGGTGACTCACTGACCGGGCTGATTTTu1"1 
8161 + + + + + + 8220 
ACTGTCGGGCCAGCGGGGCTTCCCCAGG`PACCCACTGAGTGACTGGCCCGACTAAAP_CAA 
d T V A R D G R L P R H T V* Q G P Q N Q 
e H C G P R G S P T SP HS V S R A S K T 
f S L G T A G F P D I P S E S V P S I E N 
CGCCGCTTTGGCCTCCTCGAGGATGTAGCGATAATCCACCTCAGCACCATCGGTAACGGT 
8221 + + + + + + 8280 
GCGGCGAAACCGGAGGAGCTCCTACATCGCTATTAGGTGGAGTCGTGGTAGCCATTGCCA 
d E G S Q G G R P H L S L G G * C W R Y R - 
e R R K P E R S S T AI I W R L V M P P - 
f AWE I Y R I D V E A G D T V T - 
CAGGACGCCCATTTCCACCCATTTCTGAAAGCGTTCGGCTGTCCGTCTATCTTCATTTTT 
8281 + 4- + + .+ + 8340 
GTCCT-GCGGGTAAAGGTGGGTAAAGACTTTCGCAAGCCGACAGGCAGATAGAAGTAë.F.AA 
d D P R G N G G M E S L TR S D T * R * K - 
e *5 A W K W G N R F A N P Q G D I R M R - 
f L V G M E V W K Q F R E A T R R D E E E- 
CTCGACGCTGTACACCGTGTCATACGGTACCCAGAAGCGCGGGGCCACACTGTAGTAATG 
8341 + + + +- + + 8400 
GAGCTGCGACATGTGGCACAGTATCCCATGGGTCTTCGCGCCCCGGTGTGACATCATTAC 
d E R R V G H * V T G L L A P G C Q L L - 
e R S A T C R I M R Y O S A R P W V T T I - 
f E V S Y V I D Y P V W F R P K V S Y Y 8- 
CGTTTTACCGTCAATCTCGCGGGTAT.AAAGTCGCGCCATGCTCTTCATATCCAGCTTACG 
8401 + . 4- + + + 8460 
GCAAAATGGCAGTTAGAGCGCCCATATTT-CAGCGCGGTACGACAAGTATAGGTCGAATGC 
d A N * R * D R P Y L T A G R Q E Y G A * 
e RK V T L R A P I F DR WA T * I W S V 
f T I C G D T E R T Y LR A M S N M D L I C R 
CGCCAGGTCAAAGGCCAGAATGCACGGCTGCCCCTCGAACTGCTCAAGGGTCAGTGATTT 
8461 + + + + + + 8520 
GCGCTCCAGTTTCCGGTCTTACGTGCCGACGGGGAGCTTGACGAGTTCCCAGTCACTAAA 
d A GP * L G S H V A A G R V A * P D T I - 
e R W T L P W F A R S G R S S S L P * H N. - 
f ALO F A L I C P Q G E Ir Q E L T L S E- 
ATCCTCGÇ.AGCTCTGCCAGCTCACCAGGTTGAAATACGCCGAACGCGCCGACACCCAGAT 
8521 + + + + + + 8580 
TAGGAGCGTCGAGACGGTCGAGTGGTCCAACTTTATCfyG^.,CTTGCGCGGCTGTGGGTCTA 
d * O R L E AL E G P Q F V G F A G V O L - 
e IR A A R G A * W T S I R R V R R C G S - 
f D E C 812 W S V L N F Y A S R V I I I - 
ATTGAGGTGTTTTGTTTTAAAGACGTTP('t'_CAGACGGGCGTTATTTTTCGCACGCTGCTG 
8581 + + + + + + 8640 
TAACTCCACAAAACAAAATTTCTGCAAACGGTCTGCCCGCAATAAAAAGCGTGCGACGAC 
d Y Q P T R N * L R R G S P R * R EC A A - 
e I S T N Q I C L S T Q W V P T I F C E V S S - 
f N L H R T I C F V N A L R A N N K A R Q Q - 
CTGACTTAACAAAAATTCGCGATAAACCGACACGCCAATATTTGGATTGGCTTTTTCCAG 
8641 + + + + ` 8700 
GACTGAATTGTTTTTAAGCGCTATTTGGCTGTGCGGTTATAAACCTAACCGAAAAAGGTC 
d A S K V F I R S L G V R W Y R S Q S R G - 
e S V * C F N A I F R C AL I Q I P I C K W - 
£ Q S L L F ER T V S V G I N P N A K E L - 
CACCTGCGGGTCGGTCCAGTCGTCACCTTCATCAACGGTATAGATGATCCCGAACAGTTC 
8701 + + + + + + 8760 
GTGGACGCCCAGCCAGGTCAGCAGTGGAAGTAGTTGCCATATCTACTAGGGCTTGTCAAG 
d A G A P R D L R * R * * R Y L F I D K V T - 
e C R R T P G T T V K M L P I S S G S C N - 
f V Q P D T W D D G E D V T T I I G F L E- 
ATCGTTAGGCACCGAGCCGTTGAGCATCTCGATGACTTCCCGCCGCTTGTCGTAGCACGG 
8761 + + + + + t 8820 
TAGCAATCCGTGGCTCGGCAACTCGTAGP_GCTACTGAAGGGCGGCGAACAGCATCGTGCC 
d .1R *A G L R Q A D R HS G A A Q R L V - 
e M T L C R A T S C R S S R G G S T T AR - 
f D N P VS G N L M E I V E R R K D T C P - 
CCCCTCAATGTTGTACCCGGCGGTGGTGATGGCCCACATCAGTGGCTGACGTCGCGCCCC 
8821 + +- + + + + 8880 
GGGGAGTTACAACATGGGCCGCCACCACTACCGGGTGTAGTCACCGACTGCAGCGCGGGG 
d A G * H Q V R R H R H G V D T A S T A G - 
e G R L T T GP P P S P G C * H S V D R G - 
f G R I N - T G A T T- I A W M- L P- Q- R- R A G- - 
CATCCCGGTAAGCATTGTGGTATAAAGCGCATCGGTGGCATGCTCGTGATATTCATCAAC 
8881 t + + --+ + + 8940 
GTAGGGCCATTCGTAACACCATATTTCGCGTAGCCACCGTACGAGCACTATAAGTAGTTG 
d G D R Y A N H Y L A C R H C A R S I * * - 
e W G P L C O P T ^ R M P P M S T I N M L - 
f M G T L M T T Y r L AD T A H E H Y E D V - 
CACGGCACAGTGGGGTGATGAACCATCACCGGGGTTGCCGATCAGCGGTTCAAACCGCGC 
8941 + + + + + + 9000 
GTGCCGTGTCACCCCACTACTTGGTAGTGGCCCCAACGGCTAGTCGCCAAG"1"1GGCGCG 
d G R C L P T I F W * R P Q R D A T * V A - 
e W P V TP E I H V M V P * R N L GR - 
f V A C H P S S G D G P N G I L P E F R A - 
GCCATCCTCCGGACGGTTCATGTTTGAGGCGTTAACCTCAATCCCGAACGCTTCCGTCAG 
9001 + + + + + + 9060 
CGGTAGGAGGCCTGCCAAGTACAAACT_CCGCAATTGGAGTTAGGGCTTGCGAAGGCP_GTC 
d R W G G S P E H K L R * G * D R V S G D - 
e A M R R V T .T Q P T L R L G S R R R * - 
f G D E P R N M N S A N V E I G F A E T L - 
CA1^GGGTGTGCGTTTACACATCAGTCGCGCCGGGCGAAAGACTTCCCACGCCTGTR"PCTC 
0096 + + + + + + T4S6 
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p 
Start orf164 
á SP A V G P V G R R E.411L-W I R C E Q N F - 
e R P -R R G S R G AT G AM Ei P V G P * I - 
f Q P S A R F A G G N W G Y A A S R T L N - 
TCATTTTTCGCGGGTATAAAAAACGATAA 
10081 + + 10109 
AGTAAAAAGCGCCCATATTTTTTGCTATT 
d K M K R P Y L F R Y - 
e E N K A P I F F S L - 
f * K E R T Y F V I - 
Results of the ORF analysis are summarised in Table 4.1, with the ORFs designated 
based on the number of amino acids. 
4,2.2. Putative Functions of the ORFs 
Predicted amino acids of the ORFs were derived and compared to DNA and protein 
sequences in the databases using BLASTP [Altschul, 1997 #313], FASTA and FASTX 
programs [Pearson, 1988 #314]. Significant protein similarities were detected between 
those in the database and the translation products of ORFs encoding for late phage genes 
such as the terminase, protease enzymes and phage structural proteins like the tail 
sheath, portal protein, and capsid. The most significant similarities are reported in Table 
4.2. Eight of the 14 putative ORFs showed similarity to other phage protein 
homologues. orf164 had similarity to hypothetical proteins of unknown function 
expressed by bacterial genes of cryptic prophage origin. It also showed similarity to 
unknown proteins of bacteriophage GMSE -1 and S. thermophilus bacteriophage Sfi19. 
Orfs107, 104, 168, 186 and 118 did not pick up significant homology to any database 
sequence. The remaining ORFs with relevant phage protein functions are presented in 
the succeeding sections. 
4.2.3. ORF577 
The putative gene product (gp) of phage SfV ORF577, has similarity to the large 
terminase subunits and putative terminases of several bacteriophages which infect diverse 
108 
Table 4.2. Table of similarity between phage SfV fragment A predicted gene products & proteins 
from the GenBank and Swissprot databases 
ORF Organism Matched p Percent Identity 
Protein ID 
Locus 
Accession 
Number Predicted Function 
164 E.coli 0157:H7 prophage CP -933C 2.0e -10 54% in 90 aa AAG55950 AE005328 unknown 
Bacteriophage GMSE -1 2.0e -10 46% in 141 aa AAGS0266 AF31 1659 unknown 
H. influenzae Genetic Island 1 1.0e -09 36% in 90 aa AAF27358 AF198256 unknown 
X. nematophilus proviral orf8 5.7e -06 27.8% in 158 as 
CAB58451 
XNE133022 AJ133022 hypothetical protein 
M. tuberculosis H37Rv segment 70/162 5.7e -05 27.7% in 155 as 
CAB09059 
MTCY336 Z95586 unknown 
M. tuberculosis H37Rv segment 118/162 9.8e -05 29.6% in 162 aa 
CAB02357 
MTCY441 Z80225 unknown 
S. thermophilus sfil9 2.0e -04 29.0% in 92 aa AAD44055 AF115102 unknown 
577 E. coli INTE -PIN region 2.4e -152 96.5% in 367 aa YMFN_ECOLI P75978 hypothetical 50.9 kD protein 
P. aeruginosa phage D3 2.6e -83 46.3% in 570 aa AAD38954 AF165214 terminase 
R. capsulatus strain 591003 3.6e -51 31.1 %in 559 aa AAC1 6226 AF010496 hypothetical protein 
H. influenzae Genetic Island 1 5.0e -61 29% in 552 aa AAF27357 AF198256 phage D3 terminase -like protein 
S. aureus phage phi PVL 1.4e -29 24% in 567 as BAA31875 AB009866 unknown 
B. subtilis phage phi 105 6.8e -28 29% in 415 as BAA36628 AB016282 unknown 
L. casei phage A2 gp3 4.0e -25 27% in 585 as BPHA3GP3 X97563 unknown 
Streptomyces phage phi C31 1.2e -13 25.3% in 522aa CAA07103 AJ006589 putative large terminase subunit 
S. thermophilus sfil9 9.7e -12 21.9% in 562 as AAD44056 AF1 15102 putative large terminase subunit 
S. thermophilus sfi21 8.3e -11 21.1% in 567 aa AAD41029 AF1 1 2470 terminase large subunit 
S. thermophilus phage DT1 4.7e -09 33.1% in 121 aa AAD21879 AF085222 putative terminase small subunit 
367 B. subtilis phage phi 105 4.2e -38 29.9% in 355 as BAA36631 AB016282 hypothetical protein 25 
H. influenzae Genetic Island 1 8.0e -38 31% in 352 as AAF27362 AF198256 phi -105 ORF25 -like protein 
Coliphage HK97 7.5e -27 25.7% in 428 as VP3_BPHK7 P49859 portal protein 
P. aeruginosa phage D3 1.4e -24 27.6% in 359 as AAD38955 AF165214 portal protein 
Streptomyces phage phi C31 2.0e -20 27.0% in 413 as CAA07104 AJ006589 putative portal protein 
R. capsulatus strain SB1003 1.0e -19 26.6% in 368 as AAC16225 AF010496 hypothetical protein 
S. aureus phage phi PVL 6.9e-11 22.6% in 349 as BAA31877 AB009866 portal protein 
Table 
- 
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- 
4.2, _Table of similarìy between phage 
_ from the GenBank.ari'd Swissprot 
- - 
- 
_ 
Organism Matched 
Lactobacillus casei phage A,? 
S. eureus phage phi PVL 
._.w -_ ._ 
-- 
Streptomyces phage phi C31 
B, salts phage phi,105 
W. influenzae Genetic island 1 
-- 
- 
Sfv fragment 
databases 
p 
4.0e-24_ 
-2d; 
A predicted 
(continued) 
Percent Identity 
44% in 171 as 
35% in 193 aa 
gene products 
Protein ID 
Locus 
CA863684 
BAA31878 
- 
° CA407105 
BAA35632.' 
AAF27363 
_ 
& proteins 
Accession 
Number 
^ 
Predicted Function _Predic_ 
__- .- 
putative protease -  
-  - 
AJ_251790 
A6009866 
AJ006589 
AB016282 
- 
An 98256 
Unknown -. -_ -- 
putative protease 
unknown -_ - -- - 
5.7e -15 
4.2_e-12,_ 
3,0e -14 
38% in 171 aa 
36.3% in 173 aa 
34% in 171 aa phi -C31 protease -like protein 
409 
- 
122 
136_ 
-168 
186 
56 
498 
118 
89 
116 
Coliphage HK97 
M. tuberculosis seg. 118/162 
Streptomyces phage phi C31 
H. influenzae Genetic Island 1 
S. thermophilua phage Sf1 21 
7.9e-03 
3,4e -02 
1.1e-09 
2.0e -05 
3 Ge O5ry 
1,0e -04 
 -_ 
1.7e-05 
29.9% in 157 aa 
32% in 150 aai 
23% in 397 aa 
° 20% in 405 aa_ - 
20% in 374 ai 
22% in 304 as 
-- 
__ 
-- 
VP4_BPHK7 
CA802356 
CAA07106 
P49860 
280223 
AJ006589 
---- ÁF198256 
AF112470 
AF085222 
- - -w _- 
-- -.- .- -- 
- .____ 
AF088977 
AB000833 ° 
P44233 
AB000833 
AE00 '24E60 
AF076485 
_ - - - -- 
AB008S5O 
AF153829 
ÁB008550 
prohead protease 
similar to VP4_BPHK7 
major capsid protein -- - - 
phi-C31 phage capsid protein 
major head protein precursor 
AAF27364 
AAD41033 
AAD21884 
-- - - --- - ___ 
----- - - - - -- _ -- 
___. 
AAF01 1 1 E 
BAA19194 
YP1 1_HAEIN 
6ÁA19195 
AAF41495 
AAC27632 T 
8AA36251 
AAD54238 
6AÁ36253 
S. thermophilus phage DTI 
No significant homology 
No sigrïificant hömólogp 
_- ._- -_-.__ 
No significant. homologÿ - ° 
major head protein 
uhknown- - .___ - -- 
unknown 
unknown 
No significant homology 
phage Mu complete genome 
phage Mu DNA for ORF1, sheath protein 
gpL, ORF 2,3 ` 
H. influenzae HI1511 
phage Mu DNA for ORF1, sheath protein 
gpL, ORF 2,3 
N. meningitidis MC58 
M. kanthus gene difE 
4? 3 %yin 52 as 
42.3% in 52 as 
38.4% in 495aa 
35.896 in 500 as 
29% in 486 asi 
24 295 in 248 aa 
27.1 %lin 85 as 
45.296 in 104 sa 
..- 
40% in 121 as 
unknown 
HI1510 homologue - 
-- - 
- 
-. 
ORF1 major tail subunit n hypothetical protei  
sheath protein gp L 
sheath protein 
fruiting body formation and motility 
uhkññwrí -_-------- 
ORF 24 sirríilar te E gene of P2 (essential 
tail protein) 
1,7e-05 
4.9e-56 
9.4e -50 
2.0e-41 
3.4e-02 
8.0e -01 
No significant homology 
- 
- 
P. aeruglncsa phage phi CTX 
S. typhirnurium sop E gene 
P. aeruginosa phage phi CTX 
I 2e-09 
2.1e-03 
similar to protein G of phage 186 (tail 
Protein) 
ORI. 25 similar te T gene of phage F'2 
(essential tail protein) 
hosts (Table 4.2). These phages with their corresponding gene coordinates were: 
Pseudomonas aeruginosa phage D3 ORF2 (nt 419 -2110); Staphylococcus aureus phage 
OPVL proviral protein ORF2 (nt 537 -2231); Bacillus subtilis phage Ophi -105 ORF22 (nt 
612- 1862); Lactobacillus easel phage A2gp3 ORF5 (nt 1718 -3409); Streptomyces phage 
OC31 gene 33(nt 1282- 2841); Streptococcus thermophilus bacteriophage Sfi 19 ORF623 
(nt 2107 -3978); Streptococcus thermophilus bacteriophage Sfi21 ORF623 (nt 1738- 
3609); Streptococcus thermophilus phage DTI ORF3 (nt 1103 -1792); Lactococcus lactis 
phage bIL170 gene 12 (nt 779 -2401); Lactococcus lactis phage p008 ORF2 (nt 1130- 
2752); Lactococcus lactis phage skl ORF2 (nt 788 -2410); and Lactobacillus phage adh 
ORF624 (20183- 22057). The higher percent identities were observed between ORF577 
and proteins encoded in bacterial genomes: the region of homology in E. coli is in 
prophage e 14 gene region with a 96.5% identity to ORF577 over 367 amino acid residues; 
a 31% identity over 559 amino acids with that of Rhodobacter capsulatus hypothetical 
protein; and 29% identity over 552 amino acids with that of Haemophílus ínfluenzae 
genetic island 1 ORF10. These data indicated that bacterial terminase genes could be 
encoded by a cryptic phage. More expected was the second highest homology score 
(46.3% in 570 amino acids), which was traced to a bacteriophage D3 of Pseudomonas 
aeruginosa. Its ORF1692 was reported to have significant similarity to the same phage 
and bacterial proteins as those homologous to phage SW [Gilakjan, 1999 #278]. 
Multiple sequence alignment of the E. coli YmÍN hypothetical protein, phage D3 
ORF1692 and phage SW ORF577 revealed conserved regions within a considerably large 
area of the protein (Figure 4.4). The conserved regions may represent functional 
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Figure 4.4. Multiple sequence alignment of phage SW ORF577 encoding the putative 
large terminase subunit, E. coli hypothetical protein YMFN_ECOLI (Accession No. P75978), 
and P. aeruginosa phage D3 ORF 1692 (Accession No. AF165214). Alignment was 
performed using the Eclustalw program in WAG with a gap penalty of 10. Identical residues are 
in black boxes, similar residues are boxed in dark gray, somewhat similar residues 
are italicised, and non -matching residues are not shaded. 
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terminase active sites which could also exhibit similarity in their secondary structural 
conformation. In addition, it was interesting to discover that the distinct position orf577 
immediately upstream of the head assembly genes, is also observed among other 
bacteriophages [Duda, 1995B #289][Lucchini, 1998 #318][Smith, 1999 #2761[Kaneko, 
1998 #204][Tremblay, 1999 #207][Altermann, 1999 #206]. Based on location and 
homology to several bacteriophage terminases, evidences indicate that orf577 encodes the 
SfV terminase subunit. 
4.2.4. ORF367 
ORF367 is 271 nucleotides downstream of ORF577 and shares significant homology to 
the portal proteins of the following: Bacillus subtilis phage phi -105 ORF25 (nt 2512- 
3762); Haemophilus influenzae genetic island 1 ORF25; Coliphage HK97 gp 3 ; 
Pseudomonas aeruginosa phage D3 ORF4 (nt 2264 -3568); Streptomyces phage (4C31 
gene 34 (nt 2886 -4259); Rhodobacter capsulatus strain SB1003 protein ID AAC16225; 
and Staphylococcus aureus phage ¢PVL proviral protein ORF4 (nt 2451- 3701). The 
predicted gene product had a similar isoelectric point (9.45) and molecular mass (41.9 
kDa) to the portal proteins of phage D3 and phage DTI portal protein [Gilakjan, 1999 
#278][Tremblay, 1999 #207]. However, other phages had larger portal protein 
products. For example, phage 4 C31 has a 54 kDa product and phage X has a 59 kDa 
product which unlike other phage portal protein are processed. This is why the SA' 
putative portal protein ORF367 and those of phage D3 and DT1 had higher molecular 
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masses [Catalano, 1995 #272][Smith, 1999 #276]. The organisation of orf577 and orf367 
is similar to other phage terminases and portal proteins. Based on the position of the 
gene, the location of orf367 which is immediately downstream of the putative terminase 
gene is similar to the gene arrangement found in other bacteriophages [Duda, 1995B 
#289][Lucchini, 1998 #318][Smith, 1999 #276][Kaneko, 1998 #204][Tremblay, 1999 
#207][Altermann, 1999 #206]. With this observation and considering that the protein 
product of most genes from the database homologous to ORF367 is the portal protein, it 
is likely that orf367 also encodes for a product with a similar function. In addition, 
several portal proteins were compared and found to be conserved among bacteriophages 
[Smith, 1999 #276]. Portal protein serves an important role in directing incoming DNAs 
into the head during the formation of mature phage particles. Thirteen subunits form an 
annular structure situated at the opening of the prohead shell and serve as passageway for 
DNA during the packaging process [Dube, 1993 #320]. In phage HK97, the portal 
protein participates in the capsid maturation process [Duda, 1998 #319]. 
4.2.5. ORF200 
A 22.7 kDa protein with an isoelectric point of 4.92, is encoded by orf200. FASTA 
search detected significant homology to Lactobacillus casei phage A2 protein, B. subtilis 
phage phi -105 ORF26 (nt 3752 -4378) and S. aureus phage 4PVL proviral protein ORF5a 
(nt 3694 -4278) proteins all of unknown function. The search also showed high sequence 
homology to the protease proteins of Streptomyces phage 4C31 gene 35 (nt 4240 -4881) 
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and coliphage HK97 gp4. Bacterial proteins which are similar to the ORF200 protein 
include the ORF 12 of H. influenzae genetic island 1 and M. tuberculosis segment 118/162 
MTCY441.20C, both of which were reported as similar to coliphage HK97 gp4 protein 
(SwissProt ID VP4 BPHK7)[Cole, 1998 #328]. Protease functions were assigned to 
phage 49031 23.5 kDa gp35 and coliphage HK97 25 kDa gp4, both have similar 
molecular mass to the 22.7 kDa phage SfV ORF200. Based on its similarity to several 
bacteriophage proteases in size and isoelectric point (pl), it is tempting to predict a 
similar function encoded by orf200. However, further experiments should be conducted 
in order to test for its functional properties (Chapter 5). Protease is a compotent of the 
head assembly genes and has proteolytic action that processes the major head protein 
(capsid) prior to covalent crosslinking to form the mature head shell [Kaneko, 1998 
#204][Gilakjan, 1999 #278][Duda, 1995B #289]. The processing and head maturation of 
HK97 has been characterised in detail [Duda, 1995C #301]. Similar to the position of 
phage SW orf200, the protease gene has been located immediately upstream of the capsid 
gene of other bacteriophages [Kaneko, 1998 #204][Gilakjan, 1999 #278][Duda, 1995B 
#289][Smith, 1999 #276][Altermann, 1999 #2061. Alignment of SW ORF200 product 
with L. casei phage A2 putative protease revealed significant amino acid sequence 
conservation extending throughout the entire length of the proteins (Figure. 4.5). 
4.2.6. ORF409 
The closest homologue to 51V ORF409 is the major capsid protein of temperate phage 
phi-C3 I encoded by gp36. The gene position of the capsid protein is reminiscent of the 
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Figure 4.5. Sequence comparison of Shigella flexnerí phage SW ORF200 putative 
protease and Lactobacillus casei phage A2 protease gene products (Accession 
No. AJ251790). Homology is evident throughout the entire protein. Identical residues 
are indicated by asterisks and conservative changes are indicated by periods. Alignment 
was performed using the Eclustalw program in WAG. 
gene arrangement of the late structural proteins in double- stranded DNA bacteriophages 
including phi C31, HK97, (I)PVL, D3, 4adh and phage SN (Figure 4.6) whose putative 
protease ORF200 is immediately upstream of ORF409 with only 11 intergenic bases. In 
terms of molecular mass, the 45.8 kDa phage SN ORF409 gene product is comparable to 
the 41.7 kDa protein of phage phi -C31 gp36 which in turn is homologous to coliphage 
HK97 42 kDa major capsid gp5 [Smith, 1999 #276][Duda, 1995C #3011. Although 
ORF409 showed the highest homology to phage phi -C31, its probability value (1.le -09) 
and percentage identity (23% in 397 aa) were much lower than the scores obtained for the 
other SN ORFs (Table 4.2). Furthermore, ORF409 was not similar to proteins of 
bacteriophages phi PVL, phi -105, HK97 and phage D3 whose gene products 
consistently showed high homology to other phage SN ORFs (Table 4.2). This implied 
that major capsid proteins are less conserved compared to other head assembly 
components [Smith, 1999 #276]. Smith et al., (1999), compared the percentage 
sequence identities between major capsid homologues from diverse phages using 
BESTFIT. They reported that the major capsid proteins generally have less 
conservation than the proteases and portal proteins. This could be the reason why phage 
SN ORF409 only shows significant homology to phage 4 C31 gp 36 and could also 
explain why similarity to Pseudomonas phage D3 capsid was not evident despite the high 
46% identity of its ORF1692 terminase gene product with phage SW ORF577 (Table. 
4.2) 
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Figure 4.6. Comparison of head assembly gene organization among representative bacteriophages: 
Shigella flexneri phage SPI (Chapter 4); Sireptomyces phage 4C31 (Smith et al., 1999); 
Coliphage HK97 (Duda et al., 1995A); Pseuiomonas aeruginosa phage D3 (Gilakjan et al., 1999); 
Bacteriophage X (Murialdo et al., 1978, Hendrix et al., 1974); Lactobacillus gasser- phage 4adh 
(Altermann et al., 1999); Staphylococcus aureus ph ae jP VL (kaneko et al., 1998); and 
Bacteriophage T4 (Laenuuli, 1970, Dickson et al., 1970, Powell et a1., 1990). Note the 
similarity in the sequential order of the genes or open reading frames. Coloured boxes represent 
related genes. The terminase protein genes are shown in blue, portal protein genes in yellow, 
protease genes in green, and the head protein genes in red. Lambda gene D represents the head - 
DNA stabilization gene and W represents the head -tail joining gene. 
At this stage, we can only assume that orf409 codes for phage SfV capsid protein with 
an isoelectric point of 5.08. However, the striking conservation in the organisation of 
the DNA packaging genes positioned immediately upstream of the head assembly genes 
among different bacteriophages, provided a strong evidence as to the identity of phage 
SfV orfs 577, 367, 200 and 409 (Figure 4.6). Based on the location of ORF409 and its 
protein homologies, it appears that orf409 encodes the capsid protein of SfV. 
4.2.7. ORFs 56, 498, 89, and 116 
orf498 extends from nt position 2615 to 1119 of the 10.1 kb BamHI fragment A, 
translating a 498 amino acid protein with molecular mass of 54.8 kDa and a pl value of 
5.54 (Table 4.1). Following GenBank sequence database search, ORF498 was found to 
be homologous to the 55 kDa phage Mu tail sheath ORF L (9.4e -56), which is similar in 
size to the 54.8 kDa phage SfV ORF498 [Takeda, 1998 #32 T. The highest probability 
score for ORF498 FASTX database search (4.9e -56) matched with the sequence 
designated as HI1511 of the Mu -like prophage integrated into Haemophilus ínfluenzae 
chromosome [Fleischmann, 1995 #2101 which also matched highly with phage Mu ORF 
L [Takeda, 1998 #3211 Immediately upstream of Haemophilus HI1511 is HI1510, a 
protein homologue of phage Mu ORF1 which is located upstream of ORF L. HI1510 
showed significant homology to phage SA/ ORF56 which is also found upstream of 
ORF498 (Figure. 4.7 A and B). Similarity searches of predicted ORF89 protein matched 
with Pseudomonas aeruginosa phage gCTX ORF24 which is similar to gene E of phage 
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Figure 4.7. Sequence comparison of tail proteins. A, Shigellaflexneri phage StV 
ORF498 putative sheath and Coliphage Mu sheath protein gene L (Accession No. AB000833). B, Shigella flexneri phage SfV ORF56 and 
Coliphage Mu ORFI. Identical residues are indicated by asterisks and conservative 
changes by periods. Alignment was performed using the Eclustalw program in WAG. 
P2 [Nakayama, 1999 #203]. In the GenBank database, phage P2 gene E (accession 
number AF063097; protein ID AAD03291) was identified as an essential tail protein. 
ORF116 of phage SW had 40% homology to Pseudomonas aeruginosa phage 4CTX 
ORF25 which is similar to T gene of phage P2. The T gene was also identified as 
encoding an essential tail protein of phage P2. With the pending functional 
characterisation of phage SN ORFs498, 56, 89, and 116 and based on sequence 
homolgy and clustering of these genes in a particular genomìc region, we can only deduce 
that these genes encode for the major and minor tail components of phage SW. 
4.3 Discussion 
The BamHI fragment C of bacteriophage SW flanking the the 0-antigen modification gene 
region has been well -characterised. The important function of proteins encoded by 
fragment C genes in serotype conversion has been established through sequence analysis 
and several cloning experiments [Huan, 1997B #117] [Huan, 1997A #118]. For example, 
Huan and colleagues have constructed a fully serotype- converted S. flexneri 5a strain, 
SFL1168 (Type antigen V) by introducing a 5.0 kb BamHI fragment C of phage SW into 
S flexneri serotype Y, SFL124 (Group antigen 3,4). SFL1168 was indistinguishable 
from the S flexneri 5a wild -type strain. The discovery of phage SN genomic portion 
encoding important factors for serotype conversion was followed by other experiments 
that lead to the localisation of other serotype conversion modules [Adhikari, 1999 
#112][Adams, 2000 #523]. Inspired by the wealth of information derived from such 
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limited segment of the genome, it was deemed necessary to proceed in the analysis and 
characterisation of the genetic blueprint in order to unravel and fully understand the 
biology of phage SN. 
In this project, the 10.1 kb portion of BamHI fragment A was sequenced and analysed. 
This portion yielded putative ORFs, eight of which showed similarity to other phage 
proteins. The higher FASTA similarity scores of most phage SfV ORFs were traced to 
the genomes of prophages. Examples were the E. coli hypothetical 50.9 kDa protein of 
el4 prophage, and prophages in Rhodobacter capsulatus strain SB1003 and Haemophilus 
influenzae genetic island 1. This indicated a pattern of genetic exchange and transfer of 
DNA across species mediated by mobile gene carriers like the bacteriophages. 
Bacteriophages have been known to be important transposing agents of genetic elements 
from various bacterial species that paved the way to evolutionary progress [Cheetham, 
1995 #30]. Bacteriophage infection can relay not only genes that are unnecessary to host 
existence but also important genes like virulence factors that can transform avirulent 
bacterial strain into a harmful pathogenic organism [Bishai, 1988 #352][Miao, 1999 
#524]. 
ORF577 showed significant similarity to several phage terminase subunits (Table 4.2). 
Based on the statistical significance of the E value from the database search and the 
conserved position of ORF577 immediately upstream of the putative portal protein gene 
orß67 (Figure 4.6) [Lucchini, 1998 #3181, ORF577 may also have a terminase enzyme 
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function. The terminases play an active role in DNA packaging during the phage head 
assembly [Casjens, 1988 4266]. Comprising a small and large subunit, the terminase 
complex initiates either a sequence specific (cos) or non -specific (pac) packaging cut in 
the adjoining head -tail concatemeric DNA and presents the DNA through the portal 
vertex of the prohead [Earnshaw, 1980 #270][Bazínet, 1985 #326]. The terminase and 
portal protein interact to form a headfilling packasome complex which facilitates DNA 
translocation coupled with ATP hydrolysis. When the head is filled with a certain DNA 
density or a specific sequence is reached, the terminase cuts the DNA [Black, 1995 #3251. 
Considering the constant cycle of lytic and lysogenic existence of bacteriophages, it was 
not surprising to detect a high percentage identity (96 %) between orf577 and E. coli 
ymfN. However, the extent of amino acid sequence homology of the E. coli YMFN 
encompassed only a limited region of ORF577 compared to other terminase homologues 
of bacteriophage origin. It is possible that the putative terminase region in ymfn which 
was introduced by a cryptic phage, had became latent and had acquired several mutations 
which contributed to the observed homology to a limited region of ORF577 [Campbell, 
1996 #324][Blattner, 1997 #4]. It is also possible that phage el4 terminase is encoded 
by a mosaic gene originally derived from various phage sources through gene 
recombinations. This could account for its limited sequence identity to ORF577. 
Another possible product of bacteriophage promiscuity leading to genetic mosaicism 
could be SW orf764. Although homologies to proteins of bacteriophages and prophages 
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were detected, these proteins were reported to have unknown or hypothetical function 
(Table 4.2). The size and location of orf164 is similar to other bacteriophage small 
terminase subunit. It is immediately upstream of orf577, which is a location similar to 
the 20.4 kDa small terminase subunit (gpNul) of bacteriophage X gpA -gpNul 
holoenzyme complex [Catalano, 1995 #272][Tomka, 1993 #3531. In phage D3 the 
predicted small terminase subunit gene orß81 also lies upstream of the large terminase 
subunit gene orfl 692 [Gilakjan, 1999 #278]. These terminase protein complex were also 
observed in other bacteriophages such as the gp3 and gpl6 of phi -29, gp2 and gp3 of 
P22, gpM and gpP of P2, gp16 and gp17 of T4 and gp18 and gp19 of T3 [Powell, 1990 
#354][Guo, 1987 #3551[Hashimoto, 1992 #356][Eppler, 1991 #357]. Analogies 
pertaining to orf164's location relative to terminase gene position in other bacteriophages 
are interesting to note, however, it would be very presumptuous to consider orf164 as 
being a terminase component since it only showed significant homology to bacteriophage 
proteins that are not yet identified. Further studies must be conducted on orf164 in 
order to determine its real identity. The terminases together with the portal protein at 
the prohead portal vertex comprise the packasome [Hendrix, 1978 #358][Earnshaw, 1980 
#270][Black, 1995 #325]. 
The identity of phage Mu gene L and ORF2 as the respective tail sheath and tube genes 
was confirmed by N- terminal sequencing of the purified Mu tail proteins [Takeda, 1998 
#321]. The tail components were purified by sucrose density gradient ultracentrifugation 
from the cell lysate of heat - induced lysogenic Su strain containing a phage Mu Tam 
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mutant defective in the phage head synthesis [Shore, 1982 #360]. Significant homology 
of phage SfV ORF498 protein to the gene L product of phage Mu suggests a possible tail 
sheath protein function for the ORF498 protein. in considering gene organisation, the 
immediate upstream location of phage SfV ORF56 to ORF498 is similar to the 
arrangement of phage Mu gene f, which is directly downstream of gene ORF 1 
(Figure.4.8). However, phage Mu tail tube gene ORF 2, transcribed after gene L, was 
not identified as homologous to phage SfV ORF118. ORF118 did not show significant 
homology to any database protein and yielded high levels of gap insertion when aligned 
with other phage tail protein. The gene may represent a dysfunctional ORF of host origin 
repeatedly transferred as the phage undergoes multiple lytic-lysogenic cycles, or a 
remnant tail gene of viral origin that has become vestigial in function since it was 
positioned between genes of putative tail protein identities (Figure 4.3). Predicted amino 
acid sequences for ORF89 and ORF116, downstream of ORF118, were homologous to 
essential tail proteins encoded by phage P2 gene E and phage P2 gene T, respectively 
[Nakayama, 1999 #203]. This clustering of bacteriophage SfV putative tail structural 
genes strongly suggested that ORF56, 498, 89, and 116 comprise another SfV gene 
module which codes for the phage tail assembly components. 
There are several methods adapted in identifying the late protein functions in these 
bacteriophages. Protein functions were derived using approaches such as comparison 
with conserved domains, functional assessment experiments, and identification of 
essential structural features common among known proteins [Smith, 1999 #2761[Kaneko, 
119 
1II1511 
Sheath Protein 
SW 
1111511 
4)CTX 
118 89 
27.1% 40% 
BAA36253 
Figure 4.8. Schematic diagram illustrating the homology of bacteriophage SfV tail 
region proteins to the gene products of bacteriophage Mu and Haemophilus influenzae 
Mu -like prophage. Dashed lines indicate homology between two predicted proteins 
with corresponding similarity scores shown in pink text. Represented by coloured 
arrows are genes with related protein products. Phage Mu ORF1, sheath protein gpL 
and ORFs 2 and 3 has been submitted to GenBank sequence database with accession 
number AB000833. HI1510, HI1511, HI 1512, HI1513 are proteins encoded in the 
Mu -like prophage of Haemophilus influenzae (Accession No: U32827), BAA36251 is 
the protein ID for phage (I)CTX similar to phage P2 gene E tail protein (Accession No. 
AB008550); and BAA36253 is for phage 4CTX protein similar to phage P2 gene T 
tail protein (Accession No. AB008550). 
1997 #280][Gilakjan, 1999 #278][Tremblay, 1999 #207][Desiere, 1998 #162][Kobayashi, 
1998 #3611[Garcia, 1997 #362]. Recent reports cited nonsequence alignment technique 
that used ORF length and isolelectric point (pl) to make a comparative analysis between 
the unknown proteins and the gene products of coliphage X [Chandry, 1997 #316]. 
Tremblay et al., (1999) provided further evidence of its utility when they compared the 
molecular weight and pI of Streptococcus thermophilus phage DTI proteins with those of 
coliphage X in order to support assignment of putative functions for 15 ORFs, a method 
inspired by researches on gene function prediction among Siphoviridae phages using the X 
gene map [Lucchini, 1998 #318]. Using a similar approach [Tremblay, 1999 #207], 
phage SAT ORFs were compared with the molecular weights and isoelectric points of 
phage DT1 and phage X. Some StY late gene products showed properties which are 
similar to phage DT1 and phage X. For example, ORF577 encoding for the putative 
large terminase subunit, the putative protease protein ORF200, the putative capsid 
ORF409, and tail protein ORFs 498 and 89 have molecular weights and isoelectric points 
which are comparable to those of phage DT1 and X (Table 4.3). 
The properties of the putative protease ORF200 (molecular weight, 22.7 and isoelectric 
point, 4.9) are similar to phage DT1 ORF7 scaffolding protein (MW 24.5, pI 5.0) and 
phage X scaffolding protein Nu3 (MW 20.8, pI 4.5). Comparison between the protease 
and scaffolding protein was done based on their conserved gene location adjacent to the 
major head protein and in consideration of their analogous function in providing support 
120 
Table 4.3. Comparison between the molecular weight and isoelectric point of phage SfV 
predicted proteins with phage DT1 and coliphage X. protein products. 
Protein Function MW O F p Protein l 
Terminase large subunit 577 65.3 5.3 4 42.7 4.4 A 73.3 6.1 
Scaffolding /Protease 200 22.7 4.9 7 24.5 5.0 Nu3 20.8 4.5 
Major Head Protein 409 45.8* 5.1 8 32 5.2 E 38.2 5.3 
Tail component 498 54.8 5.5 17 58.3 5.6 L 25.7 4.7 
Tail component 89 10 5.2 14 13.5 4.7 G 1 5.6 5.1 
*Unprocessed form of head protein (refer to Chapter 5) 
during the formation of the head shell [Duda, 1995B #289][Duda, 1995C #301]. 
Likewise, the putative major head protein of SN showed similar properties to its 
counterpart proteins in DT1 and X, except for a higher molecular weight of 45.8 kDa for 
phage SW major head protein (Table 4.3). However, several reports involving 
bacteriophage head assembly have experimentally confirmed the requirement for the major 
head protein to be cleaved in order to attain its mature form [Gilakjan, 1999 #2781[Duda, 
1995A #275][Smith, 1999 #276][Kaneko, 1998 #204]. If such a process occurs in phage 
SW ORF409 protein, then we would expect a reduction in its molecular size possibly 
down to the size of phage DTI major head protein (MW 32 kDa) or to that of phage X 
(MW 38.2kDa) (Table 4.3). Therefore, functional studies involving experiments which 
would elucidate the occurrence of cleavage in ORF409 putative head protein should be 
investigated not only to ascertain its role as the capsid protein but also to determine other 
factors required for such a process to take place. 
Variations in protein properties among bacteriophages SfV, DT1 and X were also 
observed for the tail components suggesting a divergent gene pool source. Another 
example is ORF367 encoding the putative portal protein which showed a higher pI value 
of 9.4 compared to DT1 ORF 6 (pI 5,2) and phage X protein B (pI 5.7), despite similar 
molecular weights for their protein products. Taken together, this method of 
comparative analysis between predicted protein properties could be useful in providing 
additional support in the assignment of putative gene functions for phage SW ORFs. 
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However, it should be used with caution and should not be considered as a substitute but 
only as an adjunct to the more definitive protein functional analysis using 
experimentations. 
Many SW late proteins are homologous to the late proteins of other Siphoviridae 
bacteriophages which infect diverse bacterial hosts. The organisation of the late 
structural genes showed remarkable conservation (Figure. 4.6). It is possible that the 
genome of bacteriophages such as 4)C31, 4)PVL, D3, 4)105, , DTI, Sfi19, Sfi21 and phage 
A2 was assembled from a common gene pool source [Hendrix, 1999 #166]. Another 
evidence showing linkage of phage SW to the Siphoviridae family is its morphology 
(Figure 4.9). Phage SW belongs to the group B category of Bradley's classification, 
possessing an isometric head and a long non -contractile tail which is also inherent among 
bacteriophages of the Siphoviridae family [Ackerman, 1987 #287][Bradley, 1967 #179]. 
Due to these genetic and structural similarities, a genetic pool lineage of phage SW to 
bacteriophage members of the Siphoviridae family was observed. 
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50nm 
Figure 4.9. Transmission electron micrograph of bacteriophage SfV. A, phage SfV stained with 
2% phosphotungstic acid (Huan et al., 1997C). B, phage SfV in cluster stained with 2% uranyl- 
acetate. 

CHAPTER 5 
Post -translational Cleavage of the 45.8 kDa Major Prohead 
Capsid Subunit is Catalysed by Shigella flexneri 
SfV Bacteriophage- encoded Protease 
5.1. Introduction 
The 10.1 kb BamHI fragment A has been shown to encode genes which are homologous 
to the late structural genes of many bacteriophages and prophages (Table 4.2). It was 
also noted that the organisation of bacteriophage SfV late genes have a similar gene 
arrangement to those found in other double- stranded bacteriophages such as D3, HK97, 
OC31, OPVL, 4adh, T4 and X (Figure 4.6). The order of transcription proceeds from 
the DNA packaging proteins, the terminases and portal protein to the head assembly 
genes comprised of the protease and the major head protein. SN ORF200 and ORF409 
products showed significant homology to the protease and capsid proteins of several 
bacteriophages including phage OC31, D3 and HK97. Recent comparative studies have 
revealed evidences supporting the similarity in the capsid structure and head assembly 
process of phage ¢C31 and D3 to phage HK97 [Gilakjan, 1999 #278][Smith, 1999 #2761. 
The capsid processing and maturation of HK97 had been studied extensively and was 
considered unique, since the process does not require the use of an independently 
encoded scaffold protein as support in the formation of a mature head shell but relied on 
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the assembly of capsid subunits that had undergone molecular modification and structural 
processing [Duda, 1995C #3011. In order to determine if phage SN follows the same 
initial head processing step during head assembly involving cleavage of the capsid protein 
prior to crosslinking, we have conducted experiments that would show the capability of a 
functional ORF200 to induce reduction in the size of ORF409 upon overexpression. 
Our experiments demonstrated the processing of a 45 kDa SW major capsid subunit after 
its translation. Our experiments have established that an intact protease gene orf200 
immediately upstream of the capsid gene orf409, is required to effectively cleave the 
unprocessed capsid subunit into a 32 kDa form of the prohead. 
5.2. Results 
5.2.1. Protein Band H N- terminal Sequence was Located within ORF409 
In order to support and establish the identity of some SW orfs, the phage structural 
proteins were separated on SDS -PAGE. The protein profile showed several bands 
which were labelled with alphabetical letters starting from the largest protein as band A 
(Figure 5.1A). Using Western immunoblotting procedure, the protein bands were 
blotted and hybridised with adsorbed and unadsorbed rabbit polyclonal antisera raised 
against the whole phage SW particles which were propagated in the S. flexneri host, 
SFL124. Adsorption procedure using SFL124 acetone powder was performed in order 
to reduce non -phage SW specific antibodies in the crude polyclonal antiserum preparation 
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Figure 3.1. A, 12% SDS -PAGE gel of PEG precipitated SW phage particles. B, Western blot 
of phage SW protein 'hybridised with rabbit polyvalent unadsorbed antisera raised against 
whole phage SfV particles. Note the SFL124 host protein band of similar molecular mass 
as the protein band F-1 of phage SfV. C, An identical Western blot as in B except that the rabbit 
polyvalent antisera used was adsorbed with SFL124 acetone powder. Note the reduced 
background and non -specific binding with crossreacting host protein on membrane using 
adsorbed antisera_ D, N- terminal amino acid sequence of protein band H revealed the first 
residue to be internal to the predicted amino acid sequence of the ORF409 protein. The first ten. 
N- terminal sequences are shown in bold print and italicized_ 
(Figure 5.1B and 5.IC). Anti -SfV antibodies detected band H at approximately 32 kDa 
level. 
Six bands were extracted from the gel, transferred electrophoretically to PVDF membrane 
and pieces of blotted membrane were analysed using an automated protein sequencer at 
the John Curtin School of Medical Research, Biomolecular Resource Facility. Only the 
N- terminal amino acid sequence of protein band H, AQGVAQDEKG, corresponded to a 
protein encoded in the 10.1 kb BamHI fragment A region. These N- terminal amino acid 
residues were found as the 116th to 125th amino acid residues of the predicted amino acids 
of ORF409 (Figure 5.1D). This indicated that the mature phage protein band H starts 
internal to the sequence of the phage SPY' capsid ORF409. Similar results have been 
reported for other bacteriophages such as phage HK97, PVL, phi -105, phi -C31, and 
D3 [Duda, 1995A #275][Duda, I995B #289][Kaneko, 1997 #280][Kobayashi, 1998 
#361][Smith, 1999 #276][Gilakjan, 1999 #278]. The major head protein of these 
bacteriophages is proteolytically cleaved. This process is well characterised in HK97. 
The proteolytic cleavage of the capsid is conferred by a protease which is encoded 
immediately upstream of the capsid gene. 
5.2.2. Localisation and Amplification of the Putative Protease and Capsid Gene Insert 
Database homology searches have detected several bacteriophage- encoded capsid 
homologues as significantly similar to phage SfV ORF409. Further support to the 
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identity of this ORF was derived after the first ten amino acid residues of phage SW V SDS- 
PAGE protein band H detected by anti -SfV antibodies, were traced within the predicted 
amino acid sequence of ORF409. With ORF200 having a similar location as the protease 
genes in other bacteriophages, the function of ORF200 in processing ORF409 was 
investigated by assessing the fate of ORF409 protein in the presence and absence of a 
functional ORF200. 
Phage SW orf200 (nt 6467 -5865) and orf409 (nt 5854 -4625) are located at the upper 5' 
end of the 10.1 kb BamHI fragment A, within the head protein cluster of the genome's 
late region (Figure 5.2A and B). Oligonucleotide primers were designed to capture the 
entire protease and capsid orfs. The forward primer 5'(5' -AAT GAA TTC ATC TGA 
CGG GGC TTT TAC -3'), designated as proteasestart, is located 207 nucleotides 
upstream of the orf200 start codon (ATG) and the reverse primer 3'(5' -AAT GGA TCC 
GAC TAA TCA ACC ACC AAC -3'), called capsidend, flanks the complementary 
termination codon (TGA) of orf409 (Figure 5,2C). A gene segment containing part of 
orf200 and the entire orf409 was also amplified. PCR primer proteasemiddle 5'(5' -AAT 
GAA TTC GCA CGC TGA ATC TCT CAG -3') was designed to anneal at the upper 
third portion of the protease DNA sequence amplifying the 3' half of the gene (Figure 
5.2C). The 5' end of the primer was situated at exactly 232 nucleotides downstream 
from the start codon of orf200. When paired with primer capsidend, PCR yielded an 
insert comprising the 371 bp 3' half of orf200 and the entire orf409 DNA sequence. 
This insert with a truncated putative protease gene and a complete putative capsid gene 
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Figure 5.2. A, Physical map of bacteriophage SIV showing the whole genomz s BumHI fragment: 
B, Map of the sequenced 10.1 kb BannHi fragment A with corresponding ORF designation and 
putative function, arrows indicate transcriptional direction; C, Map of the head assembly genes 
showing coordinates of primers used to amplify the complete protease- capsid insert and the 
incomplete protease -capsid insert, the primers were tagged with EcoRI or Hamill linkers for 
directional cloning. The PCR products were cloned into the EcoRIiBamHI sites of 0:7 -5 to create 
pNV769 and pNV774, respectively. 
was cloned and overexpressed to compare its protein products with recombinant strains 
containing the complete putative protease gene. 
For directional cloning with expression vector pT7 -5 [Studier, 1990 #300][Tabor, 1985 
#245][Tabor, 1987 #262], extra AAT -EcoRI linkers were tagged on to the 5' end of the 
proteasestart and proteasemiddle primers and an AAT -BamHI linker was included at the 
5' end of the capsidend primer. This facilitated directional cloning ensuring the correct 
transcriptional orientation of the insert with reference to the vector's promoter sequence. 
The proteasestart /capsidend primers successfully amplified 2055 bp flanking the putative 
protease and capsid genes including their likely ribosomal binding sites, 
GAGGGAAAAA with 3 nt spacer sequence from orf200 start codon and 
GtAAAGGAAA with 4 nt spacer sequence from the orf409 start codon. The 
proteasemiddle /capsidend primers amplified 1616 bp flanking the truncated putative 
protease gene and the complete putative capsid gene. Both inserts were cloned, 
overexpressed and the protein profiles compared with SDS -PAGE and immunoblotting 
results. 
5.2.3. ORF200 is Required to Cleave ORF409 Gene Product 
The PCR products were digested and ligated into pT7 -5 and transformed into P4189. E. 
coli P4189 has a single copy of the T7 RNA polymerase gene under the control of the 
IPTG -inducible lacUV5 promoter. After transformation, the identity of the 
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recombinant plasmids were confirmed through restriction digest analysis. Plasmids were 
cut with SacI and Pstl which have restriction sites located at the polycloning site as well 
as nucleotides 5591 and 5220 of the capsid gene, respectively. This generated three 
fragments indicating the transformation of strains with the desired recombinant plasmids. 
The resultant transformants were strain B876 with pNV769 containing the 2.4 kb pT7 -5 
vector and 2 kb complete protease- complete capsid insert and strains B877 and B878 
with pNV770 containing the vector and the 1.6 kb truncated, incomplete protease - 
complete capsid insert (Figure 5.3). The protein products were overexpressed using 
0.4mM IPTG to induce a log phase culture, and aliqouts were taken at 0, 60, and 180 
minutes intervals prior to visualization in 12% SDS -PAGE stained with Coomassie blue. 
Upon induction, the 45 kDa capsid protein accumulated over time in strains B877 and 
B878 without a pronounced increase in protein band intensity at the processed 32 kDa 
level (Figure 5. 4A, lanes 4 -7 and Figure 5.4B, lanes 4 -5). This indicated that the 45 
kDa capsid proteins were not being cleaved because the incomplete protease was non- 
functional, thus the unprocessed capsid at this level accumulated. A separate 12% SDS- 
PAGE was prepared that clearly illustrated the increasing band intensity at the 45 kDa 
capsid level in B877 over time (Figure 5.5, lanes 6 -9). The accumulation of the 45 kDa 
protein was not observed in B876, instead, a gradual increase in intensity of the 32 kDa 
capsid band was observed over time (Figure 5.5, lanes 1 -4; Figure 5.4A, lanes 2 -3; and 
Figure 5.4B, lane 3). Neither protein accumulated in the control strain B866 containing 
the vector only. This suggested that the complete protease insert orf200 in B876 
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Figure 5.4. 12% SDS -PAGE gel of IPTG induced log phase growth of strains B866, B876, B877 
and B878. lane L LMW protein calibration marker; lanes 2 and 3: strain B876 at 0 and 60 min. 
post- induction; lanes 4 and 5: strain B877 at 0 and 60 min, post- induction; lanes 6 and 7: strain 
B878 at 0 and 60 min. post -induction. B, Lane I: B866, control strain containing the vector only 
at 180 min. post- induction; lane 2: LMW protein calibration marker; lane 3: B876 at 180 min. 
post- induction; lane 4: B877 at 180 min. post- induction; and lane 5: B878 at 180 min. post - 
induction. 
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Figure 5.5. 12% SDS -PAGE gel of strains B876 and B877 in IPTG post - 
induction time series. lanes 1 -4: strain B876 at 0, 60, 120, and 180 min. 
post - induction, respectively; lane 5: M, LMW protein calibration marker; 
lanes 6 -7: strain B877 at 0, 60, 120, and 180 min. post -IPTG induction, 
respectively. 
encoded for a functional protein that caused the cleavage of the 45 kDa capsid protein 
generating a 32 kDa protein digest product. 
5.2.4. Immunoblot Analysis Confirmed ORF409 Gene Product as the Capsid 
Polyclonal rabbit antiserum raised against whole phage SW particles which earlier 
detected the processed capsid (section 5.2.1), was used to confirm the position and 
expression of capsid proteins from clones containing the ORF409 insert. Aliquots of 
phage SW stock and strains B866, B876, and B877 at 120 min post -IPTG induction, 
were separated on a 12% SDS -PAGE then blotted onto to Hybond N+ nitrocellulose 
membrane for Western immunoblotting. Although the sera had been adsorbed with 
saturating amount of competitor host SFL124 protein, anti -Shigella SFL124- specific 
antibodies that crossreacted with proteins of E coli P4189 control strain B866 were still 
present (Figure 5.6 lanes A4 and B8). Six bands were detected representing proteins of 
B866 which were also detected in B877 and B876 (Figure 5.6 lanes 5, 6, 8). This was 
expected as all three strains are derivative strains of E. coli P4189. Two major phage 
SW structural proteins were detected, one representing the deduced 32 kDa processed 
capsid band, the only form composing the mature phage head, and a --55 kDa protein 
band suspected as representing the putative tail protein sheath ORF498 with a 54.8 kDa 
molecular weight (Figure 5.6 lanes A3 and B7). 
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Figure 5.6. Western immunoblot of strains B866, B876, B877, and phage SfV protein. A, lanes 
1 -2: 12% SDS -PAGE gel of strains B877 and B876 respectively, at 120 min post -IPTG induction; 
lane 3: phage SN; and lane 4: strain B866 (control strain with pT7 -5 vector). B, Western immuno- 
blot using rabbit anti -SW polyclonal antisera, lanes 5-6: strains B877 and B876, respectively; 
lane 7: phage SW; and lane 8: B866 control strain. 
The deduced 45 kDa capsid which is unprocessed was not detected in the phage SW lane, 
suggesting that the 32 kDa processed capsid is the only form of head protein utilised in 
the formation of mature phage particles. This 32 kDa processed form of the capsid was 
also detected in B876 (Figure 5.6 lane 6) with the complete protease gene insert but was 
not as pronounced in B877 (Figure 5.6 lane 5) with the incomplete protease gene insert. 
Autoradiographic signals with similar intensity at the 32 kDa level were detected for both 
B877 and the control strain B866 (Figure 5.6 lanes 5 and 8). This signifies that the 32 
kDa protein band visualised in B877 does not represent the processed capsid but an E. 
coli host protein of similar molecular mass, an observation clearly illustrated upon direct 
comparison of the 32 kDa band signal intensities between the processed capsid in B876 
and phage SN capsid (Figure 5.6 lanes 6 and 7) and the E. coli host proteins in B877 and 
the control strain B866 (Figure 5.6 lanes 5 and 8). Another proof of the absence of the 
processed capsid in B877 was the accumulation of the 45 kDa unprocessed form which 
was as evident in B876 (Figure 5.6 lanes 5 and 6). Considering the homology of ORF409 
to other bacteriophage capsid protein, its molecular size, N- terminal amino acid 
sequence and identity based on the immunoblot results, our functional experiments 
provided additional evidence which would support the designation of orf409 as the phage 
SW gene encoding for the capsid protein that gets cleaved in the presence of the complete 
orf200- encoded protease protein. 
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5.3. Discussion 
In this study we have identified the genes encoding the protease and capsid protein of the 
serotype -converting S. flexneri bacteriophage SW. Alanine was the first amino acid 
residue of the mature processed capsid band H whose first 10 amino acid residues were 
determined (Figure 5.1). It was found to be the 116`h amino acid residue of the mature 
capsid protein sequence. This indicated that the start of the mature protein sequence is 
internal to ORF409 and suggested that processing of the capsid protein may be involved. 
Functional studies of the ORF200 indicated its role as the protease protein required in the 
processing of the capsid through cleavage. SW ORF200 has significant homology to 
putative proteases of bacteriophages such as phage A2 of Lactobacillus casei ORF242 
gene product which is similar to CIpP -like (protease Ti) [Chung, 1996 #508] proteins in 
the chromosome of bacteria and eukaryotes such as Caenorhabditis elegans (Q27539), 
Yersenia enterocolitica (Q60170), Homo sapiens (Q16740), Paracoccus denitrificans 
(P54414), E. coli (P19245) and Haemophilus influenzae (P43867) [Altermann, 1999 
#206]. C1pP is a proteolytic subunit of the Clp complex which exhibits potent 
proteinase activity when combined with the C1pA, C, X subunits of the Clp enzyme 
system [Wawrzynow, 1996 #359]. The Serine108 and Histidine85 residues of phage 
Oadh ORF242 protease with 22 interpeptide residues were found to correspond to E. coli 
C1pP protein residues Serine111 and Histidine136 with 24 interpeptide residues. These 
important amino acid components were reported to form part of the enzyme's catalytic 
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site [Maurizi, 1990 #3291. Similarly, these sites were found in phage SfV ORF200 
residues Serine 61 and Histidine 85 and residues Serine 45 and Histidine 69 of L. easel 
phage A2 protease protein. It is also interesting to note that for both bacteriophages, 
the putative serine and histidine catalytic sites are separated by 23 interpeptide residues 
(Figure. 5.7). Again, we can observe the similarity in protein properties suggestive of 
the probable protease characteristics of SfV ORF200 product. 
The diversity of capsid assembly processes adapted by double- stranded bacteriophages 
has been well -studied [Casjens, 1988 #2661[Casjens, 1992 #265][Hendrix, 1994 
#263][Hendrix, 1999 #166][King, 1974 #264]. While the basic mechanism involves a 
common transition of structural components from the detailed arrangement of subunits 
through the formation of a mature icosahedral head, the steps and intermediate molecules 
involved in the capsid development process vary. For example, phage P22 requires 
multiple copies of a cigar- shaped scaffold protein that interacts with the viral coat subunit 
to ensure the proper shell configuration [Fuller, 1982 #2671. This protein is absent in the 
developed phage particles and only found inside the protein shell coat of immature 
proheads, signifying its transient role in the development of the head [Murialdo, 1978 
#268]. Other phages encoding the scaffold protein are phage T4 genes 22 and 67 [Black, 
1974 #269]; phage X gpNU3 [Earnshaw, 1980 #270][Black, 1978 #271] [Catalano, 1995 
#272]; phage P2 gene P2N and phage P4 sid gene [Marvik, 1994 #273][Marvik, 1995 
#274]. In the pseudo T -even bacteriophage RB49 [Monod, 1997 #284] and the well - 
studied coliphage T4, a substantial portion removed from the amino terminus of its initial 
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Figure 5.7. Protein sequence alignment of Shigella flexnerí phage SfV ORF200 putative 
protease and Lactobacillus easel phage A2 protease (Accession No. ÁJ251790) showing the protease 
catalytic sites composed of serine and histidine residues which are numbered for both bacteriophages. 
There are 23 amino acid residues separating the serine and histidine residues indicated by italicised 
text. Alignment was performed using the Eclustaiw program in WAG. 
capsid subunit through cleavage mediated by a phage- encoded protease enzyme [Dickson, 
1970 #285][Hosoda, 1970 #286]. The apparent contrast in the head assembly pathway 
between phage HK97 and phage T4 is that the latter use scaffold proteins to support 
shell structure integrity and these are eventually cleaved into several pieces prior to DNA 
headfilling [Mesyanzhinov, 1990 #327]. Duda et al. [Duda, 1995A #275] demonstrated 
that HK97 capsid is an assembly of pentameric and hexameric head protein subunits 
without the use of scaffold proteins, and referred to the cleaved amino terminus portion 
of the capsid protein as a substitute scaffold. Conversely in P22, capsid assembly 
utilises monomer units that serve as assembly intermediates in shell formation [Prevelige, 
1993 #279]. Although there are variations between the many double -stranded phages 
studied, one central fact that prevails is, that subunits of the mature head are not 
produced as pre- fabricated molecules ready to be incorporated as an intact shell. The 
components of the head need to undergo proteolytic digestion, structural changes and 
molecular interaction prior to the final assembly (Figure 5.8). 
About a third of ORF409 protein was released after proteolytic cleavage, a mechanism 
not unique to phage SW [Casjens, 1988 #266]. For example, both Vibriophage KVP20 
[Matsuzaki, 1998A #281] and KVP40 [Matsuzaki, 1992 #283][Matsuzaki, 1998B #2821 
capsid had 62 N- terminal amino acid residues of pro -MCP (Major Capsid Protein) 
released upon maturation to MCP. These similarities were also observed in the head 
morphogenesis of bacteriophage members of the Siphoviridae family, possessing long, 
non -contractile tail [Ackerman, 1987 #287][Ackerman, 1997 #288]. Phage StV capsid 
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protein shared closest homology (31% ID) to Streptomyces phage OC31 whose putative 
capsid (gp36) translation product was discovered to have had an additional 111 amino 
acids at the N- terminus [Smith, 1999 #276]. A putative gp35 protease product was 
suggested to have cleaved the gp36 to produce the mature form. Gp35 of phage 4 C31 
was found to be homologous to HK97 gene 4 which is the prohead protease. During 
head assembly in HK97, the initial shell structure prohead I composed of 420 units of 
unprocessed 42 kDa capsid protein and 12 portal protein units, is cleaved by the 
protease enzyme eliminating 102 amino acids from the 5' terminus of the capsid subunit 
and generating prohead II [Duda, 1995B #289]. In the mitomycin -C induced 
Staphylococcus aureus V8 bacteriophage OPVL [Kaneko, 1997 #280], the N- terminal 
amino acid sequences of protein B (major head) are located between the 117th and 146th 
amino acid residue of ORF 7. Internal amino acid sequences were also found at the I Ith 
residue of the ORF4 putative portal protein [Kaneko, 1998 #204]. The 34 kDa size of 
its processed capsid approximates that of its 32 kDa phage SPI counterpart. Recently, 
Gilakjan et al., 1999, reported the discovery of a 186 kDa high molecular weight protein 
in serotype- converting phage D3 that failed to enter the gel matrix upon SDS -PAGE 
[Gertman, 1987 #290][Miller, 1974 #2911. Sequencing revealed the protein as an 
aggregated cross -linked hexamer derived from the head monomer subunit starting at 
Ala112. The mature phage D3 head protein was demonstrated to have lost 111 amino 
acid residues from its N- terminus upon proteolytic cleavage. These events were 
analogous to our phage SfV in which N- terminal sequencing of the mature capsid yielded 
an Ala116 as its first residue with a total 115 amino acids cleaved off from the precursor 
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protein (Figure 5.9). Head morphogenesis in phage HK97 and D3 is also similar, both 
having a 31 kDa processed head unit [Cilakjan, 1999 #2781. From the discussion 
presented so far, it can be deduced that the processing of major head proteins is well - 
established and is universal among dsDNA bacteriophages. 
Other similarities between phage SfV and HK97 head morphogenesis were also observed. 
For example, phage SfV has a slightly larger 45.8 kDa unprocessed head subunit 
compared to its 42 kDa prohead I precursor counterpart in phage HK97. It is also 
possible that phage SfV primary cleavage site located between Arg115 and Alal 16 could 
have similar properties as the HK97 cleavage site. Based on experimental results, Duda 
and his colleagues [Duda, 1995B #289] located the phage HK97 head protein cleavage site 
between Lys103 and Serf 04 and had proven that the site sequence requirement is not 
absolute since there was only a modest decrease in cleavage when lysine was changed to 
leucine. This suggests the role of substrate conformation in the specificity of cleavage 
and the possibility of having intermediate cleavage sites. 
Adding support to the designation of phage SN orfs 200, and 409 as the protease and 
capsid proteins, respectively, is the identical organisation of the these head assembly 
genes among representative bacteriophages belonging mostly to the Siphoviridae family 
(Figure 4.6). Taken together, we have proved that cleavage of the phage SN 45 kDa 
ORF409 capsid only occurs when the complete and intact protease gene orf200 is present 
and that the phage encoded proteins required for head subunit processing are the capsid 
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1 ATGAAACTGCATGAACTGAAACAGAAACGTAATACTATCGCAACTGACATGCGCGCCCTG 60 
1 MK L HE L K Q K RN T I A T D M R A L 20 
AATGAAAAAATTGGTGATAACGCATGGACGGAAGAGCAGCGCACGGAGTGGAACAAAGCA 
N E K I G D N A W T E E Q R TE W N K A - 
AAATCCGAACTGGAAGCGCTTGATGAACGAATTGCACGCGAAGAAGAACTGCGTCGTCAG 
K S EL E AL D E R IA R E E E L R R Q - 
GATCAGGCGTACATTGAAAGCAATGAGGAAGAGCAGCGTCAGAATCTTGATCCGGAAAAC 
D Q A Y I E S N E E E Q R Q N L D P E N - 
AATTCGCAACAGGATGAGAAACGAGCTCAGGTTTTTGATAAGTGGATGCGTCACGGTGCC 
N S Q Q D E K R A Q V F DE W MR H G A - 
AGTGAGCTGACATCAGAAGAGCGAAAGGCGTTGCGTGAACTTCGTGCCCAGGGTGTAGCT 
S E L T S E E R K A L R E L G V A - 
115-116 
CAGGATGAAAAGGGCGGATATACCGTACCAGAAACATTCCTGGCGAAAGTTGTTGAGAAG 
Q D E K GG Y TV PE T F L AK V V E K - 
ATGAAATCCTACGGTGGCATCGCCAGTGTGGCGCAGATTCTGACCACTTCTGACGGTCGC 
M R S Y G G I A S V AQ I L T T S D D R - 
481 ACCATGGAGTGGGCAACAGCTGATGGTACTTCCGAAGTTGGTGTTCTGCTGGGCGAAAAT 540 
161T M E N A T A DG T S E V G V L L G E N 180 
Figure 5.9. Partial sequence of bacteriophage SfV orf409 encoding the capsid protein. 
The primary cleavage site containing the argininc- alanine tandem is boxed and indicated 
by a red arrow. Also boxed are other putative cleavage sites upstream of the primary 
site. The first ten N- terminal amino acid sequence of protein band H are written in 
italics and blue coloured text. 
substrate and the protease. Finally, in considering the remarkable similarity in capsíd 
assembly and processing not only in physical and molecular properties of the genes and 
their products, we have observed that bacteriophage SW shares an evolutionary linkage 
to the bacteriophages belonging to the Siphovíridae family. 
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CHAPTER 6 
The Role of Shigella flexneri 
Bacteriophage SfV Genome in Host Virulence 
6.1. Introduction 
Majority of bacteriophage SAT genome has been characterised and further studies on the 
protein products should be performed in order to determine their function. Several 
studies on the role of bacteriophage in pathogenesis have been reported recently. The 
aim of this project was to determine if phage SfV plays a role in S. flexneri pathogenesis, 
a study based on recent reports on the role of bacteriophages in bacterial host 
pathogenesis [Waldor, 1998 #537][.Vliao, 1999 #524]. 
The initial step in the pathogenesis of shigellosis is the invasion of intestinal epithelium 
[LaBrec, 1964 #331]. Penetration of epithelial cells by Shigella involves a three main 
stage process. Initially, bacterial entry occurs by induced phagocytosis. This is 
characterised by the bacterium being engulfed by long pseudopods [Sansonetti, 1992 
#24]. Shigella evades fusion with the phagosome enabling them to escape from the 
phagocytic vacuole [Sansonetti, 1986 #339]. The release of bacteria is followed by 
intracellular organelle -like movement (olm) along stress fibers [Vasselon, 1991 #340] or 
along the actin filament ring at the perijunction area [ Vasselon, 1992 #341]. Passage of 
bacteria into adjacent cells is mediated by a bundle of actin filaments which push the 
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bacteria and form a protrusion into the other cells. This allows intercellular transfer of 
bacteria to occur without bacterial exposure to the extracellular fluid, a movement 
designated as infra- and intercellular spread [Ogawa, 1968 #342] 
Animal models have been used to study the virulence and infection process of Shigella. 
For example, the Sereny test is performed in guinea pigs and involves testing the capacity 
of Shigella to cause keratoconjunctivitis via invasion of the corneal epithelium [Sereny, 
1957 #1091. Ligated rabbit ileal loops have also been utilised. Injection of Shigella into 
the loops results in fluid secretion into the gut lumen and ulcer formation if the bacterium 
is invasive [Gots, 1974 #332][Wassef, 1989 #3331. Pathogenic mechanisms of Shigella 
were also observed in orally challenged Rhesus monkeys [Takuchi, 1968 #334]. 
However, most knowledge regarding Shigella invasiveness has been derived from 
mammalian tissue culture experiments [Gerber, 1961 #335][Oaks, 1985 #336][Sasakawa, 
1988 #337]. 
In addition to invasion, it would be useful to identify genes in bacteriophage SfV that 
could convey important properties to its Shigella host upon lysogeny. In this study, 
we investigated how the subtraction or addition of phage 51V, or the addition of segments 
of the SfV genome affect the capacity of S. flexneri to invade mammalian IIeLa cells. 
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6.2. Results 
6.2.1. Preparation of SFL124 and SFLI lysogen strains 
Bacteriophage SfV particles were serially titrated ten -fold and propagated on wild type 
host SFL1339 (SFL1 with Congo red binding ability, Pcr +) and SFL124 (attenuated 
derivative of SFL1) expressing group antigen 3,4. SFL124 lysogen designated SFL1333 
and SFL1339 lysogen designated SFL1338 were identified using various genetic and 
serological procedures. To ensure phage SfV had integrated into the host chromosome, it 
was induced by LTV irradiation and isolated. The genomic DNA was extracted and the 
characteristic DNA fingerprint band pattern typical of phage SfV was visualised 
following restriction digest with BamHI and EcoRI (Figure 3.1A). Phage sensitivity test 
was also used to confirm that the lysogen strain was protected against phage SfV 
superinfection (Table 6.1A). For the lysogen strains SFL1333 and SFL1338, growth 
was evident on an area in the bacterial lawn where 20 µl of phage SfV suspension was 
dropped. This indicated that the lysogen strains have acquired immunity from phage SfV 
infection which was not observed in SFL124 and SFL1339. 
The lysogen strains strongly reacted with monovalent antisera containing agglutinins 
specific to S. flexneri type antigen V and group antigen 3,4. This suggested serotype Y 
(SFL1339 and SFL124) conversion to serotype V (Denka Seiken Co., Ltd., Japan), and 
denoted successful integration of the phage genome into the host chromosome. The 
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Table 6.1A Analysis of SFL124, SFL1339 and their derivative lysogen strains 
Strains Phage SfV 
Sensitivity 
UV induction 
of SW 
PCR 
Amplification 
of gtrV 
Serogroup 3,4 
Agglutination 
Serotype V 
Agglutination 
Congo Red 
Binding 
SFL124 S NI NA + - + 
EW595/52 R I A + + + 
SFL1333 R I A + + + 
SFL1339 S NI NA + + 
SFL1338 R I A + + + 
Table 6.1B Analysis of putative cured derivatives of EW595/52 I 
Strains Phage SW 
Sensitivity 
PCR 
Amplification 
of gtr V 
Serogroup 3,4 
Agglutination 
Serotype V 
Agglutination 
Congo Red 
Binding 
SFL124 S NA + - + 
EW595/52 R A + + + 
SFL1336 R A + + + 
SFL1337(I12) S NA + - + 
El R A + + + 
F2 R A + + + 
F3 R A + + + 
G4 R A + + + 
G5 R A + + + 
H6 R A + + + 
147 R A + + + 
I8 R A + + + 
I9 R A + + + 
110 R A + + + 
I 1 1 R A + + + 
J13 R A + + 1 
S= sensitive; R= resistant; 1= induced; NI= not induced; A= amplified; NA =not amplified 
identity of the lysogen strains was confirmed when the 1.3 kb glucosyltransferase gene 
(gtrV) was amplified from representative colonies using the primer pair created by D. 
Bastin: DB2-5' -AGAGAATTCCT ACCATTCAACATTAAGGCT-3' and DB3 -5'- 
AGAGGATCCACAT CGCCCAAAATACATCAT. The presence of the large 
invasion plasmid associated with S. flexneri virulence was endorsed by the lysogen's 
ability to bind Congo red and grow in Congo red supplemented Trypticase Soy agar 
(Pcr ")[Sansonetti, 1982 #3491. Strain SFL1338 bound Congo red and satisfied all other 
criteria that confirmed it was an SW lysogen. The virulence characteristics of SFL1338 
was compared to its parental strain SFL1339 in the cell invasion assay in order to assess 
the contribution of the phage genome to its invasive capability (section 6.2.4). 
6.2.2. Preparation of cured wild -type EW595/52 Type V strain 
Two methods were used to cure 51 flexneri EW595/52 (Type V, SW lysogen). Initially, 
the mitomycin C method of Stanley et al., [Stanley, 1999 #248] was used. The strain 
was plated onto LB medium containing varied concentrations of mitomycin C. Thirty 
surviving colonies were screened by phage sensitivity testing but all were found to be 
resistant to phage SW. This indicates that the prophage was still present and providing 
immunity to superinfection. The second method used involved inducing the phage out 
of the bacterial host chromosome by overexpression of the excisionase gene (xis) [Leffers, 
1998 #246]. Phage SfV xis gene was obtained from strain B377 with pNV324 containing 
the 7.3 kb BamHl fragment B in pUC19 (Genbank Accession No. SFU82619)[Huan, 
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1997C #230]. The recombinant plasmid was digested with Hindlll, which cleaved at nt 
8590 upstream of the 5' end of xis, and at nt 8761 in the pUC 19 multiple cloning site 
(MCS). The MCS is adjacent to the BamHI nt 9538 site which is located at the 3' end of 
the xis gene (Figure 6.1). The I kb xis- containing Hindlll fragment was ligated into the 
pTrc 99A expression vector which has a strong IPTG -inducible trc promoter upstream of 
the MCS. The ligation mix was then transformed into rubidium chloride competent 
JM109 cells. Plasmids were obtained from several transformants and digested with both 
Hindlll and BamHI. The plasmid DNA from strain B885, designated pNV775, yielded 
the 1 kb xis insert and the 4.1 kb pTrc 99A vector, indicative of having the xis gene in the 
correct orientation with respect to the vector promoter. Plasmid pNV775 was then 
transformed into electrocompetent wild -type EW595/52 (Type V) and designated as 
SFL1336 (Figure 6.1). The Xis protein was overproduced in SFL1336 through IPTG 
induction at two timepoints of 60 minutes and 180 minutes, and 784 of the resultant 
colonies were inoculated onto duplicate plates for colony blotting hybridisation (Figure 
6.2). Each plate included a positive control strain SFI,1334 (EW595/52 with pTrc 99A) 
which was uninduced , and a negative control strain, SFL1266 (SFL124 containing 
pUC18). 
Alkali blotted DNA from test colonies was probed with radioactive 32P- labelled 
glucosyltransferase gene, gtrV. This probe was amplified from the plasmid pNV323 
which contains serotype- conversion cluster, gtrA(v), gtrB(v), and gtrV. Thirteen 
colonies that did not hybridise to the gtrV probe were screened using the phage 
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Figure 6.2. Colony blot hybridisation experiment of SFL1336 colonies after IPTG induction. The 
colonies were grown overnight on duplicate plates after 60 minutes (membranes C, D, E, F) and 
180 minutes (membranes G, H, I, J) post -IPTG induction (0.4mM). Membranes A and B contain 
colonies of control strain SFL1334 inoculated after 60 minutes and 180 minutes post -IPTG 
induction, respectively. The colonies were transblotted (coloony lifts) on nylon membranes, 
denatured, and the DNA subjected to alkali fixation, before probing with the 1.3 kb SfV 
serotype- conversion gene (gtrV) PCR amplified from pNV323 (B376). Colonies El, F2, F3, G4, 
G5, H6, H7, I8, I9, I10, Ill, 112 and J13 were not detected by the probe and were examined further. 
Each membrane was inoculated with a positive control strain ( \), EW595/52 with pTrc99A, and 
a negative control strain SFL1266 which is SFL124 with pUC18 (.), followed by the first test strain ( /). 
Figure K represents the template pattern used during colony inoculation. 
sensitivity test, colony PCR and slide agglutination test to ensure the phage StV genome 
had been excised from EW595/52 (Table 6.1B). Only colony I12 designated SFL1337 
was sensitive to Sf V, did not agglutinate with type V antisera, did not yield a gtrV PCR 
product, and was Congo red positive. Our curing frequency of 1.3x10.3 was similar to 
that of phage Lambda cI857 lysogens which was 3.8x10.3 [Leffers, 1998 #246]. Test 
results suggested that SFL1337 was cured of SW. 
Having determined the loss of type V antigenic expression in the cured strain SFL1337 
and the presence of gtrV in lysogen SFL1338, a Southern hybridisation experiment was 
performed to confirm the integration of the whole SW genome into the lysogen 
chromosome and the loss thereof in the cured strain. Chromosomal DNA of relevant 
Shigella strains was extracted, digested with BamHI and EcoRV, blotted onto membrane 
and probed with 32P- labelled phage SW genomic DNA (Figure 6.3). 
The DNA fingerprint band patterns of the phage SW genome was visualised in the phage 
BamHI and EcoRV 32P- labelled digest fragments (Figure 6.3, lanes 2 and 3) that showed 
similar BamHI band pattern observed in an earlier gel electrophoresis (Figure 3.1A). 
These BamHI and EcoRV SfV restriction band patterns were also seen in the SW lysogen 
EW595/52, its transformed clone SFL1336 containing pNV775 with the xis insert, SfV 
lysogens SFL1333 and SFL1338 (Figure 6.3 lanes 4 -7, 12 -13, and 16 -17). Conversely, 
the phage DNA restiction pattern was not evident in the cured strain SFL1337 and the 
serotype Y strains SFL124 and SFL1. (Figure 6.3, lanes 8 -9, 10 -11, and 14 -I5). Strains 
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Figure 6.3. Southern hybridisation of chromosomal DNA of prepared lysogen, cured and SFL1339 
strains probed with the 32P- labelled SfV genome. A, 0.7% agarose gel electrophoresis run at 12V 
for 17 hours and blotted to Hybond N+ nucleic acid transfer membrane. B. Autoradiograph of A. 
M, SPPI cut with EcoRI; B, Bnm.HI digests; E, EcoRV digests. 
of the same background showed similarity in the restriction bands produced. For 
example, the bands seen in SFL1336 were also observed in EW595/52 which was the 
parent strain transformed with pNV775 to produce SFL1336. Likewise SFL124 band 
pattern showed similarity to its parental strain SFL1339 (SFL1, Pcr +) and between their 
respective lysogen strains SFL1333 and SFL1338. This supported the identity between 
the parent strains and their derivative strains. The slight difference in the band patterns 
observed between the lysogen strains and phage SfV is attributed to the presence of SfV- 
integrated bacterial host DNA in the lysogen strains. The -1 kb extra band detected in the 
BamHI digests and the -5 kb band in the EcoRV digests of SFL1336 and SFL1337 are 
generated from pNV775 which contains the SAT xis gene ligated to pTrc99A vector 
(Figure 6.3, lanes 6 -9). SFL124 was the bacterial host used during the propagation of 
phage SfV, therefore, it is possible that SFL124 DNA could still be present in the SfV 
genome DNA preparation which was used for labelling. Both SFL124 and its parental 
strain SFL1339 only showed DNA fragments which cross -reacted with phage host 
SFL124 DNA present in the probe preparation, and did not show the band pattern 
typical of phage SlV (Figure 6.3, lanes 10, 11, 14, 15). Above results thus confirm the 
identity of SFL1336, SFL1337, SFL1338 and SFL1333 with respect to the presence or 
absence of the prophage. 
6.2.3. Preparation of SFLI isogenic strains transformed with plasmids containing 
genomic portions of phage SfV 
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SFL1 derivatives carrying plasmids with various phage SfV genomic fragments were 
constructed in order to investigate the role if any, of specific phage SfV genes on host 
invasiveness. Five isogenic strains of SFL1339 (SFL1 Pcr +) containing recombinant 
plasmids with various portions of the phage genome were produced (Figure 6.4). These 
include SFL1342, SFL1346, SFL1347, SFL1348 and SFL1349 (Figure 6.4). SFL1342 
is SFL1339 with only the pUC18 vector, this was used as a baseline control. SFL1346 
is SFL1339 containing pNV731 which has pUC18 with PCR amplified ( -2.8 kb) three - 
gene serotype- conversion cluster, gtrA(v), gtrBty} and gtrV. SFL1347 is SFL1339 
containing pNV724 which has pUC18 with the BamHI fragment E portion (3.1 kb). 
This was originally cloned in the B828 E.coli strain and codes for the putative origin of 
replication, DNA adenine methylase and other regulatory proteins. SEL1348 is 
SFL1339 containing pNV314 which has pUC 19 with the EcoRl fragment D portion ( -3.4 
kb). This was originally cloned in the B367 E. coli strain and codes for the excisionase 
(Xis), the amino terminal half of the integrase protein (Int) and some unknown protein 
[Huan, 1997A #118][Allison et al., submitted for publication]. SFL1349 is SFL1339 
containing pNV324 which has pUC19 with the BamHI fragment B portion ( -7.3 kb). 
This was originally cloned in the B377 E. coli strain and codes for the putative early 
regulatory and immunity proteins. These strains were tested for their capacity to invade 
confluent HeLa cell monolayer. 
6.2.4. HeLa cell invasion assay 
The strains containing SfV genes were assessed for their invasive capabilities using the 
HeLa cell invasion assay. The invasion level of the lysogen strain SFL1338 was 
evaluated against its serotype Y parent strain SFL1339. AIso tested were the cured 
strain SFL1337 versus its serotype V parent strain SFL1336 and the SFL1339 isogenic 
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Figure 6.4. Diagram showing phage SIN segments cloned in isogenic SFL1339 strains . 
The functional map of the phage genome, as derived by Allison et al., is included 
strains were compared against the baseline invasin value for SFL1342 (SFL1339 with the 
vector only). 
Six invasion assay trials were performed in duplicate to compare the level of invasion 
between SF1.1338 and SFL1339. This was performed in order to determine if there are 
factors encoded in the integrated SfV genome that could enhance the invasive potential of 
the lysogenic strain SFLI338. Results revealed a consistently higher level of invasion 
with the lysogenic Shigella, SFL1338, than for SFL1339 (wild -type SFL1, Pcr+)(Figure 
6.5A). At a 95% confidence interval, paired comparison one -sample t -test for the mean 
invading SFL1338 and SFL1339 yielded a 2.669 t value. This denotes a statistically 
detectable difference in the mean invasion between the two groups (p=.044). For the 
cured strain SFL1337 and the serotype V SFL1336, a higher statistical difference of 
6.738 t value (p =.007) was observed (Figure 6.5B). The mean level of invasion for the 
cured strain was significantly lower than the invasion level for the control strain SFL1336 
which is the wild -type V strain containing the uninduced xis gene. The data indicates 
that the presence Sty in the bacterial chromosome enhances S. flexneri invasiveness. 
This is apparent since both the lysogenic type Y strain SFL1338 and the wild -type SfV 
lysogen strain SFL 1336 showed consistently higher percent invasion values. 
In order to determine how invasiveness is effected by specific phage SW genomic regions, 
the level of invasion by strains SFL1342, SFL1346, SFL1347, SFLI348 and SFL1349 
was compared (Figure 6.6A). The Tukey multiple comparison test was used to detect 
145 
0.9 
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0 
Figure 6.5A. Invasion Comparison between 
SFL1338 and SFL1339 
2 3 4 
Trial Number 
5 6 
SFL1 339 
SFL1338 
1.2 
9 1 
R 0.8 
to 
ú 0.6 
m um 
0.4 
0.2 
o 
Figure 6.5B. Invasion Comparison between 
SFL1336 and SFL1337 
2 3 
Trial Number 
4 
SFL1336 
SFL1 337 
Figure 6.5. A, Comparison of the invasion level between the serotype V lysogen strain SFL1338 
and its serotype Y parent SFL1339. B, Comparison of the invasion level between the serotype V 
strain SFL1336 and its serotype Ycured strain SFL1337. 
ai 1.2 
R 1 } 
y m 0.8 
m 
á 0.6 
m 
m 0.4 
a a 
e 0.2 
0 
Figure 6.6A. Invasion Comparison between 
Transformed SFL1339 Isogenic strains 
2 3 
Trial Number 
4 5 
-4- SFL1342 
E -SFL1 346 
SFL1 347 
3E- SFL1348 
SFL1349 
Figure 6.6B 
co 
M 
co 
r i i 
0.35 0.44 0.47 0.75 1.39 
SED LSD (Fisher) 
LSD (Tukey) 
Different strains -log(ratio) 
Figure 6.6. A. Comparison of the invasion level among isogenic SFL1339 strains transformed with 
recombinant plasmids containing different segments of SfV genome as insert. The location of the 
segments in the SfV physical map with their functions in the functional map are indicated in Figure 
6.4. B. Tukey multiple comparison showing the ratio values of the different strains on 
a logarithmic scale. SED, standard error of difference is equal to 0.26; LSD (Tukey), is 
more conservative with the least significant difference being equal to 0.79; LSD (Fisher), is 
more liberal with the least significant difference being equal to 0.55. 
significant differences between the mean invasion values (Figure 6.6B). Ratio values 
were derived for each strain using analysis of variance that allowed for treatment as well 
as batch effects. Using the more stringent least significant difference, LSD 
(Tukey = 0.79), the strain's ratio values on a log scale were compared (Figure 6.6B). This 
analysis showed that there was no significant difference between the invasive capabilities 
of SFL1342 (ratio value =0.35) and all the other strains except for SFL1346 (ratio 
value = 1.39). Likewise, no significant difference was observed in the level of invasion 
between SFL1347 (ratio value =0.44) and all the other strains except for SFL1346, 
between SFL1349 (ratio value =0.47) and all the other strains except for SFL1346 and 
between SFL1348 (ratio value =0.75) and all the other strains. From this data, it was 
concluded that SFL1346 containing the serotype conversion genes was the only strain 
showing significantly higher invasion values than the control strain SFL1342 (which does 
not have any phage SW gene insert). This suggests that the SW serotype- conversion 
genes are involved in increasing S. flexneri's ability to invade HeLa cells. Although there 
was no significant difference between the invasion values of SFL1348 and SFL1346, it 
should be noted that SFL1348 invasiveness is not significantly different from that of the 
SFL1342 baseline value. However, had we made our comparisons based on the more 
liberal LSD (Fisher= 0.26)(Figure 6.6B), we would see a significant difference in the 
invasion value between SFL1348 and the baseline SFL1342. Therefore, due to this 
discrepancy between LSD (Tukey) and LSD (Fisher), the contribution of SFI.1348 
containing genes encoding the phage's site -specific integration proteins, in stimulating 
Shigella invasiveness should be further investigated. 
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6.2.5. Invasiveness of gtrV mutant (gtrV) 
The role of the three gene serotype -conversion cluster in invasion was investigated 
further. The results described above had shown statistically significant increase in 
invasion by SFL1346, which carries gtrAtio gtrB(v) and gtrV. In order to determine if 
the increase in invasion was mediated by serotype -conversion, mutations that would 
cause a frameshift in the gtrV gene were constructed. Initially, pNV731 NcoI site (nt 
1074) was digested, filled -in, re- ligated and transformed into JM109 host (B1039). The 
resulting recombinant plasmid, pNV909 was sequenced and the presence of the predicted 
frameshift mutation confirmed. Four bases G, T, A and C were inserted between nt 
1076 and 1077 of the gtrV gene causing a frameshift from frame a to c. The amino acid 
sequence was conserved until Pro158, afterwhich, the succeeding Trp159 was displaced 
with a cysteine residue followed methionine and aspartic acid. Plasmid pNV909 was re- 
transformed into SFL1339. However, the resulting recombinant strain SFL1367 still 
exhibited strong agglutination with anti -TypeV antisera, with the supposed gtrV mutation 
(4 base insertion at the 180th nucleotide upstream from the C terminus). This suggested 
the gtrV gene was still functional and capable of adding glucosyl groups into the 0- antigen 
to mediate serotype- conversion. It also indicated that the product encoded by the 180 
nucleotide bases downstream from the gtrV NcoI site was not required to mediate 
serotype- conversion and that the active site of the glucosyltransferase is still intact. 
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An alternative gtrV restriction site, BcII was also used to disrupt the gtrV gene. The BcII 
enzyme used was sensitive to Dam methylation, so pNV73I was initially transformed 
into the Dam host, B834, creating B1040. The non -methylated pNV73I was digested 
with BcII at gtrV nt 425, filled -in, re- ligated (the recombinant plasmid was designated as 
pNV934), and transformed into the Dam" E. coli host to yield strain B1076. pNV934 
sequence revealed four bases C,T,A,and G inserted into the BcII site of the gtrV gene 
between nt 427 and 428 (Figure 6.7). The amino acid sequence was conserved until Asp 
312, afterwhich His 313 was displaced with an arginine residue followed by serine and 
leucine found along the d frame. When digested with MI, plasmid pNV934 was not cut 
because it had lost its MI site due to the alteration of BcII palindrome sequence brought 
about by the four base insertion into the restriction site (Figure 6.7). The latter strain did 
not agglutinate with anti -TypeV antisera but only with the anti -Group 3,4 antisera. This 
suggested that the serotype conversion glucosyltransferase gene (gtrV) in SFL1394 
became non -functional due to the frameshift mutation (Figure 6.7). After confirmation of 
pNV934 genotype, it was then electroporated into SFL1339 (SFL1, Pcr +) to produce 
SFL 1394. 
SFL1394 was tested against SFL1342 and SFL1346 in the invasion assay. Using the 
Tukey multiple comparison test, the percent mean invading SFL1342, 1346 and 1394 
cells were compared using the LSD value on a log scale equivalent to 0.99. There was no 
statistically significant difference between the ratio values of invading SFL1346 (ratio 
value =0.66) and SFL1394 (ratio value = 0.31). And the mean percentage invasion of 
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Figure 6.7. Diagram showing insertion of four nucleotide bases (blue letters) after 
pNV731 restriction with MI (site indicated by red dashed lines). Frameshift mutation 
resulted in changes in the translated amino acid residues (encircled). Shown are six 
amino acids: Threonine310, Asparagine311, Aspartic Acid312, Histidine313, 
Tryptophan314, and Tyrosine315, out of a total 417 amino acid residues of the GtrV 
protein. 
SFL1394 was consistently lower than SFL1346 but consistently higher and significantly 
different from the baseline SFL1342 invasion ratio value (ratio value =0.07) (Figure 6.8A 
and B). The observed difference between SFL1346 and SFL1342 confirmed the 
reproducibility of previous experiments implicating the role of the serotype- conversion 
genes in the increased invasion capability of S. flexneri host. SFL1394 did not revert to 
the SFL1342 baseline value despite the introduced gtrV mutation. This led us to 
speculate that gtrA and gtrB together or individually may contribute to host invasive 
potential. The data also suggests that gtrV may play a partial role in conferring invasive 
traits. Therefore, further invasion experiments should be conducted which would 
include SFL1394 (gtrA +, gtrB +, and girt) being tested against strains containing 
mutated gtrA and/or gtrB genes. 
6.3. Discussion 
The ability of S. flexneri to invade and proliferate in colonic epithelial cells is essential for 
the pathogen to induce bacillary dysentery [L aBrec, 1964 #3311. The primary factors 
involved in the invasive process are expressed by complex genes on the large 230 -kb 
virulence plasmid [Watanabe, 1985 #497][Sasakawa, 1992 #52] as demonstrated by 
tissue culture studies [Hong, 1998 #141][Perdomo, 1994a #41]. It has been shown that 
virulence genes such as bacterial toxins and adhesion molecules can be encoded by 
bacteriophages [Sjogren, 1994 #5001[Cheetham, 1995 #30]. Thus the aim of this study 
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Figure 6.8. A, Comparison of the invasion level among SFL1342 (SFL1339 containing the pUC18 
vector), SFL1346 (SFL1339 containing the serotype -conversion genes in pUC18), and SFL1394 
(SFL1339 containing pNV731 with a mutated gtrV gene). B, Tukey multiple comparison showing 
the ratio values of the different strains on a logarithmic scale. SED, standard error of difference 
is equal to 0.36; LSD (Tukey), is more conservative with the least significant difference 
being equal to 0.99; LSD (Fisher), is more liberal with the least significant difference being 
equal to 0.80. 
was to investigate whether serotype converting bacteriophage SAT was able to influence 
the ability of Shigella to penetrate mammalian HeLa cells. 
To assess the effect of the phage SAT genome, we initially tested lysogen SFL1338 
against its wild -type progenitor strain SFL1339 (SFL1 Pcr +), and the wild -type V 
SFL1336 carrying the uninduced xis gene against the cured derivative SFL1337 via an 
invasion assay. During the selection of the strains, the Congo red binding phenotype 
(Pcr +) was maintained. This was necessary since lack of ability to bind Congo red is 
correlated with loss of virulence [Sereny, 1957 #109][Murayama, 1986 #498] and occurs 
when the large virulence plasmid is mutated or lost [Maurelli, 1984B #499]. In our 
curing experiments, excess Xis production successfully induced the SfV prophage from 
the host chromosome [Kaneko, 1997 #280][Stanley, 1999 #248]. Similarly, Xis 
expression from pRK5 resulted in a dramatic increase in the curing rate for both wild -type 
and Ton lysogens, indicating that Xis was the limiting factor rather than Int for curing 
[Leffers, 1998 #246]. Weisberg and Gottesman [Weisberg, 1971 #501] first observed 
that excessive quantities of Xis in vivo inhibit phage integration and instead promote 
phage excision, and that protease degradation of Xis leads to rapid phage lambda 
lysogenisation. In phage SfV, ORF 8 encodes for Xis, and overlaps with the integrase 
gene. Similarity in the overlap and the organisation and sequence of attP, int and xis 
between phage SfV and P22 were also observed [Huan, 1997A #118][Vander Byl, 2000 
#351][Allison, 2000 #199]. 
150 
Part of the screening process used to ensure phage integration and deletion was phage 
sensitivity. This was observed in earlier experiments in which S. flexneri serotype Y 
(3,4), became resistant to superinfection with homologous phages after phage Sf6 
infection of S. flexneri [Lindberg, 1978 #120][Clark, 1991 #119]. In our experiments, the 
lysogen strains SFL1333 and SFL1338 had successfully acquired phage SW which 
conferred resistance to further SW infection. The lysogens grew and did not lyse when 
reacted with phage SW. Conversely, the cured strain SFL1337 had lost phage SW 
which made it susceptible to phage SfV infection as demonstrated by a clear zone where 
the phage suspension was placed. This supports the role of 0-antigen modification in 
eliciting immunity against infecting phage. 
The consistently higher invasive capacity of wild type V strain and lysogenic S. flexneri 
strain suggested one or several factors encoded by the phage genome may be involved in 
invasiveness. This led us to create various SFL 1339 isogenic strains which were 
basically identical except that they carried various portions of the phage SW genome 
introduced through recombinant plasmids. These strains with an identical genotypic 
composition except for the introduced plasmid insert were ideal for determining the 
specific genomic part which contributes to the invasive potential of the bacteria. Of the 
constructs prepared, each carried specific 51V gene fragment inserts encoding for different 
proteins (serotype conversion, attachment, excision, integration, replication, 
methylation, immunity and regulation) [Huan, 1997B #117](Allison et al., submitted for 
publication). The strain SFL1346, had the highest level of invasion, it was significantly 
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different and higher than the other mutant constructs, most specifically to the baseline 
value of SFL 1342. This indicated that the addition of a glucosyl residue to the rhamnose 
II of the 0- antigen sugar units via an a1,3 linkage as occurred in SFL1346 confers a 
conformational change in the LPS structure which made it more reactive or accessible to 
the epithelial cell membrane. 
The alteration of the LPS through 0- antigen modification has been consistent with the 
knowledge that LPS has important roles in bacterial entry, intercellular spread in the 
intestinal epithelium as well as resistance to host defences [Hong, 1998 #141][Okada, 
1991A #221[Rajakumar, 1994 #128]. Studies involving rough mutants of S. flexneri 
lacking 0- antigen and those having mutated 0- antigen chain length and composition were 
observed to be capable of cell invasion but incapable of intra- and intercellular spread 
[Okamura, 1983 #447][Hong, 1997 #545][Okada, 1991A #22][Sandlin, 1996 #544]. 
However, the specific role of 0- antigen conversion on virulence in S. flexneri has not 
been investigated. This made our experiments important and unique in that SfV is the 
first S. flexneri bacteriophage characterised to have played a role in the invasion potential 
of its host. 
The gtrV gene is the main gene involved in the addition of the glucosyl moiety into the 0- 
antigen. Therefore, a frameshift mutation was introduced in this gene in an attempt to 
hamper the attachment the glucosyl residue to the repeating sugar units of the LPS and 
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thus prevent the modification of the 0- antigen. However, only partial reduction in the 
invasion level of SFL 1394 was observed. 
It is also possible that gtrA and gtrB may have a role in enhancing the invasive properties 
of S. flexneri. Therefore, further experiments should be conducted to prove this. These 
will involve recombinant clones containing plasmids with varied combinations of mutated 
serotype- conversion genes insert. These strains should then be tested for invasiveness in 
order to refute or add support to our findings and provide information as to the precise 
contribution of each of the three serotype -conversion genes in conferring invasive traits. 
Also, further work can be performed to determine if other 0- antigen glucosylating 
systems of other S. flexneri bacteriophages such as SfX, SfII, and Sfl, would also exhibit 
similar effect on host invasiveness. 
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CHAPTER 7 
General Discussion 
The primary objective of this study is to characterise additional portions of the 
bacteriophage SfV genome. Specifically, we have sequenced a 10.1 kb BamHI fragment 
A segment which contains the late gene region. Eight open reading frames were found to 
have homology to proteins which are essential for the structural integrity and 
morphogenesis of the phage. Some of these include the terminase, portal protein, tail 
assembly proteins, the capsid and the protease whose functions were subsequently 
confirmed through experiments. 
7.1. The serotype conversion and early region of phage SfV genome 
The serotype- conversion genes of several S. flexneri bacteriophages including SETT, SfV, 
SfX and Sf6 have been sequenced and characterised in the previous decade [Huan, 1997B 
#117][Mavris, 1997 #16][Adhikari, 1999 #112][Guan, 1999 #151][Verma, 1993 #116]. 
An additional 15 kb portion of the phage SfV early region has recently been characterised 
in our laboratory (AIIison et a1, submitted for publication). This region contains genes 
which are concerned with regulation, DNA modification, recombination, replication and 
immunity. Important genes identified were orf129, orf224, orf66, orf217 and orf77. 
The orfl 29 gene encodes for a putative recombination factor and is also involved in DNA 
repair. The gene product has homology to the RusA endonuclease encoded by E. coli 
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DLP12 prophage and phage 82 (Allison et al., submitted for publication) [Mandi, 1996 
#502][Sharples, 1999 #503]. Other genes Orf224 and orf66 were shown to have 
homology to lambda phage el- and cro repressor genes, respectively (Allison et al., 
submitted for publication). The CI repressor protein promotes lysogeny by attaching to 
operator sequences adjacent to the cf gene. This binding prevents transcription of lytic 
genes and stimulating transcription of cL while the Cro protein prevents the transcription 
of cL Conversely, the Cro protein prevents transcription of cl by attaching to the 
operator sequences upstream of the gene [Campbell, 1994 #164]. Functional studies 
confirmed that the protein product of orf217 induces DNA adenine methylase (Dam) 
activity (Allison et al., submitted for publication). Based on functional and sequence 
analysis, Allison et al., also reported on three superinfection immunity mechanisms 
adapted by phage SfV. These include the 0-antigen modification, repressor -mediated 
lambdoid immunity system and immunity involving transcription termination (Allison et 
al., submitted for publication). Since serotype- conversion genes and most early genes 
have been identified and characterised, we have characterised further the genes 
downstream and to the right of the serotype -conversion locus, specifically the 10.1 kb 
portion of BamHI fragment A adjacent to the pac site. 
7.2. Fragment A encodes for phage SW structural proteins necessary for viral 
packaging of DNA and morphogenesis. 
The 10.1 kb BamHI fragment A portion of the genome contains late region genes involved 
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in DNA packaging and viral morphogenesis. Our experiments demonstrated that 
ORF200 is a phage SW protease while ORF409 is a phage SW capsid protein (Chapters 
4 and 5). It also indicated that ORF409 is a processed primary translation product 
suggesting the occurrence of capsid cleavage similar to the head assembly process of other 
bacteriophages such as coliphage HK97 [Duda, 1995A #275]. Database homology 
searches of fragment A found bacteriophages HK97, C31, D3, OPVL and 0105 showed 
similar head morphogenesis gene function and organisation. These observations suggest 
that the portal, protease and capsid proteins encoded in these bacteriophages may exhibit 
similar head assembly mechanisms. 
Observations and experimental results indícate there are similarities between the head 
assembly process of phage SAT and HK97. Thus, it is possible that phage SAT may also 
utilise other steps employed by HK97 in its head assembly process. The HK97 head 
assembly pathway illustrates the serial transitions which occur in the capsid subunits of 
phages that do not utilise a scaffold protein [Hendrix, 1994 #2631. Initially the 42 kDa 
pentameric and hexameric capsid subunits assemble into the first form of the shell in the 
absence of a scaffold protein. These subunits are then cleaved by the viral protease from 
its amino terminus to attain their mature conformation. Following cleavage, the head 
shell expands, resulting in a major conformational change [Duda, 1995A #275]. This 
triggers an ultimate shell strengthening transition where all shell subunits become 
covalently crosslinked in an autocatalytic reaction. Although it is tempting to consider a 
paralIeI mechanism being employed for phage SW head assembly, further experiments 
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should be conducted before conclusions can be drawn as to the similarity in head 
processes between the two phages. 
The tail assembly components contained in fragment A are similar to other viral 
counterparts. SW orf56 and orf498 are homologous to phage Mu tail tube and sheath 
protein, respectively [Takeda, 1998 #321]. Downstream of orf498 are orf89 and orf116 
which both have homology to the phage P2 essential tail protein E gene and T gene, 
respectively. This grouping of SW tail protein genes is another example of gene module 
clustering which was also observed in the head assembly gene region. In the assembly 
process of the T4 tail, the presence of a complete T4 tail baseplate triggers a 
conformational change in gp19. The gp19 polymerises into a tail tube on the baseplate 
and is surrounded by co- polymerising sheath monomers [Arisaka, 1988 #5251[F.íserling, 
1983 #509]. When infection occurs the sheath contracts and the tube penetrates the 
outer membrane of the host E. coli. The T4 genome is then transferred through the tube 
into the periplasmic space of the bacterial cell. This suggests that other phage SW tail 
region genes may encode for tailspike proteins that possess endorhamnosidase activity. 
These proteins would be capable of digesting the 0- antigen to allow passage of the phage 
through the LPS barrier and onto the surface of the outer membrane where tight binding 
occurs [Steinbacher, 1997 #5101. Recently, functional studies involving assay of 
cytoplasmic extracts containing the S. flexneri bacteriophage Sf6 orf -encoded tailspike 
protein demonstrated the ability of the tailspike to hydrolyse the 0- antigen [Chua, 1999 
#547]. Tailspike proteins possess one of the most vital functional roles in viral 
157 
propagation in the host, since they are involved in the initial steps of attachment and 
penetration [Steinbacher, 1997 #5101. Therefore, the tail component genes of SW 
should be further characterised. 
7.3. The role of phage SfV ORF577 putative terminase in DNA packaging 
There are components in DNA packaging which are common among different phage. 
These are a mature head shell which acts as the DNA container and two subunits of 
packaging proteins, the terminases [Fujisawa, 1994 #5111. The smaller subunit is the 
DNA binding protein while the larger subunit contains metal and ATP binding motifs and 
is able to cut the DNA concatemer [Guo, 1987 #512]. DNA concatemers are mature 
replicated phage DNA that are joined together in a head to tail fashion through terminal 
repetitions, and these are the substrates for terminase protein action. When the prohead 
shell is full of DNA, terminase cutting of concatemeric DNA molecule occurs. For 
phages using the headful packaging mechanism, this cleavage takes place via recognition 
of specific sequences at the pac site [Black, 1995 #325]. 
The experiments conducted to elucidate the role of phage SW ORF577 putative large 
terminase subunit involved cloning orf577 into the IPTG -inducible overexpression vector 
pT7 -5. Upon induction, DNA samples from the clones were observed on agarose gel for 
DNA smearing as an indicator of terminase cleavage activity. This procedure was 
previously used by Bhattacharyya and Rao (1993) who showed that the overexpression 
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of the 18 kDa gp16 (small subunit) with the 69 kDa gp17 (large subunit) results in 
cleavage of the resident plasmid DNA plus also the host E. coli genomic DNA 
[Bhattacharyya, 1993 #5141. Compared to the uninduced clones, our preliminary trials 
showed reduction in viable cell growth over time after induction, suggesting a Iethal effect 
of overproduced terminase by excessive cutting of the DNA. However, no smearing of 
cleaved DNA was observed. This implied that there may be additional factors that need 
to be cloned and expressed along with the putative large terminase ORF577. One factor 
could be encoded by orf164, which is located immediately upstream of ORF577 and has 
a similar size to other phage small terminase subunits. Studies have observed that the 
small subunit enhances DNA packaging and has ATPase activities associated with phage 
T4 gp17 [ Bhattacharyya, 1993 #514][Bhattacharyya, 1994 #515]. However, the action 
of the small terminase subunit in phage T4 is thought to be redundant since the large 
subunit (gp17) alone can catalyse the cleavage of both plasmid and host DNA when 
expressed in E. coli. Also, gp17 is highly active during in vitro DNA packaging where it 
exhibits ATPase activity [ Bhattacharyya, 1994 #515][Leffers, 1996 #516]. Therefore, 
the possible role of the of phage SW orfl 64 putative small terminase subunit should be 
investigated further. 
Another protein which could be incorporated with the terminase insert is the putative 
portal protein ORF367. The portal protein is a dodecameric ring structure at the base of 
the prohead and contains a central channel of diameter 3 -4 nm where the DNA is held 
prior to prohead entry and exit [Valpuesta, 1994 #517]. Orß67 could have been 
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expressed with the putative terminase gene in order to mediate DNA cleavage since it 
could have bound the DNA securely before the terminase could execute more precise 
cutting. Recent findings on phage T3 reported that the portal -bound terminase is 
essential for DNA translocation, as well as for processing the DNA concatemer [Black, 
1995 #325] [Morita, 1995 #5181. In another study, functional domains of bacteriophage 
T4 large terminase (gp17) and portal protein (gp20) were determined by mutant analysis 
and sequence localisation [Lin, 1999 #5191. It was discovered that DNA packaging 
occurs due to an ATP -driven translocation of concatemeric DNA into the prohead, a 
process driven by the phage terminase which is complexed with the portal vertex 
dodecamer of the prohead [Black, 1995 #325]. These findings support the theory that 
the portal protein and large terminase are vital components of the packasome complex 
and that they are involved in the processing and packaging of DNA into the prohead. 
Recombinant plasmids could he created which would include SfV orß67 along with 
orf577 as gene inserts for the overexpression experiment. Constructs of this genotype 
may elicit DNA cleavage which would be visualised as smearing, not observed on earlier 
trials. Cloning of the terminase and portal protein was attempted but not completed due 
to time constraints. Therefore, the role of the putative portal gene should be 
investigated in future functional analysis of the phage SfV terminase protein. 
7.4. Serotype -conversion genes are phage SfV- encoded virulence factors. 
There are several reasons for characterising the genomic composition of phage SPI. This 
160 
includes the discovery of genes which encode for structural proteins, such as those 
encoded in the fragment A, and genes encoding for essential functions such as regulation, 
immunity, replication, methylation, and morphogenesis. In addition, phage SfV- 
encoded virulence factors may be identified. Several studies on bacteriophage- encoded 
virulence genes have been carried out recently [Miao, 1999 #524][Waldor, 1998 
#537][Cheetham, 1995 #30]. For example, Vibrio cholerae bacteriophage VPI4 encodes 
for a pilus that functions as a colonisation factor in the human intestine in addition to 
being the receptor for the cholera toxin -encoding OCTX bacteriophage [Karaolis, 1999 
#165]. Another example is the Salmonella bacteriophage encoded SopE 1 [Hueck, 1998 
#139][Hardt, 1998 #5211. The sopE gene product, is an effector of the Salmonella type 
III secretion systems (TTSS) that has been described as a sort of bacterial syringe for 
simultaneous injection of multiple effector proteins which induce host cell physiological 
modifications [Hueck, 1998 #139]. SopE is involved in the induction of in vitro 
epithelial cell invasion by induction of membrane ruffling as well as stimulation of 
gastrointestinal inflammation [Hardt, 1998 #5211. Virulence factors such as toxins may 
be encoded by phage SfVand could provide the bacterium with mechanisms to breach host 
structural barriers. Examples of where this occurs are diphtheria toxins, cholera toxins 
and E. coli serotype 0157:H7 toxin that causes hemolytic -uremic syndrome in children 
[ Groman, 1984 #522][Waldor, 1996 #241][O'Brien, 1984 #242]. Several studies have 
demonstrated the role of LPS as a virulence factor regulating the ability of S. flexneri to 
spread intercellularly and to evade host immune defences [Hong, 1997 #545][Okada, 
1991A #22][Rajakumar, 1994 #128], however, the effect of LPS 0-antigen modification 
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in S. flexneri virulence has not been investigated, and this has made our experiments very 
important and unique. 
As exemplified above, virulent bacterial strains can evolve by acquiring virulence factors 
from bacteriophages. Hence, we have tested the contribution of phage SfV genome in 
enhancing S. flexneri's capacity to invade mammalian cells as a measure of virulence. Our 
results showed that S. flexneri strains with integrated phage SW had significantly 
increased invasion capability compared to their isogenic non -lysogens. The serotype- 
conversion genes were identified as the portion of the SW genome which enhanced 
Shigella invasiveness. Invasive Shigella strains transformed with the serotype- 
conversion genes showed a statistically significant increase in invasive potential. This 
indicate that the serotype -conversion may permit S. flexneri to evade the host defence 
system by varying the bacteria's surface LPS molecular and structural conformation. 
This change in LPS structure may have permitted increased elaboration of S. flexneri type 
III secretion system facilitating bacterial host capacity to invade. It is possible that the 
modified LPS may have become more reactive to the target epithelial cell receptor, 
resulting in increased cell surface binding and subsequent facilitated intrusion. The new 
LPS conformation may have also effected the mobilising components of the host 
phagocytic mechanism such as the actin filaments that form under the phagocytic 
vacuolar membrane during invasion. We then went on to construct a gtrV` mutant in 
order to determine its influence on invasion level. Disruption of the gtrV gene resulted in 
a partial reduction in the level of invasion, suggesting that the other serotype- conversion 
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genes may also be involved in enhancing invasiveness. Therefore, further studies on the 
effects of gtrA(v) and gtrB(v) should be conducted. 
7.4. Conclusion and Future Direction 
This study has reported on the molecular characterisation of the 10.1 kb portion of phage 
SW BamHI fragment A. The protein sequence homology data established the genetic 
linkage between phage SW and other double stranded bacteriophage which infect bacteria 
of a broad phylogenetic range. We have located orfs which encode for DNA packaging 
and structural morphogenetic factors within fragment A. These include genes which we 
have confirmed as being involved in capsid cleavage during phage head assembly. Given 
the complexity of the process and the broad similarities within bacteriophage groups, it is 
important to conduct further experiments in order to understand subsequent steps in the 
phage assembly process after the capsid cleavage. Other SN orf functions should also 
be investigated. For example, the N- terminal sequence of the -55 kDa protein detected 
by the anti -SW antisera could be determined and aligned with the predicted amino acid 
sequences of the StY orfs. Morphological studies of tail components could also be 
performed by doing purification and visualisation through transmission electron 
microscopy. Lysogenic strain mutants containing aberrant SW tail genes can also be 
created, induced out and their morphology observed. The putative terminase subunits 
and portal protein genes comprising the putative SN DNA packaging module could also 
be investigated using mutation studies to establish protein identity and function. 
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Plasmids carrying inserts of various combinations of the DNA packaging genes could be 
constructed and compared in their ability to cut DNAs which can be visualised as a smear 
along the agarose gel lane. 
Further studies on the role of SW genome in S. flexneri virulence could be investigated. 
Aside from HeLa cell invasion assay, experiments involving mutagenesis, other virulence 
tests involving animal models such as guinea pig eyes or mouse ileal loops and other 
functional assays such as the plaque assay and serum sensitivity assay can be performed 
in order to establish and support the true role of Sf i genes not only in their contribution 
to bacterial invasiveness but also in other virulence properties like their ability to manifest 
intra- and intercellular spreading and survival within phagocytic cells. Our results 
implicating the influence of the serotype- conversion genes in bacterial invasion is 
preliminary and other experimental set -ups can be considered. For instance, the invasion 
level of SFL1339 SfV lysogen and SFL1346 containing the 0-antigen glucosylatìon genes 
can be compared to assess if there are factors other than the serotype- conversion region 
that are active in enhancing invasiveness. The role of gtrA(v) and gtrB,n should be 
examined by mutational studies since only partial reduction in S. flexneri invasion level 
was observed when the gtrV gene was mutated. This implicated gtrAm and gtrBao as 
factors working in adjunct with the gtrV gene in eliciting increased level of S. flexneri 
invasion. 
Most of SfV genes have now been determined and characterised. However, completion 
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of phage SfV genome analysis should be accomplished in order to discover not only 
essential regulatory and structural genes but other sequences which could be utilised in the 
development of large -capacity vectors and site -specific integration vectors necessary in 
the application of genetic engineering techniques. Finally, decoding the complete genetic 
blueprint will ultimately lead to a comprehensive understanding of the physiology and 
molecular biology of bacteriophage SfV. 
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APPENDIX 
Bacterial Growth Media 
LB Broth 
Tryptone 10 g 
Yeast Extract 5 g 
NaCI 5 g 
Make up to 1 L in water and sterilize by autoclaving. 
LB Agar 
As for LB broth, adding 15 g/L agar before autoclaving. 
Ampicillin 
Add filter -sterilised ampicillin (10 mg /mL) to cooled broth or agar ( <55 °C) to a final 
concentration of 100 tg /mL. 
IPTG /X -Gal Plates 
Add 204 each of X -Gal and IPTG solutions (20 mg /mL) and spread on plate. 
Bacteriophage Techniques 
NZCYM Medium 
NZ Amine 10 g 
NaCI 1.7 g 
Cassamino acids 1 g 
MgSO4.7H2O 0.7 g 
Yeast extract 1.7 g 
Dissolve in 1 L of water and sterilize by autoclaving. 
SM Buffer 
1 M Tris.HCI (pH 7.5) 5 mL 
NaC1 0.4 g 
MgSO4.7H2O 0.2 g 
2% gelatine solution 0.5 mL 
Make up to 100 mL with water and sterilise by autoclaving. 
Plasmid Miniprep 
Solution I 
50 mM glucose 
25 mM Tris.HC1 pH 8.0 
10 mM EDTA pH 8.0 
Sterilised by autoclaving. Stored at 4 °C. 
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Solution II 
0.2M NaOH 
1% SDS 
Freshly prepared from sterile stock solutions (10% SDS, 3 M NaOH) before use. 
Solution III 
5 M CH3COOK 60 mL 
Glacial ethanoic acid 11.5 mL 
Water 28.5 mL 
Prepared from sterile stock solutions and stored at 4 °C. 
Chromosomal DNA Preparation 
TES Buffer 
1 M Tris.HCI pH 8.0 5 mL 
5 M NaCI 1 mL 
0.5 M EDTA pH 8.0 1 mL 
Make up to 100 mL with water and sterilise by autoclaving. 
Lysis Solution 
1 M Tris.HCI pH 8.0 
0.5 M EDTA pH 8.0 
10% SDS 
MQ 1-120 
5 mL 
12.5 mL 
50 mL 
32.5 mL 
TE Buffer 
1 M Tris.HC1 pH 8.0 200 µL 
0.5 M EDTA pH 8.0 1 mL 
Make up to 100 mL with MilliQ water and autoclave. 
Agarose Gel Electrophoresis 
0.6% TBE /Agarose Gel 
0.6 g DNA grade agarose (Progen) 
100 mL 0.5X TBE buffer 
5X TBE Buffer 
Tris Base 
Boric acid 
0.5 M EDTA pH 8.0 
Make up to 1 L with water. 
54 g 
27.5 g 
20 mL 
Agarose Gel Loading Buffer 
Glycerol 1.2 mL 
10µg /mL Bromophenol blue 2.8 mL 
MilliQ water 1 mL 
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Southern Hybridisation 
20XSSC 
3 M NaC1 
0.3 M tri- sodium citrate 
20X SSPE 
0.6 M NaCI 
0.2 M Sodium Phosphate 
0.02 M EDTA 
Dissolve in distilled water, adjust to pH 7.4 and autoclave. 
100X Denhardt's Solution 
2% w/v BSA 
2% w/v FicollTM 
2% polyvinyl pyrrolidone 
Colony Hybridisation 
Denaturing solution 
1.5 M NaCI 
0.5 M NaOH 
Neutralising Solution 
1.5 M NaC1 
0.5 M Tris.HCI pH 7.2 
1 mM EDTA 
Immunogold Labelling 
Phosphate Buffered Saline (PBS) 
NaC1 8 g 
KH2PO4 0.24 g 
Na2HPO4 1.44 g 
KC1 0.2 g 
Make up to 1 L with water and sterilise by autoclaving. 
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